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Abstract
The synthesis of pure tris(6-hydroxymethyl-2-pyridylmethyl)amine (H3L11) is reported
for the first time. New complexes of H3L11 with copper(II), manganese(II) and iron(III) have
been characterised by X-ray crystallography. Linear [Fe3(L11)2](ClO4)3 reveals the tightest Fe-
O-Fe angle (87.6o) and shortest Fe…Fe distance (2.834 Å) presently found for a weakly
antiferromagnetically-coupled high spin alkoxide-bridged polyiron(III) system.
H3L11 provides a route to various hydrophobic peralkylated TPA ligand derivatives for
creating a hydrophobic pocket for the assembly of iron catalysts for the novel 1-hydroxylation
of n-alkanes. New 6-py substituted TPA ligands containing methyl (L15) and n-octyl (L16)
ether linkages were synthesised via alkylation. Two further novel 6-py substituted ligands
were synthesized incorporating n-hexyl substituents on one (L21) and two (L22) of the py
moieties. Here a urea spacer group was used to promote hydrogen–bond assisted heterolytic
O-O cleavage (generation of the potent FeV=O oxidant) within the hydroxoperoxoiron(III)
precursor. High spin [FeII(L)(CH3CN)x](CF3SO3)2 complexes (x = 0–2, L = L15,16,21,22) were
characterised in solution by 1H NMR. The structure of [Fe(L22)](CF3SO3)2 reveals a distorted
iron(II) centre bound to four N atoms and two urea carbonyls.
Iron(II) complexes of H3L11, L15,16,21,22 and tris(6-Br)-TPA (L24), were investigated for
catalysis of the oxygenation of cyclohexane by H2O2. Reaction of the iron(II) complexes with
H2O2 and tBuOOH was followed by time-resolved EPR and UV-VIS spectrophotometry. A
correlation between the observed catalytic activity and the nature of the FeIII(L)-OOR
intermediates generated is apparent.
A convenient ‘one-pot’ synthesis of benzene-1,3,5-triamido-tris(l-histidine methyl
ester) is reported along with attempts at preparing N,N’-bis(pyridylmethyl)-1,3-
diaminopropane-2-carboxylic acid (L25), a new water soluble pyridine-amine ligand. The final
demetallation step resulted in ligand hydrolysis to the novel amino acid; 1,3-diaminopropane-
2-carboxylic acid which was characterised as its HCl salt by X-ray crystallography.
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Abbreviations
General Experimental Conditions
Abbreviations
Å Angstrom unit, 10-10 m
A/K alcohol/ ketone ratio
BIPBMP [bis(imino)pyridine] N-(2-methoxyethyl)-N,N-bis(pyridin-2-yl-methyl)amine)
BISP bis(amine)tetrakis(pyridine)
BPPA bis(6-pivaloylamido-2-pyridylmethyl)-2’-pyridylmethylamine
BLM Bleomycin
Bn-tpen N-benzyl-N’N’’N’’’-tris(2-pyridylmethyl)ethane-1,2-diamine
Bpmen N'-dimethyl-N,N'-bis(2-pyridylmethyl)ethane-1,2-diamine
Bpy bipyridine
tBu t-butyl,-C(CH2)3
cm-1 wavenumber
DBE dissociation bond energy
DNA dexoxynucleotic acid
dimest trans-6,13-bis(methoxycarbonyl)-1,4,8,11-tetraazacyclotetradecane
DMF N,N´-dimethylformamide, Me2NCHO
dapsox H2dapsox = 2,6-diacetylpyridine-bis(semioxamazide)
EI MS electron impact mass spectrometry
en ethane-1,2-diamine
ES MS electrospray mass spectrometry
FBC fluorous biphasic catalysis
FT Fourier Transform (NMR spectrospcopy)
CG gas chromatography
HBPClNOL (N-(2-hydroxybenzyl)-N-(2-pyridylmethyl)[(3-chloro)
H4CDTA trans-1,2-cyclohexanediamminetetraacetic acid
H3L11 tris(6-hydroxymethyl-2-pyridylmethyl)amine
Hpic pyridine-2-carboxylic acid (picolinic acid)
Hz Hertz
J coupling constant, Hz
k rate constant
KIE kinetic isotopic effect
L11 tris(6-hydroxymethyl-2-pyridylmethyl)amine
L15 tris(6-octanoxymethyl-2-pyridylmethyl)amine
L16 tris(6-methoxymethyl-2-pyridylmethyl)amine
L21 [6-(hexylureyl)-2-pyridylmethyl)-bis-(2-pyridylmethyl)]amine
L22 [Bis-(6-(hexylureyl)-2-pyridylmethyl)-2-pyridylmethyl]amine,
L23 tris-(6-(hexylureyl)-2-pyridylmethyl)amine
L24 tris(6-bromo-2-pyridylmethyl)amine
L25 benzene-1,3,5-tricarboxamide of L-histidine methyl ester
mCPBA m-chloroperbenzoic acid
Me methyl,-CH3
3-Me3TPA tris(3-methyl-2-pyridylmethyl)amine
5-Me2TPA [bis(5-mehyl-2-pyridylmethyl)(2-pyridylmethyl)]amine
5-Me3TPA tris(5-methyl-2-pyridylmethyl)amine
6-Me2TPA [bis(6-mehyl-2-pyridylmethyl)(2-pyridylmethyl)]amine
6-Me3TPA tris(6-methyl-2-pyridylmethyl)amine
MMO monooxygenases
MPPH 2-methyl-1-methyl-1-phenyl-2-propylhydroperoxide
MPZPBY 6-(N-3,5-dimethylpyrazolyl)-2,2'-bipyridine
N4Py N,N-bis(2-pyridylmethyl)-N-[bis(2-pyridyl)methyl]amine
NBS N-bromo succinamide
m/z mass-to-charge ratio
OAc acetate -O2CCH3
Oct Octyl, -(CH2)7CH3
OPPh3 triphenylphosphine oxide
PCP pentachlorophenol
PEO poly(ethylene oxide)
PPO poly(propylene oxide)
Ph phenyl,-C6H5
PHIO Iodosobenzene
ppm parts per million
POMs polyoxometalate
Por porphyrin
py pyridine
pyO pyridine N-Oxide
salen H2salen = N,N’–bis(salicylidene) ethanediamine
TAML tetraamido macrocyclic ligands
TBUA tris(t-butylureylethyl)amine
TEPA tris[2-(2-pyridyl)ethyl]amine
THF tetrahydrofuran, C4H8O
TMC 1,4,8,11-tetramethyl-1,4,8,11-tetraazacyclotetradecane
TNPA tris(6-neopentylamino-2-pyridylmethyl)amine
tren tris(aminoethyl)amine
TPA tris(2-pyridylmethyl)amine
TPOEN N-(2-pyridylmethoxyethyl)-N,N-bis(2-pyridylmethyl)amine
TON turnover number
χM magnetic susceptibility
NMR: s = singlet, d = doublet, t = triplet, q =quartet, m = multiplet, br = broad.
General Experimetal conditions
Materials
All commercially available solvents and reagents were purchased from Aldrich or Across and
used as received unless stated otherwise, in which case standard schlenk line techniques were
employed under argon or dinitrogen atmosphere using glassware which had been pre-dried in
an oven at 100 ºC overnight. Pyridine was dried and distilled from CaH2, THF and diethyl
ether were dried and distilled from sodium-benzophenone ketyl. Hexane was dried and
distilled from sodium. Dichloromethane and acetonitrile were dried and distilled from calcium
hydride respectively
Physical Measurements
1H (400.0 and 300.0 MHz) 13C {1H}( 75.4 MHz ) 19F NMR ( 282.0 MHz) NMR spectra were
recorded on 400 Advance and 300 Advance Bruker NMR spectrometers. Chemical shifts are
refered to internal tetramethylsilane (δ 0)using the high frecuency positive convention.GC
analysis was carried out on Agilent 6890A chromatograph with HP-5 column (30 m x 0.25
mm, film thickness 0.25 µm) Toluene was used as a standard for quantitative analysis. UV-vis
spectra were recorded at 25 ºC in acetonitrile solution on a Perkin-Elmer Lambda 2
spectrometer. EPR experiments were recorded on Bruker EMX 10/12 spectrometer operating
at 9.5 GHz with 100 kHz modulation. The sample was transferred to a quartz EPR tube,
(12cm length x 0.4cm i.d.) which was then immersed in a Dewar of liquid nitrogen, and
transferred to a cooled sample holder within the EPR spectrometer whose cavity was
maintained at 110 K. X-ray crystallography was carried out at 93(2)K using Mo K radiation
from a Rigaku MM007 rotating anode diffractometer operating with a low temperature.Mass
spectra were acquired on a Water’s 2795 HPLC with Micromass LCT equipped with a “lock
spray“ for accurate mass measurements. Elemental analysis for C, H and N were determined
on dried samples using a Carlo Erba CHNS analyser. Variable-temperature, solid-state direct
current (dc) magnetic susceptibility data down to 5 K were collected on a powdered
microcrystalline sample using a Quantum Design MPMS-XL SQUID magnetometer in an
applied field of 0.1 T. Diamagnetic corrections were applied to the observed paramagnetic
susceptibilities using Pascal’s constants. Electrochemical measurements were carried out on a
3.15 x 10-4 M solution in CH3CN containing 0.1M [nBu4N][BF4]. A standard three electrode
system was used comprising a Metrohm 6.1241.060 Pt working electrode, Metrohm
6.0726.100 Ag/AgCl reference electrode and a Pt wire reference electrode. Data were
captured on a DELL Pentium III desktop PC with General Purpose Electrochemistry system
(GPES) version 4.8 connected to an Autolab PGSTAT30 potentiostat. Quoted data were
recorded using a scan rate  = 0.1 Vs-1 and are displayed in the form (Epa + Epc) /2 V (Epa -
Epc). Potentals are vs Ag/AgCl referenced to the ferrocinium/ferrocene couple taken as +0.55
V. In situ UV/Vis/NIR spectroelectrochemistry was performed using an optically transparent
thin layer electrode (OTTLE) cell using a Perkin-Elmer Lambda 9 spectrophotometer. The
spectra were captured on a Datalink Pentium desktop PC running UV Winlab software,
version 2.70.01. A platinum gauze working electrode (transparency = 40 %) was used in the
quartz cell (path length = 0.5 mm). The platinum wire counter and Ag/AgCl reference
electrodes were separated from the test solution by sintered frits in a quartz reservoir above
the flat cell. A tight fitting PTFE lid prevented the oxygen-purged solutions being exposed to
the atmosphere. The assembly was then placed in a PTFE block fitted with two pairs of
quartz windows, inside the spectrometer. Dry, pre-cooled N2 was passed between the cell and
the inner pair of quartz windows to cool the solution. Dry, room temperature N2 was passed
between the outer and inner quartz windows of the PTFE block to prevent frosting of the cell
and windows. The spectrometer cavity was kept under N2. The temperature was monitored
using a thermocouple connected to a digital thermometer and could be controlled by careful
adjustment of the N2 flow rate. Potential was applied and bulk electrolysis performed with
UV/Vis/NIR spectra measured every ten minutes. Conversion of the electroactive species
was deemed complete when the spectrum became constant and current flow ceased. The
potential was then set back to re-generate the original species to ensure reversibility of the
redox process.
1Chapter 1
Biomimetic Catalysis of Selective Hydrocarbon Oxidation
1.1 Introduction:
One of the most relevant transformations carried out by the chemical industry is the
catalytic and selective oxidation of the unactivated alkane molecules such as methane (to
methanol) and cyclohexane (to cyclohexanol).1, 2 The alkane raw materials utilized in these
chemical processes come from natural gas such (methane), or from crude oil (cyclohexane).
Alkanes are by nature relatively cheap and although the process is thermodynamically
favoured they remain difficult to activate for selective reaction. This is largely because (i) the
C-H bond energy is high (~ 400 kJ mol-1) and moreover higher than that of its oxidation
products resulting in over oxidation to mixtures of alcohol, ketone/aldehyde, and carboxylic
acid products, and (ii) there are no activating functional groups available to direct selective
reaction. As a result, finding effective routes for the selective functionalization of alkane
feedstocks remains one of the most important contemporary goals in academia and industry.3
In the past, expensive and relatively non-selective stoichiometric oxidants such as chromates
and permanganates have been utilized. They have since been replaced by cheaper and more
environmentally friendly oxidants such as air or peroxides under metal catalysis. However
these processes remain relatively inefficient requiring constant recycling of the substrates.
For instance, the oxidation of cyclohexane to a mixture of cyclohexanol and cyclohexanone is
maintained below 5% to avoid further oxidation of the products, hence the substrate has to be
separated from the reaction mixture and recycled. The latter constitutes a part of the DuPont
process where every year 106 tonnes of nylon-6 and nylon-6´6 are produced.4 Increasing the
net efficiency of these processes is a key research objective for industry and academia.
2In nature, the activation and selective oxygenation of C-H substrates is carried out
routinely by a number of metalloenzymes.5, 6, 7, 8 Some examples are cytochrome P450,
methane monooxygenase, and bleomycin. All three contain an iron centre and carry out
important selective oxidations. For instance, as well as its role in the water solubilizing of
toxic and waste molecules in the body (via C-H hydroxylation) cytochrome P450 plays a
crucial role in the biosynthesis of the female hormone progesterone via catalysis of the
selective oxidation of aliphatic long chain C-H bonds of cholesterol.9 Methane is oxidized to
methanol by methane monooxygenase during the metabolic process of methanotrops,6 and the
4´-hydrogen of the rings of ribose on DNA are abstracted by bleomycin in its role as an
antitumour drug.10 All these processes are accomplished under mild conditions, which could
be hugely advantageous for the chemical industry. However, the use of biological catalysts in
industry is not far advanced because of the need for harsh conditions. There have been some
advances in terms of alcohol production from renewable carbon sources, where non
fermentative pathways have been utilized to obtain branched chain alcohol which can be used
as biofuels. By means of this method it has been possible to synthesise phenylethanol,
isobutanol, 2 methyl-1 butanol and butanol.11 Liao and co-workers reported that alcohols with
longer chains would be obtained, via a new synthetic approach in E.coli, (a bacterium with
metabolic ability), combined with the last two steps of the Erhlich pathway, where a large
variety of substrates containing 2-ketoacid are degraded from different organisms. The 2-keto
acid decarboxylases (KDCS) can reduce substrates to aldehydes which are then reduced by
alcohol dehydrogenases (ADHs) to alcohols.11 However, the production, via the C8 petroleum
fraction, of high value long chain alcohols such as 1-octanol, a precursor of some PVC
plasticizers and detergent additives, still requires expensive hydroformylation of the long
chain C8 alkene followed by hydrogenation of the corresponding aldehyde. Inspired by the
iron based alkane metallooxygenases, the development of a number of biomimetic heme and
3non-heme catalysts has raised a huge interest within the chemical community over the past
thirty years.
Progress in the understanding of the mechanism of action of heme oxygenase enzymes
has led to the development of a range of biomimetic heme catalysts.12 The corresponding
family of non-heme iron catalysts consists of two different groups; dinuclear systems,
mirroring alkane monooxygenases such as methane monooxygenase, and mononuclear
systems analogous to bleomycin. The availability of X-ray structural data on many of the
biocatalysts has led to vast insights into the possible design of effective biomimetic analogues
for alkane functionalization.
1.2 Biological Alkane Monooxygenases
Enzymes such as Cytochrome P450, which contains a porphyrin ligand, methane
monooxygenase and bleomycin all use iron to catalyse the oxidation (by dioxygen) of C-H
bonds in substrates. The respective active sites are shown in figure 1.1, 1.3 and 1.4. A few
enzymes like NO synthase,13, 14 peroxidases15, 16 and prostaglandin synthase,17, 18 have a
similar heme active site to that of cytochrome P450. The non-heme enzyme methane
monooxygenase however has a binuclear carboxylate-bridged diiron centre. This centre is
also present in fatty acid desaturase and also in ribonucleotide reductase which uses the diiron
centre to generate a tyrosyl radical which is an integral part of the catalytic process.6
Figure 1.1 Schematic representation of the iron-containing enzymatic centre of cytochrome
P4501
4Finally bleomycin is a mononuclear non-heme iron enzyme wherein five nitrogen containing
ligands are coordinated to the iron centre; two amines, a pyrimidine, an amidate and an
imidazole.10 Great strides in understanding how these catalysts perform have been
accomplished although much remains to be understood such as the role of endogeneous
radicals.
1.2.1 The active site and mechanism of Cytochrome P450
Intensive studies have been carried out during the past 30 years to elucidate how
hydrocarbons are oxidized by heme iron-containing enzymes such as cytochrome P450.19 The
generally agreed reaction mechanism is shown in figure 1.2.
Figure 1.2 Schematic representation of the proposed alkane hydroxylation reaction
mechanism for cytochrome P450.1
Que et al have reviewed and summarised the various steps taking place during the oxidation
process.1 First of all, the alkane (RH) is bound to the catalytic centre, this step induces the
reduction of FeIII to FeII. In the next step, O2 is bound to the reduced active site, forming
adduct which is equivalent to that in oxy-hemoglobin. Subsequent transfer of a proton and
5electron then results in an iron-hydroperoxo intermediate species; (Por)FeIIIOOH, which has
been characterised with spectroscopic techniques such as EPR, and ENDO.20 According to
DFT calculations21 this intermediate clearly takes part in the catalytic process. The heterolytic
cleavage of the O-O bond of the hydroperoxide then produces formally (Por∙+)FeIV=O (or
(Por)FeV=O), the active species responsible for substrate oxidation. The [(Por·+)FeIV=O]
formulation is preferred from comparisons with heme peroxide compound I. [(Por·+)FeIV=O]
can also be obtained when the inactive (resting) P450FeIII form reacts with hydrogen peroxide
(the peroxide shunt).15,16 Here H2O2 effectively supplies the two electrons and a proton
required to get to the hydroperoxide directly. Oxygen transfer agents such as PhIO can also be
used to transfer a single atom of oxygen to the resting P450FeIII form.19 In each case the
enzyme works via insertion of the oxygen of [(Por·+)FeIV=O] into the C-H bond of the
substrate. P450 dependant enzymes will also epoxidise alkenes again via ‘addition’ of the O
atom.
1.2.2 The active site and mechanism of Methane Monooxygenase (MMO)
MMO belongs to a class of non-heme iron containing enzymes which lack the
porphyrin group. Its active site, figure 1.3, consists of a carboxylate-bridged diiron centre.
However the overall catalytic mechanism is very similar to P450.22, 23 During the oxidation
process, several intermediates, P (or peroxo) and Q, have been characterized following the
Figure 1.3 Schematic representation of active diiron site of methane monoxygenase in its
oxidized form.1
6binding of oxygen to the diiron(II) centre. Spectroscopic data suggests that P is a μ-1,2-
peroxodiiron(III) complex24, 25 and Q is a diiron(IV) species with a Fe2(μ-O)2 core.26, 27 DFT
calculations are in agreement with the proposed structures.28, 29, 30, 31 Close comparison
between the cytochrome P450 and methane monooxygenase reaction intermediates, figure
1.5, shows that an analogy is observed between the mechanisms of the two enzymes.
Intermediate P (MMO) directly corresponds to the heme FeIIIOOH (hydroperoxo)
intermediate for P450 wherein a proton has been replaced by the second iron(III). Species Q
(MMO) then corresponds to the high valent species [(Por·+)FeIV=O] with the porphyrin radical
cation replaced by the second iron(IV). Kinetic studies indicated that intermediate Q carries
out the C-H bond oxidation step. However, exactly how oxygen is incorporated into the
substrate is still the subject of intensive debate.32 33-35
Soluble fatty acid desaturase also contains a dinuclear iron centre identical to MMO as
shown by its X-ray structure.36 A similar intermediate P has been characterized by Raman and
Mössbauer spectroscopy.37 However no diiron(IV) intermediate similar to Q has so far been
detected. Like MMO, the coordination around the two irons in FD is carboxylate-rich. It is
believed that in both cases the activation of oxygen and incorporation into the C-H bond is
carried out by a high valent iron species.
1.2.3 The active site and mechanism of Bleomycin.
Bleomycin, figure 1.4, is a non-heme iron enzyme with a high antitumour activity.10, 38
This property is believed to originate from its capacity to induce DNA cleavage in the
presence of dioxygen. Many studies indicate that an FeII species initially reacts with dioxygen
in the presence of proton source forming a hydroperoxo intermediate similar to P450.39 The
activated BLM intermediate40 generated after the one electron reduction and incorporation of
a proton generates a low spin FeIIIOOH intermediate41 as indicated by spectroscopic studies.
The DNA C-H bond oxidation is believed to relate to O-O bond cleavage of the hydroperoxo
7Figure 1.4 Schematic representation of the active centre of bleomycin (shown here as its
cobalt hydroperoxo form). 1
species. However, since DNA cleavage has been observed in the presence and absence of
dioxygen, it is still not entirely clear which intermediate species is responsible for the C-H
bond activation step.10, 38 Finally, the Rieske dioxygenase family of enzymes form another
group of non-heme iron dependent oxygenases that have been recently characterised. Here
both atoms of dioxygen are transferred to the substrate.
Que et al1 have commented that the various iron dependent oxygenase enzymes, heme
or non-heme, share many common features within their catalytic reaction mechanism. In all
three enzymes an O2 adduct is formed initially, called (superoxo), which is converted to a
metal peroxide (peroxo), and finally to a high valent oxo-iron form after cleavage of the O-O
bond.42 Once the high valent intermediate is formed, it may follow one of several pathways.
Amongst the different possibilities is a direct reaction with the alkane. Here the difference
between each enzyme lies in where the oxidizing equivalents are located. For example, in
cytochrome P450 they are located on both the iron centre and the heme group, whereas in
MMO they are located in electron deficient bridging oxygen atoms between the two irons.
Finally in the Rieske Dioxygenase family the oxidizing equivalents are believed to be located
solely on the iron centre in the form of a perferryl FeV=O(OH) species.42
8Figure 1.5 Analogies in the reaction mechanism of metallooxygenases (the heme paradigm)
(a) mechanism proposed for O2 activation by heme iron monooxygenases, (b) mechanism
proposed for O2 activation by non-heme diiron alkane monooxygenases and (c) that for
mononuclear non-heme iron monooxygenases (e- = electron; P = porphyrin).
The intensive study of metalloporphyrin-catalysed oxidations during the 80’s has
contributed much to our present understanding of the mechanism of heme enzymes such as
P450. With the study of the non-heme iron enzymes following at a similar pace during the
90´s, a huge body of work is now available concerning a wide range of putative biomimetic
heme and non-heme iron catalysts for C-H bond substrates. Because of its relevance to the
studies described in this thesis the remainder of the chapter now focuses on the area of
biomimetic non-heme iron catalyst for oxidation, its reaction mechanism and its development.
91.3 The development of biomimetic non-heme iron oxidation catalysts.
When iron(II,III) ions react with aqueous solutions of hydrogen peroxide, they
generate a flux of hydroxyl radicals, the Fenton-Haber-Weiss reaction. Although known for
almost a century, and commonly represented by figure 1.6, the precise nature of the steps
involved and the intermediates generated therein are still the subject of much intense debate
and disagreement.43 44-46
Figure 1.6 Schematic representation of the Fenton-Haber-Weiss reaction
Intense debate surrounds whether short lived but highly reactive FeIV=Oaq (or even FeV=Oaq)
species are generated in significant quantities in addition to ROO∙ and RO∙ radicals via the
initially formed hydroperoxoiron(II,III) species. Aqueous Fenton reagents based on H2O2 are
generally non-selective and show little preference for the type of C-H bond, 1o, 2o or 3o
indicating that the dominant reactant is the hydroxyl radical. Product profiles stemming from
controlled reaction with diffusively free hydroxyl radicals (e.g. generated from aqueous
H2O2/UV) mirror those obtained from Fenton reagents and have been used as a benchmark for
deciding between the involvement of diffusively free hydroxyl radical-based or metal-oxo
based processes. In this context a range of biomimetic iron analogues of non-heme iron
oxygenase enzymes have been investigated. Tables 1.1 and 1.2 summarize the results from
recent investigations of catalytic peroxide (tBuOOH and H2O2) oxygenation, respectively, on
a series of alkane substrates under a number of standardised conditions including reaction
with free OH∙ radicals.1 In most of the studies cyclohexane is the chosen substrate since the
ketone and/or the secondary alcohol are the only products normally formed and these can be
easily identified by GC. Moreover such studies have direct relevance to the development of
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R-H + Fen+=O R + Fe(n-1)+-OH R-OH + Fe(n-2)+ (3)
C-H abstraction rebound
more efficient high throughput routes to the production of Nylon-6 and Nylon-6’6 via
cyclohexanone.
Tables 1.1 and 1.2 summarise the different efficiencies observed in product
distribution. Conversion of alkane solely to alcohol is only observed in a few cases. Because
of the variation in product distribution it might be concluded that the mechanism for alkane
oxygenation varies somewhat between the different catalysts. However detailed studies have
now shown that care is needed when defining the conditions of the experiment. It has been
found that product distributions vary with a number of definable parameters, namely the
catalyst, the particular peroxy oxidant employed, the oxidant / catalyst ratio, temperature,
solvent, time of reaction, presence / absence of dioxygen, presence / absence of a reducing
quenching agent, e.g. PPh3, (probe for the alkylhydroperoxide) and the way the peroxy
reagent is administered either as one batch at the start or by slow incremental addition e.g.
using a syringe pump. The widely varying conditions employed globally by various research
groups have meant that a detailed comparison between different systems is often difficult.
However in the data summarized in tables 1.1 and 1.2 some degree of standardisation of the
conditions of the experiment has been achieved.
1.3.1 General consideration of the mechanism.
The oxygenation of alkanes catalyzed by high valent iron oxo species has a
mechanism which can be separated into two steps. The first is the rupture (activation) of the
C-H bond. The second is the creation of the new C-O bond.
The time elapsed between these two steps can explain the differences of the products
obtained. If the two steps are synchronised in a concerted fashion, the oxygen atom will be
efficiently incorporated into the C-H bond. Alternatively the alkyl radical formed after the
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rupture of the C-H bond could be trapped very quickly to form the C-O bond, termed short
lived. These two mechanisms are difficult to distinguish but are believed to operate for P450
and MMO, where the stereospecific hydroxylation of alkanes occurs with partial retention of
the configuration when chiral alkanes are used as substrates.47, 48 Another possibility is the
formation of long lived alkyl radicals occurring when both steps are not synchronized. These
radicals are then available for trapping by other radicals including dioxygen. This is believed
to be the case for the antitumour drug bleomycin wherein different products are obtained
depending on the presence of absence of oxygen.10, 49, 50 Thus the reaction mechanism that
takes place depends on the lifetime of the new emerging radical and its following reactions.
All the biomimetic catalysts employed in tables 1.1 and 1.2 imply the formation of iron
peroxoalkyl intermediates obtained from the reaction between the iron catalyst and the
peroxide. These intermediates have been characterised spectroscopically. 3, 51-58
Figure 1.7 shows the four different decomposition pathways of the transient species FeIII-
OOR, and the five distinct oxidants which are derived from it.
(a) Pathway (i) corresponds to the Haber-Weiss reaction, wherein the peroxo radical
ROO∙ and FeII are generated from Fe-O bond homolysis. The peroxo radical
(ΔHBD(tBuOO-H) = 372.4 kJ mol-1, ΔHBDE (HOO-H) = 368.2 kJ mol-1)52 is
capable of abstracting H only from those alkanes where C-H bond are not strong
(e.g. Ph(Me)CH-H, ΔHBDE = 364 kJ mol-1.59 On the other hand, when two ROO∙
radical react, the powerful oxoradical RO∙ is generated (ΔHDBE (tBuO-H) = 439.3
kJ mol-1 (ΔHBDE (HO-H) = 497.9 kJ mol-1),58 which is capable of abstracting H
from stronger C-H bonds such as in cyclohexane (ΔHBDE = 399.6 kJ mol-1). 59
12
Table 1.1: Alkane oxidation with tBuOOH using biomimetic catalysts.a 1
Entry Catalyst Time Eff.(%)b A:K KIE 3°:2° Ref.
1 [Fe(OPPh3)4]2+ 4-6 h 24 0.2 5.2 60
2 [Fe(CH3CN)4]2+ 4-6 h 22 0.1 5.6 60
3 [Fe(bipy)2]2+ 4-6 h 20 0.1 4.8 60
4 [Fe2(OH)(Mac16)]3+ 5 min 61
100 equiv. tBuOOH 28 0.8
10 equiv. tBuOOH (sp) 60 min 34 14
5 FeCl3 4-6 h 34 0.6 4.3 60
6 [Fe(PMA)]2+ 30 min 40 1.0 6.5 6 62
7 [Fe(PMC)]2+ 30 min 22 1.1 62
8 [FeCl2(NTB)] (ClO4) 2 h 23 1.3 5.4 7 63, 64
9 [FeCl2(NTB)] (BF4) 2 h 12 1.5 65
10 [FeBr2(TPA)](ClO4) 1 h 21 0.7 7 63, 64
11 [FeBr2(NTB)](ClO4) 36 h 5 1 63, 64
12 [Fe2O(bpy)4(H2O)](ClO4)4 3-5 min 31 0.9 7.1f 10 66,67
13 [Fe2O(OAc)(bpy)4](ClO4)3 2 h 28 1.2 6.1f 11 67
14 [Fe2O(OAc)2(bpy)2(H2O)2](ClO4)2 10 h 31 1.2 67
15 [Fe2O(OAc) 2Cl(bpy)2] (ClO4)2 72 h 54 1.5 67
16 [Fe2O(tmima)2(H2O)2](ClO4)4 g 5%/h 1.0 10 68
17 [Fe2O(OAc)(tmima)2] (ClO4)3 g 24 h 26 0.9 68, 69
18 [Fe2O(OAc)(bMimen)2](ClO4)3 h 1 h 6 0.8 4 70
19 [Fe2O(OAc)(bpmen)2](ClO4)3 h 1 h 21 0.9 3.7 70
20 [Fe2O(OAc)(bpia)2(H2O)](ClO4)3 h,i 1h 24 0.8 71
21 [Fe2O(OBz)2(BPA)2](ClO4)2 16 h 25 1.2 6.1 72
22 [Fe2O(OAc)(NTB)2](ClO4)3 16 h 10 1.1 7.1 72
23 [Fe2O(OAc)(TPA)2](ClO4)3 15 min 24 0.8 4.6 72
24 [Fe2O(Obz)(TPA)2](ClO4)3 15 min 23 0.9 4.4 72
25 [Fe2O(CO3)(TPA)2](ClO4)2 4 h 15 1.0 4.6 72
26 [Fe2O(Obz)(TPA)2](ClO4)3 10 min 73
150 equiv. tBuOOH 27 0.7 6 f
150 equiv. tBuOOH (sp) 32 2.0
10 equiv. tBuOOH (sp) 40 >100 7-8
a all reactions were performed at r.t in acetonitrile under argon or N2 unless noted. b Eff= Σ(oxidized products)/ tBuOOH x 100.c A/K = cyclohexanol/ cyclohexanone in the
oxidation of cyclohexane. dKIE =Kinetic Isotopic effect for cyclohexanol formation in the oxidation of cyclohexane and cyclohexane-d12. e 3°/2° = 1-adamantanol/(2-
adamantanol+2-adamantanone) in the oxidation of adamantane multiplied by 3 (to correct for the threefold higher number of 2° C_H bond). f KIE value based on both alcohol
and ketone. g Under O2. h Under air. i carried out in aqueous micelles
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Table 1.2: Cyclohexane oxidation with H2O2 using biomimetic non-heme catalysts.a 1
Entry Catalyst Eff.(%)b A:K KIE 3°:2° e RC (cis) (%)f RC (trans) (%)f Ref.
1 HO˙ ~1 1~2 2 9 8 43, 53, 74, 75
2 (Por)FeIII g 5~15 13 6~48 96 78 57, 76-78
3 Fe(ClO4)3 37 1.9 1.5 3.3 79
4 [Fe(OPPh3)4]2+ 13 1.2 1.9 60
5 [Fe(CH3CN)4]2+ 10 1.0 1.8 60
6 [Fe(bipy)2]2+ 9 0.8 1.4 60
7 [Fe(PMA)]2+ h 10 0.9 53
8 [FeCl2(HDP)]+ 3 1.2 80
9 [FeOCl2(epy)2]2+ 2 1.4 81
10 [Fe2O(OAc)(bpmen)2]3+ 2.5 0.8 82
11 [Fe2O(OAc) 2Cl(bpy)2] (ClO4)2 ~8 ~ 1 1.4 3.6 72
12 [Fe2O(OAc)(tmima)2](ClO4)3 ~9 < 1 1.6 3.4 72
13 [Fe2OCl(tfpy)2]2+ 3 2.0 81
14 [Fe(DPA)2]2- 16 2.3 83
15 [Fe2O(5-NO2Phen)4(H2O)]4+ 2.0 3.5 (1.6h) 72 84
16 [Fe2O(bpy)(H2O)]4+ h 6~9 1.3 12 67, 85
17 [Fe2O(bpy)(H2O)]4+ 2.4 4.5 (3.3h) 84
18 [Fe2O(4,4’-Me2bpy)4(H2O)2]4+ 3.1 6.2 (5.0h) 48 84
19 [Fe2O(pb)4(H2O)2]4+ h 30 2.0 86
20 [Fe2O(N4py)(CH3CN)2]2+ 31 1.4 1.5 3.3 27 (31i) 16 (30i) 87
21 [Fe2O(TPA)(CH3CN)2]2+ 37 4.3 3.5 17 100 100 88
22 [Fe2O(bpmen)(CH3CN)2]2+ 63 8 3.2 15 100 100 88, 76
a all reactions were performed at r.t in acetonitrile under argon or N2 unless noted. b Eff= Σ(oxidized products)/ tBuOOH x 100.c A/K = cyclohexanol/ cyclohexanone in the
oxidation of cyclohexane. dKIE =Kinetic Isotopic effect for cyclohexanol formation in the oxidation of cyclohexane and cyclohexane-d12. e 3°/2° = 1-adamantanol/(2-
adamantanol+2-adamantanone) in the oxidation of adamantane multiplied by 3 (to correct for the threefold higher number of 2° C_H bond). f KIE value based on both alcohol
and ketone. g Under O2. h Under air. i In acetone
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Figure 1.7: Representation of the probable four decomposition routes of FeIII-OOR
species1
(b) Direct attack of the FeIII-OOR transient species to the alkane similar to the behaviour
of early transition metal peroxo complexes.3
(c) Homolytic cleavage of the O-O bond from FeIII-OOR transient species to generate two
powerful oxidants capable of oxidizing the alkane; the high valent iron oxo FeIV=O
and the oxo-radical RO∙ corresponding to pathway (ii).
(d) Heterolytic cleavage of the O-O bond from FeIII-OOR, path (iii) to generate an FeV=O
intermediate which oxidizes the alkane, this species is comparable to the
[(Por.+)FeIV=O] P450 oxidant Q, Rieske dioxygenase and peroxidase compound I.
The answer to elucidating the reaction mechanism for the oxidation of alkanes is to prove the
lifetime of the generated radical, since the oxidant species can be metal based such LFeIII-
OOH, LFeIV=O, or LFeV=O, or radical based such as HO∙ or RO∙. Two types of mechanisms
are relevant depending on the lifetime of the radicals generated in the oxidation of alkanes,
whether the alkyl radicals are short or long lived. The heme-enzyme cytochrome P450 and
non- heme MMO generates a high valent iron oxidant and a short–lived alkyl radical, which is
Chapter 1 Introduction
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generated close to the iron and thus being rapidly trapped producing the alcohol, path (iii).
However, if Fenton/Haber-Weiss reactions take place this generates HO∙ or RO∙ free radicals
which produce long-lived R∙ radicals which are non-selective. When the reaction is carried
out under air, the oxygen present will initiate a radical chain autoxidation process, which is
responsible for the products formation. Much of the efforts invested in this field are focused
towards obtaining a biomimetic catalyst capable of producing a high-valent iron oxidant
similar to that believed to operate in cytochrome P450 and MMO.
1.3.2 Mechanistic evidence.
In order to obtain insight into the nature of the species responsible for hydrogen atom
abstraction from the substrate C-H bond and the lifetime of the radical R∙ generated, indirect
evidence can be helpful in elucidating the mechanism since it is often very difficult to monitor
the key intermediates responsible of the oxidation.
1.3.2.1 Alcohol / ketone ratio (A/K) (cyclohexane)
A powerful indicator of the nature of the oxidant is to measure the A/K ratio in the
reaction with cyclohexane which is a measure of the lifetime of the nascent radical. Long
lived alkyl radicals may be generated with substrates like cyclohexane which contains only
secondary C-H bonds. When the reaction is carried out under air, such alkyl radicals are
trappable by dioxygen generating alkylperoxo radicals (4).58 These species can participate in a
Russell-type termination step, figure 1.8 generating the alcohol and ketone with an A/K ratio
of near unity (5).59 Furthermore, the yield of alcohol and ketone will diminish considerably in
the absence of O2 (when reaction is carried out under inert atmosphere), since the radical
chain reaction will not propagate. Short-lived alkyl radicals can be generated by high valent
metal species, wherein the radical and a high valent M-OH species, formed by H-abstraction
from C-H, react rapidly generating the hydroxylated alcohol product (3). This step is termed
Chapter 1 Introduction
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Figure 1.8: A Russell-type termination step.
the oxygen ‘rebound’ reaction89 and has a typical rate constant in the range ~ 1010 ~1013 s-1.90,
91 Here cyclohexanol would be the only product. However, amounts of cyclohexanone are
also typically seen due to over-oxidation of the alcohol or via competition from O2 with the
high valent M-OH species for the nascent alkyl radical leading to participation from (4) and
(5).
1.3.2.2 Kinetic isotopic effects (KIE)
The kinetic isotope effect is indicative of the selectivity of the oxidant measured by
using standard alkane substrates and their deuterated analogues, which have ~7.14 kJ mol-1
energy difference in the C-H/D bond strength. Depending on the substrate utilized it is
possible to determine an intermolecular KIE (e.g. using cyclohexane/cyclohexane-d12) or an
intramolecular KIE (using CHnD4-n). For hydroxyl radicals as the oxidant species the typical
kinetic isotopic values obtained are ~1-253 which indicates a strong but non-selective oxidant
with little or no selectivity for C-H vs C-D bonds. Other oxygen radicals are more selective
however. When tBuO∙ is the active species, the KIE value is significantly higher, 4~5.54 Since
the hydroxyl radical is more reactive than the alkoxyl radical, ((ΔHDBE (HO-H) = 500 kJ mol-1
vs ΔHDBE (RO-H) = 441 kJ mol-1), its lower KIE compared to tBuO∙, is a direct reflection of
its stronger oxidising power which corresponds to a lower selectivity.58 Metal-based oxidants
can give even higher KIE values indicative of a higher discriminatory behaviour. For example
KIE values higher than 7 are commonly found in metalloenzyme reactions,55 where the
selectivity can be enhanced by changes to the geometry of the active centre, favouring the
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entrance of the substrate to the active centre. Examples are Cytochrome P450 with a KIE
higher that 1116 and MMO with a reported KIE of 50-100.92
1.3.2.3 Substrate-based probes of alkyl radical lifetime.
In order to establish, whether short or long-lived alkyl radicals are generated, decalin
and the cis and trans isomers of 1,2-dimethylcyclohexane have been used as substrates in
alkane hydroxylation reactions which take advantage of the competition between alcohol
formation and epimerization of the presumed formed tertiary alkyl radical species, generating
cis and trans 3º-hydroxylated products. It is known from literature that epimerization of a
tertiary carbon has a first order rate constant of 109 s-1.76, 93 When long lived radicals are
present, both cis and trans hydroxylated products are obtained with a cis/trans value of 1.2.74
However, when short-lived radicals are generated, the oxygen-rebound step takes place with a
rate constant of 1010~1013 s-1 (for examples wherein a porphyrin group is present) and
retention of the original configuration is maintained. These catalysts hydroxylate substrates
with much greater stereospecifically.16, 62
1.3.2.4 Regioselectivity
Another method of probing the nature of the oxidant is by studying the competitive
oxidation of secondary and tertiary C-H bonds in the same molecule (intramolecular). For this
purpose the hydrocarbon adamantane is often employed as it contains only 3o and 2o C-H
bonds. Here the regioselectivity factor is measured from the 3º/2º ratio (mols of 1-
adamantanol / mols of 2-adamantanol/one) multiplied by 3 to correct for the larger number of
2º C-H bonds. Powerful but unselective oxidants such as HO∙ typically give regioselective
factors of ~2 whereas values ≥10 can indicate more selective oxidants such tBuO∙.56 For heme
oxygenases like cytochrome P450 the regioselectivity factor for adamantane can reach values
as high as 48.94
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1.3.3 Reactions with Alkylperoxides
As shown in table 1.2, regardless which iron complexes are utilized as catalyst, all
reactions where alkyl hydroperoxides is used as the oxygen source have a series of common
characteristics, figure 1.9. In most cases the A/K ratio is ~ 1 when ROOH reagents are used as
Figure 1.9: Products derived from the catalytic oxidation of cyclohexane by an iron complex
with tBuOOH1
the oxygen source in the oxidation of alkanes indicating that long lived radicals are generated.
When O2 is present, the long lived alkyl radicals are trapped giving alkylperoxyl radicals
which then take part in Russell-type termination steps giving A/K ratios near unity, figure.1.8.
In the absence of O2 similar A/K ratios are observed since O2 is generated in-situ from the
decomposition of ROOH via ROO∙ (Haber-Weiss reaction). When reactions are carried out
under argon, tBuOOC6H11 is obtained from the reaction between tBuOO∙ and C6H11∙. On the
other hand its generation is significantly reduced and even completely suppressed when the
reaction is carried out under O2. At the same time, KIE values of ~5 and regioselectivity
factors (for adamantane) near 10 indicate that RO∙ radicals are probably generated from the
homolytic cleavage of the O-O bond of tBuOOC6H11.
With the help of the data presented in table 1.1, Que et al have attempted to explain how
catalytic performance is directly affected by the catalyst structure, especially the reaction rate
in which ROOH is decomposed. There are three important features which are found to
increase the reaction rate.
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(i) The activity of the metal complex catalyst is found to correlate with a high overall
cationic charge on the complex (only a few active catalysts have anionic ligands)
(entries 12-15 and 19-26 in table 1.1). This may be due to the Lewis acidity of the iron
centre.95
(ii) Among all nitrogen-containing heterocycles, the catalytic activity of pyridine-
containing ligands is higher (see 10 and 11, 18 and 19, 22 and 23, and 16 and 26).
(iii) When weak ligands are present, which are rapidly exchangeable with H2O, the
catalytic activity is higher (see 12 and 13, 14 and 15, 16 and 17, and 23 and 26 with 10
equivalents of tBuOOH). When weak ligands are bound, tBuOOH can easily react
with the metal centre. A number of the metal complexes which contain aqua ligands,
generate FeIII-OOR transient species which can be detected at low temperature.3, 52, 53
1.3.3.1 ‘Gif’ Oxidants (utilizing O2!)
In 1980 Tabushi et al. described the first dioxygen-dependent system for the oxidation
of adamantane mediated by [{Fe(salen)}2(µ-O)}] [H2salen = N,N’–bis(salicylidene)
ethanediamine] in the presence of 2-mercaptoethanol in pyridine.96 1-adamantanol and
2-adamantanone were the products. A few years later this system was re-investigated
by Barton who showed that the reaction to be far from reproducible. The addition of
iron powder and acetic acid yielded better results. Barton’s first system used dioxygen
and iron powder in a 10:1 pyridine acetic acid mixture in the presence of hydrogen
sulphide to catalyse the oxygenation of adamantane.97 This led the development of
what are called Gif systems98 (after the town of Gif-sur-Yvette in France where Barton
at the time was director of the Institut de Chimie des Substances Naturelles). The Gif
systems were of much interest early on due to the employment of simple reagents, and
in several cases, the use of atmospheric dioxygen as oxidant. The GifIV and GoAgg
systems (the latter named after Gif-Orsay-Aggieland (Texas A&M University) - the
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various locations for the studies), table 1.3, have proven the most viable for practical
use and mechanistic studies. To achieve efficient Gif oxygenations both oxidising and
reducing equivalents are necessary; either dioxygen, combined with a reducing agent,
or via a reduced form of dioxygen. A heterogeneous mixture of iron(II), dioxygen,
acetic acid as the proton source and zinc dust as a reducing agent (GifIV) supports the
most effective oxygenation system in the former category, turnovers number can
routinely exceed 2000 under certain conditions. The latter category is best represented
Table 1.3: The various ‘Gif’-catalytic systems.
System Catalyst Electron Source Oxidant
GifIII Fe(II) Feo O2
GifIV Fe(II) Zno O2
GO Fe(II) Hg/cathode O2
GoAggI Fe(II) KO2
GoAggII Fe(III) H2O2
GoAggIII Fe(III)/Hpic H2O2
Hpic – pyridine-2-carboxylic acid (picolinic acid)
by the GoAggIII system which is a homogeneous combination of iron(III) chloride and
picolinic acid (pyridine-2-carboxylic acid) and H2O2 which behaves like a shunt “agent”. The
presence of picolinic acid increases the rate of Gif oxygenations by 50 fold over acetic acid.99
The presence of a carboxylic acid source is necessary for hydrocarbon oxidation; otherwise
only disproportionation of hydrogen peroxide is observed.100 Gif/GoAgg systems are notable
for their high selectivity to the cycloalkanone – in some cases it is the exclusive product. Key
to this high selectivity is the presence of pyridine as solvent. A continual source of dioxygen
and iron(II) is also essential. In the absence of O2 the major products are various
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cycloalkylpyridines. Richens et al, have proposed a scheme, figure 1.10, for the oxidation of
cyclohexane by the various Gif/GoAgg systems.101 It is believed that pyridine stabilizes
(increases the lifetime of) the cycloalkyl radical through a reversible outer-sphere redox
reaction with its protonated form (path (b)). This effectively increases the lifetime of the
nascent cycloalkyl radical allowing effective trapping by O2 (path (a)) followed by reaction of
the cycloalkylperoxyl radical with iron(II) to generate a cycloalkylperoxoiron(III) species.
Figure 1.10: Mechanism of Gif catalytic oxygenation on cyclohexane.101
This complex then effectively dehydrates in the pyridine solvent to give the cycloalkanone. In
the GoAgg systems it is possible to monitor the build up and subsequent decay of the
cycloalkylhydroperoxide in presumed equilibrium with its iron(III) complex as the precursor
to the ketone product. Amounts of cycloalkanol are also observed although here the timescale
of appearance suggests formation, as a result of competitive reduction (e.g. by zinc) of the
cycloalkylhydroperoxide or its iron(III) complex precursor.101 Pyridine is decisive for
obtaining good turnover numbers and unusually high K/A ratios (~ 3-10) observed in Gif
oxygenations, but its toxicity and potential corrosive properties make the Gif family of
reactions presently non-viable for industrial scale oxidation processes. Furthermore solutions
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turn brown and oily with time due to polypyridine and hydroxy(poly)pyridine side products,
figure 1.10. Although other solvents such as acetonitrile or even the hydrocarbon itself can be
used, a minimum amount of a co-ordinatively unhindered pyridine (≥ 10 equivalents over
catalyst) is essential for turnover.102, 103
1.3.4. Catalysts based on iron complexes of tris(2-pyridylmethyl)amine (TPA).
Much interest has surrounded the effective catalysis of alkane oxidation carried out by
biomimetic iron(III) complexes. One such family that have received detailed study are
complexes containing the tetradentate ligand (L1) tris(2-pyridylmethyl)amine (TPA). Que and
co-workers have shown that alkanes are catalytically oxidized by peroxides with high
efficiency using iron-TPA complexes in the absence of O2. Using tBuOOH as a oxygen
source, 150 equivalents are consumed efficiently overtime with a variation from min to hours
depending on the ancillary ligand.102, 64, 73 Using the aqua complex [Fe2O(TPA)(H2O)]4+ a
transient blue intermediate was observed to persist for a short time at room temperature. This
intermediate was characterized by MAS, EPR, Raman spectroscopy104 as the low spin t-
butylperoxoiron(III) species [Fe(TPA)(OOBut)(H2O)]2+. Based on indirect evidence such as
the kinetic isotopic effect, regioselectivity factor (adamantine) and reaction time variations, it
was concluded that the active species was either the t-butylperoxoiron(III) species or a high
valent iron oxo species derived from it via homolysis of the O-O bond.102
Subsequently a different mechanistic conclusion was proposed by Ingold and co-
workers,105, 106 after they re-examined Que’s work. According to them Que’s experiments
could not explain the A/K ratios near unity and that the yield of products was considerably
modified by the presence of O2. These two observations were used by Ingold to propose that
long-lived alkyl radicals were formed. He proposed that tBuO∙ radicals were generated via
homolytic cleavage of tBuOOH and that this radical was responsible for abstracting hydrogen
from the alkane C-H bond. Thereafter the products obtained could be rationalised by a
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standard a radical autooxidation process. They argued that it was not necessary and indeed
incorrect to propose a reactive high valent iron species.
To further confirm whether a specific alkoxyl radical was formed from the
alkylperoxide, Ingold and co-workers performed studies using 2-methyl-1-methyl-1-phenyl-2-
propylhydroperoxide (MPPH).105 MPPH was employed because it generates a very unstable
alkoxyl radical which undergoes rapid β-scission (k ~ 2.2 x 108 s-1) forming acetone and
benzyl radical, Fig 1.11. The resulting benzyl radical is much less reactive than e.g. tBuO∙
since the single electron is delocalized over the aromatic ring and as a consequence cannot
abstract hydrogen from cyclohexane.
Fig 1.11 Generation of benzyl radical from the synchronised homolysis of FeIII/ MMP
If however the oxidant species was a peroxo iron or oxo iron species in a high oxidation state,
the yield of the product should not be affected by the use of MPPH instead of tBuOOH. At the
same time it was claimed that if the oxidant species was the alkoxyl radical this would
decrease the yield of the product. This was shown when using MPPH wherein no cyclohexane
oxidation could be observed. Finally, the likelihood that MPPH behaves like a special
peroxide undergoing a concerted fragmentation to form the benzyl radical directly was also
refuted by the observation that MPPH is a more superior oxidant than tBuOOH in “genuine”
2e- oxidative processes such as TiIV- catalyzed alkene epoxidation.107 In later work Que et al.
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demonstrated the importance of using diluted solutions of tBuOOH added to the reaction
mixture via syringe pump,73 in order to reduce the amount of O2 generated from tBuOO∙
decomposition. For example, the addition of 150 equiv of tBuOOH over 10 min injected to a
solution of acetonitrile containing the substrate and the iron complex increased the A/K ratio
from 0.7 to 2, table 1.1. When the number of equivalents of tBuOOH was reduced to only 10,
cyclohexanol was observed as the sole product and in a 40% yield based on tBuOOH as
oxidant, table 1.1. Thus it was concluded that it was possible to compromise the radical chain
autoxidation under these conditions, such as to encourage the more selective metal-based
catalysed reaction. Despite the use of syringe pump and tBuOOH to avoid the radical chain
autooxidation process, RO∙ radical is still considered to be the principal oxidant since
cyclohexanol on its own is obtained when the reaction is carried out under an inert Ar
atmosphere. In the presence of O2 the A/K ratio was unity. Moreover when deuterated
substrates such as C6D12 or C8D14 are used the kinetic isotopic effect (KIE) values are the
same as that seen using RO∙. The key experiment was the replacement of tBuOOH by MPPH,
adding diluted solutions via syringe pump wherein no cyclohexanol was obtained. Based on
the results from Ingold and Que, a hybrid mechanism was proposed which could explain all
the experimental observations when [Fe2(TPA)2(H2O)]4+ is reacted with ROOH. Homolytic
O-O bond rupture of the intermediate [FeIII-OOH]2+ generates the high valent iron(IV) oxo
species; FeIV=O along with the oxyl radical RO∙. The alkyl radical is formed from the reaction
between the alkane and the oxyl RO∙ radical. When the reaction is carried out under Ar with
no O2 present R∙ can then react with the high valent iron(IV) oxo species to generate the
hydroxylated product via an alkoxide. These ideas were supported by labelling studies using
tBuO18OH wherein the alcohol product was obtained with labelled oxygen.91 Homolytic O-O
cleavage as above would generate a high valent iron(IV) oxo species with labelled oxygen
which ultimately traps the alkyl radical forming a bound alkoxide complex which hydrolyses
to alcohol. When the reaction is carried out under air (O2), R∙ can be intercepted by triplet
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dioxygen, generating the alkylperoxyl radical initiating the radical chain autooxidation
process. It has been demonstrated that the chemistry of the Fe(TPA)/tBuOOH combinations is
not limited to reactions involving only hydrogen abstraction from an alkane by the alkoxyl
radical. Lange et al. have taken advantage of homolytic O-O cleavage of the FeIIIO-OtBu bond
to show that a high valent iron(IV) oxo complex itself can hydroxylate an arene moiety, figure
1.12.108 Here a 6-phenyl substituted
Figure 1.12 Schematic representation of proposed reaction mechanism when [Fe(6-Ph-TPA)]
is reacted with tBuOOH.
TPA derivative ligand was employed. They showed that in the presence of tBuOOH they
could isolate a derivative wherein the phenyl substituent of (L2) 6-Ph-TPA became
hydroxylated at the ortho position (deprotonated and coordinated to iron via the inserted O).
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This could only have resulted via direct reaction of a high valent iron oxo species on the arene
group. Experiments carried out using labelled tBuO18OH showed that the oxidized product
contained the labelled oxygen of the tBuO18OH. The intermediate FeIIIOOR (A) was
characterised at very low temperature (-40°) before reacting on to generate the high valent
iron oxo reactant.
Further proof supporting involvement of the high valent iron oxo species resulted from
the reaction in the presence of H218O in solution resulting in the hydroxylated phenyl ring
contained 18O. The high valent iron oxo species is the only intermediate which could
exchange an atom of oxygen with water.109 These studies proved that high valent iron oxo
species can be generated from the reaction of Fe(TPA) complexes with ROOH reagents and
moreover such species possessed the capability themselves of hydroxylating C-H bonds.
1.3.5 Oxidations with Hydrogen peroxide
Table 1.2 shows that hydrogen peroxide can be used as the oxygen source for catalytic
oxidation of alkanes by biomimetic non-heme iron complexes. However in most cases the
hydroxyl radical is the predominant species generated via metal promoted decomposition of
H2O2, Fenton-Haber-Weiss chemistry. A/K values <2 were obtained for cyclohexane was
used as substrate. This value moreover decreases further in the presence of O2 indicating the
presence of long live alkyl radicals. The generation and isolation of cyclohexyl hydroperoxide
via cyclohexyl radical was first reported by Fish and co-workers as a product of radical chain
autooxidation.79 Further evidence for the involvement of hydroxyl radicals came from
observations of KIE values < 2 (C6D12) indicating the presence of a strong but non-selective
oxidant. This was further confirmed by a regioselectivity 3º/2º factor for adamantane of ~ 3.
Hydroxyl radicals react by hydrogen abstraction generating long lived alkyl radicals from
alkane which are then trapped by dioxygen initiating a radical chain autoxidation. However in
the case of some of the biomimetic iron complexes e.g. with tetradentate pyridine-based TPA
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and BPMEN-type ligands, table 1.2, the results indicate involvement of the more selective
oxidant – possibly a high valent iron oxo species. There is evidence that short lived alkyl
radicals can be formed giving preferential formation of alcohol over the ketone.79, 84 Iron
complexes such as [Fe(BPMEN)(CH3CN)2]2+ and [Fe(TPA)(CH3CN)]2+ are very efficient
catalysts54 converting 40-70% of hydrogen peroxide into products. Here A/K ratios
(cyclohexane) are between 4-8 in the presence and absence of oxygen indicating the absence
of long lived alkyl radicals. When deuterated cycloalkanes are used, KIE values of ~3 are
obtained with correspondingly higher 3º/2º regioselectivity factors for adamantane of ~15-17
indicating the presence of a very selective oxidant different from hydroxyl or even alkoxyl
radicals. Alkane substrates such as cis or trans 1,2-dimethylcyclohexane have also been used
to provide powerful insights into the nature of the oxidant involved. Using
[Fe(BPMEN)(CH3CN)2]2+ and [Fe(TPA)(CH3CN)]2+ as catalysts the tertiary bonds are
hydroxylated stereospecifically. On this basis it has been concluded that short lived alkyl
radicals are generated which are immediately trapped by the metal oxo oxidant. A major
challenge in this field is to promote heterolytic O-O cleavage within the initially formed
hydroperoxoiron(III) species since hydroxyl radicals are generated when the O-O bond is
cleaved homolytically. Heterolytic O-O cleavage is desirable since it generates a potentially
more powerful putative perferryl metal oxo species (LFeV=O or L+.FeIV=O (LFeIV-O∙-) (cf. cyt
P450, peroxidase compound 1) as the oxidant while avoiding the co-formation of free oxygen
radicals. The contemporary objective is to produce a high valent iron complex which can
oxidise alkanes with high chemo-regio and stereoselectivity.42
1.3.6 The nature of the high valent iron oxidizing intermediate.
Analysis of products coupled with KIE values and regioselectivity factors has
provided the strongest evidence yet that reaction between [Fe(TPA)(CH3CN)]2+ or
[Fe(BPMEN)(CH3CN)2]2+ and H2O2 generates a high-valent iron oxo complex which is
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largely responsible for the hydroxylation of the alkane substrate. This has prompted further
studies to investigate the nature of the putative reactive high valent intermediate and the
conditions required to maximise its formation. In section 1.3.3 it was noted that the presence
of weak ligands such H2O enhance the catalytic activity of the complex. At the same time
folded tetradentate pyridine based N-donor ligands such as TPA (L1) and BPMEN (L3) which
facilitate the coordination of peroxide cis to a labile coordination site appear to generate the
most active catalysts. When the reaction between [Fe(TPA)(CH3CN)]2+ and tBuOOH is
carried out at low temperatures (≤ -40oC), an intermediate blue species can be detected.54, 55
This species has been formulated as [Fe(TPA)(OOtBu)(S)]2+ (S = CH3CN or H2O). Similar
reaction with H2O2 yields a similar blue species formulated as [Fe(TPA)(OOH)(S)]2+ (S =
CH3CN or H2O) as indicated by ES-MS. Both of these species have been characterized by
EPR and Raman spectroscopy as low spin FeIII complexes with a terminal OOH(But) bound to
the iron. When low spin [Fe(TPA)(OOH)(S)]2+ is compared to other iron peroxo complexes
the terminally bound OOH- ligand is found to possess a much lower O-O stretching vibration
frequency consistent with its tendency to cleave.55 The pentadentate iron complex
[Fe(N4Py)(CH3CN)]2+ reported by Feringa and co-workers forms a hydroperoxoiron(III)
species [Fe(N4Py)(CH3CN)]2+ with a similarly low O-O stretching frequency but here its
catalytic behaviour towards alkane oxidation by H2O2 is significantly different from that of
[Fe(TPA)(CH3CN)]2+. [Fe(N4Py)(CH3CN)]2+ gives rise to a very low A/K ratio (for
cyclohexane oxidation) of 1.4 along with a KIE of 1.5 (using C6D12) which are altered when
the reaction is carried out under O2 (air). Similarly, a much lower regioselectivity 3°/2° factor
for adamantane of ~3.3 is seen compared with [Fe(TPA)(CH3CN)]2+ (~15-17) and the reaction
is not stereospecific for oxidation of cis and trans 1,2-dimethylcyclohexane. These results
indicate for [Fe(N4Py)(CH3CN)]2+ the presence of long lived alkyl radicals generated via
reaction of the alkane with hydroxyl radical. In the case of both [Fe(TPA)(OOH)(S)]2+ and
[Fe(N4Py)( OOH)]2+ the low O-O stretching frequency indicates a tendency to cleave at the
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O-O bond. In each case low temperature trapping experiments have subsequently led to
characterisation of a green species resulting from decay of the hydroperoxoiron(III) complex
believed to contain the iron(IV) oxo complexes [Fe(TPA)(O)(S)]2+ and [Fe(N4Py)(O)]2+.3, 56
The different catalytic behaviour suggests for TPA as ligand that the high valent species is
more reactive and intercept the alkyl radicals as they are formed. For pentadentate (L4) N4py
it appears the high valent iron oxo species generated is a less potent reactant allowing long
lived alkyl radicals to be generated via free hydroxyl radical. It is now believed that the
difference between TPA and N4py lies in the denticity of the ligand which for TPA allows a
labile cis site to be present adjacent the OOH- ligand which appears to be involved in its
activation to give a more highly potent oxidising species. In the case of pentadentate N4py the
extra labile cis site is absent. Nonetheless ready O-O cleavage within [FeIV(N4Py)OOH]2+ is
suggested from the low O-O stretching frequency implying ready formation of
[FeIV(N4Py)(O)]2+. This then argues for [FeIV(N4Py)(O)]2+ being a much weaker oxidant than
[FeIV(TPA)(O)(S)]2+ or
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Figure 1.13: Schematic representation of ligands; TPA (L1), BPMEN (L3) and N4Py (L4) and
their corresponding iron(II) complexes; [Fe(TPA)(CH3CN)2]2+ 1, [Fe(BPMEN)(CH3CN)2]2+ 1
and [Fe(N4Py)(CH3CN)2]2+.1
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a species generated there from. Indeed more recent studies by Que et al have shown that
[FeIV(N4Py)(O)]2+, generated separately via the reaction of [Fe(N4Py)(CH3CN)]2+ with PhIO,
is a relatively sluggish oxidant and as a result one of the longest lived iron(IV) oxo species
known with a half life of ~60h at 25oC.110 The marked selectivity of [Fe(TPA)(CH3CN)2]2+
and [Fe(BPMEN)(CH3CN)2]2+ compared with [Fe(N4Py)(CH3CN)]2+ towards hydroxylation
of cycloalkanes by H2O2 appears for the former to be related to the presence of two cis labile
sites on the iron. Initially this was believed to relate to the rapid formation of the
hydroperoxoiron(III) intermediate and, in turn, the high valent iron(IV) oxo species allowing
it to be available for reaction with alkyl radicals. However recent work in regard to alkene
epoxidation activity has suggested that it may be due to the accessing for the former of the
more potent iron(V) oxidant, figure 1.7 pathway (iii). The behaviour of [Fe(N4Py)
(CH3CN)]2+ indicates that the homolytic O-O cleavage pathway (ii), figure 1.7, is involved
generating LFeIV=O and OH∙. Iron(IV) oxo species have now been characterised for a number
of biological non-heme systems such as the 2–oxoglutarate-dependent enzyme TauD.111, 112 A
number of iron(IV) oxo compounds have proved stable enough to crystallise. Reaction of
[Fe(TMC)(O3SCF3)2] with PhIO in CH3CN gives the crystallographically characterised
[FeIV(O)(TMC)(CH3CN)]2+(TMC–1,4,8,11-tetramethyl-1,4,8,11-tetraazacyclotetradecane)
(L5).113 On the other hand C2 [FeIV(O)(TPA)(S)]2+ (S = CH3CN or H2O) generated via the
reaction of [Fe(TPA)(CH3CN)2]2+ with CH3CO3H is only stable below -40oC. Both iron(IV)
oxo complexes have been tested towards the stoichiometric oxidation of alkane and alkene
substrates. While [FeIV(O)(TMC)(CH3CN)]2+ can transfer oxygen only to PPh3 at -40°C,114
[FeIV(O)(TPA)(S)]2+ is able to epoxidise cyclooctane at this temperature. In the reaction
between tBuOOH and various non-heme iron(II) polypyridine complexes the products are
characterised by absorption band between 550 and 650 nm (εm ~ 2000 M-1cm-1).92 For TPA as
ligand the maximum is at 600 nm (εm ~ 2000 M-1cm-1) assigned to the blue low-spin iron(III)
complex C1 [FeIII(TPA)(OOtBu)(S)]2+. In these solutions the formation of small amounts of
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pale green [FeIV(O)(TPA)(S)]2+ could have been overlooked in the beginning due to the
dominant absorption from low spin [FeIII(TPA)(OOtBu)(S)]2+. However direct evidence for
the formation of [FeIV(O)(TPA)(S)]2+ from [FeIII(TPA)(OOtBu)(S)]2+ has now been obtained
in the presence of added Lewis bases, figure 1.14.115 It is believed that the higher detectable
yields of [FeIV(O)(TPA)(S)]2+ is due to accelerated formation via a ‘push’ effect from the
Lewis base facilitating rapid homolytic cleavage of the O-O bond.115 For example when
[FeIII(TPA)(OOtBu)(S)]2+ is reacted with 12 equivalents of 4-picolinate it increases its first
order decay by 10 fold resulting in a 90% yield of [FeIV(O)(TPA)(S)]2+ (from Mössbauer
measurements). With pyridine-N-oxide the yield of the iron(IV) oxo complex is 95%. The
need to generate [FeIV(O)(TPA)(S)]2+ rapidly in order to maximise its yield is because of the
thermal instability of the iron(IV) oxo complex. Both the Mössbauer and UV-visible spectrum
of [FeIV(O)(TPA)(S)]2+ are dependent of the nature of the Lewis base. The peak maximum
shifts from 700 nm (no added base) to 718 nm (for 4-picolinate) or to 742 nm (for pyridine-N-
oxide). As shown in figure 1.14, these changes in the λmax indicate that the S (CH3CN)
ligand in [FeIV(O)(TPA)(S)]2+ is likely replaced by the Lewis base. It is interesting to note
that here pyridine-N-oxide acts does not function itself as an oxygen transfer agent as in other
literature examples.116 If it had functioned in this way
ROOH
-40ºC
X
Fe
N
N NCCH3
NCCH3
N
N
2+
Fe
N
N O
NCCH3
N
N
2+
O
R
Fe
N
N O
X
N
N
2+
IV
Figure 1.14 Schematic representation of [FeIV(O)(TPA)(X)] (C2) formation by reaction of
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pyridine would have replaced the S in [FeIV(O)(TPA)(S)]2+ resulting in a much lower λmax
similar to that for S = CH3CN (similar donor properties). Recently Que et al reported that the
introduction of a carboxylate ligand CF3CO2- trans to the oxo group in the S = 1 complex
trans-[FeIV(O)(TMC)(CH3CN)]2+ (C3) enhance its reactivity.117 This is believed to occur
through a weakening of the Fe=O bond providing greater access to the more reactive S = 2
surface, figure 1.15.
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Figure 1.15: Conversion of S = 1 trans-[FeIV(O)(TMC)(CH3CN)]2+ (C3-NCMe) into S = 2
trans-[FeIV(O)(TMC)(O2CCF3)]+ (C3- CF3CO2-) via the addition of CF3CO2-. 117
Several non-heme iron metalloenzymes such MMO, TauD and ribonuclotide reductase are
believed to form reactive S = 2 iron centres in carrying out their enzymic reactions. All three
enzymes have an iron coordination sphere rich in carboxylate ligands. Recently the number of
persistent iron(IV) oxo complexes has been expanded. In addition to [FeIV(N4Py)(O)]2+
mentioned earlier a long lived iron(IV) oxo complex of pentadentate Bn–tpen, figure 1.16, has
N
N N
NN
Bn-tpen
Figure 1.16: Structure of Bn-tpen (L6).
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been characterised. The most striking properties of [FeIV(N4Py)(O)]2+ and [FeIV(Bn-
tpen)(O)]2+ containing (L6) are the higher temperature stability110 and their ability to
hydroxylate C_H bonds as strong as those in cyclohexane. [FeIV(L)(O)(S)]2+ complexes are
usually prepared by treatment of the iron(II) derivative [FeII(L)(CH3CN)x]2+ with the oxygen
transfer agent PhIO and are noted by their green colour. For L = N4py the green colour is
associated with a band at 695 nm (є = 400 M-1 cm-1) with a shoulder near 800 nm. Treatment
of [FeII(Bn-tpen)(O3SCF3)]2+ with PhIO also yields green [FeIV(O)(Bn-tpen)(O3SCF3)]2+ with
λmax at 739 nm (є = 400 M-1 cm-1) and a shoulder near 900 nm but this species has a much
shorter lifetime (t1/2 ~ 6 h).118 Similar near-IR bands ~ 700nm have been reported for the
iron(IV) oxo complexes [FeIV(O)(TMC)(CH3CN)]2+ and [FeIV(O)(TPA)(CH3CN)]2+113, 114.
[FeIV(O)(Bn-tpen)(O3SCF3)]2+ exhibits the highest KIE value (KIE = 50) so far observed at
ambient temperature for catalysis of cyclohexane oxygenation by a synthetic non-heme iron
complex. Similar KIE value were reported for the reaction of ethylbenzene with
[Fe2O(TPA)2]4+ at -40°C119. Such large isotopic effects have been observed in the case of
some non-heme iron enzymes such as TauD enzyme which has led to the proposal that the
hydrogen atom abstracting agent is a high valent iron(V) oxo species.111, 112, 120 Similarly large
KIE values have also been reported for MMO for which a hydrogen tunnelling mechanism
has been proposed.6, 117, 121
The high activity towards preferential hydroxylation of cyclohexane shown by
iron(II/III)-TPA and related polypyridine ligand complexes was discovered thanks to an
important observation which was the use of diluted H2O2.42 Moreover, by adding diluted
solutions of H2O2 via syringe pump at a steady rate equalling its H2O2 consumption was
found to have a significant effect on the A/K ratio due to suppression of reactions that stem
from the production of highly reactive but non-selective hydroxyl radicals.122 Thus, under
these conditions the observed A/K ratio for catalytic ROOH oxidation of cyclohexane
increased and moreover it was not influenced by the presence of O2. Furthermore when cis-
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1,2-dimethylcyclohexane is used as substrate, the stereospecific hydroxylation of the cis-1,2-
dimethyl groups was detected.123 Such reactivity patterns suggest very short lived alkyl
radicals not consistent with reactions involving RO∙. A further characteristic of this family of
non heme iron complexes is that they will catalyse the epoxidation of alkenes by H2O2 as well
as stereospecific cis-dihydroxylation.124.
Several non-heme iron-based catalytic oxidation systems with relevant potential
applications have been developed. For instance, the iron(II) complexes of N4py and TPA
catalyse alcohol oxidation via oxygen transfer from the [FeIV(N4Py)(O)]2+ and
[FeIV(TPA)(O)]2+ complexes.125, 126Another important observation is that of Jacobsen et al127
who found that the addition of acetic acid enhanced the catalytic alkene epoxidising activity
of several non-heme iron complexes. The acetic acid was found to significantly enhance the
yield of epoxide. Using acetic acid as a 30% additive the epoxidation of terminal alkenes by
[Fe(BPMEN)(CH3CN)2]2+ could be carried out in 90% yield, using only 3% of the iron
catalyst and H2O2 at 4°C in 50% excess. A similar enhancement of alkene epoxidation
activity, at the expense of cis-dihydroxylation, was observed when acetic acid was added to
[Fe(TPA)(CH3CN)2]2+.128 Such activity has been attributed to the in-situ generation of
peracetic acid in these solutions on the basis of largely identical behaviour (enhancement of
epoxidation) seen on substituting acetic acid/H2O2 by peracetic acid.129 It has been well
documented that cyclohexane oxidations by peracids such as m-chloroperbenzoic acid
(mCPBA) when catalysed by the tetradentate [Fe(BPMEN)(CH3CN)2]2+ and
[Fe(TPA)(CH3CN)2]2+ give significantly higher A/K ratios than when using H2O2 or tBuOOH.
This a feature attributed to heterolytic O-O cleavage of the percarboxylatoiron(III) precursor
to generate a formally LFeV=O species. The formation of this species has been proposed to
account for enhanced epoxidation activity, in particular when seen at the expense of cis–
dihydroxylation. A correlation between high A/K ratios in cyclohexane oxygenation catalysis
with high alkene epoxidation activity can be observed and particularly when at the expense of
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cis-dihydroxylation offers the best marker yet for the presence of an active formally LFeV=O
centre. However it appears that formally LFeV=O may not be formed in all cases of iron
catalysis of peracid oxygenations. The percarboxylatoiron(III) adduct formed from reaction of
pentadentate [Fe(N4Py)(CH3CN)]2+ with m-CPBA parallels the behaviour of the hydroperoxo
adduct in as it appears to only undergo homolytic O-O cleavage to access an FeIV=O oxidant
reflecting the need for a second labile (cis) site to be present in order to access the more
potent LFeV=O oxidant128. The homolytic O-O behaviour is apparent in a significantly lower
cyclohexane A/K ratio (1.3) when oxygen is present compared to when the reaction is carried
our under inert atmosphere (5.6) implying both a metal based oxidant but also the presence of
O2 trappable long lived alkyl radicals presumably via competing H abstraction by C- or O-
centred radicals.130
Figure 1.17: Enantioselective catalysis of H2O2 hydroxylation at 2o and 3o C-H bonds in the
antimalarial drug artemisinin, and tetrahydrogibberellic acid, respectively, by the asymmetric
complex; [Fe(L7)(CH3CN)2]2+ (L7 = S,S-PDP) in the presence of acetic acid.131
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One of the most remarkable applications of the Fe(BPMEN)-H2O2-acetic acid system
was recently reported by White and Chen using an iron complex of an asymmetric BPMEN-
type ligand; [Fe(L7)(CH3CN)2]2+ (L7 = S,S-PDP), figure 1.17. It was discovered that tertiary
C-H bonds such as C10 in the antimalarial drug artemisinin are catalytically hydroxylated by
this metal complex and H2O2 in the presence of acetic acid, without altering other functional
groups. The enantioselective hydroxylation was carry out using 5 mol% catalyst; the product
being obtained in 40-60% yield.131 In most cases, the tertiary C-H bonds hydroxylated are the
most rich electronically as well as the most accessible. It was also found that if the substrate
possessed carboxylate functionality, such as in the case of the tetrahydrogibberellic acid
analogue, it was able to direct the iron-based oxidant to attack at a particular nearby C-H
bond, to give the lactone, figure 1.17. This implies that the promoting effect of the acetic acid
might, at least in part, be through coordination of acetate (or indeed any other available
carboxylate moiety) to the iron active species. These two examples show how simple
biomimetic iron-based catalysts can be active in promoting enantioselective and
regioselective hydroxylation of organic molecules with complex structures.
Another family of iron complexes highly active towards promoting peroxide
oxygenations in aqueous media are those of the macrocyclic tetraamide ligand TAML (L8),
figure 1.18, developed by Collins et al. Several of these have moreover been investigated for
Figure 1.18: Structures of the tetraamide macrocycle ligand TAML (L8) (left) and its S = 1 d4
iron(IV) complex [Fe(O)(TAML)]2- complex (C4).
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the removal (complete oxidative degradation) of various toxic environmental POMs such as
PCPs. Fe-TAML species show promising activity towards activating H2O2 for this purpose
and wide scale environmental use is a possibility. Possible uses include the removal of
persistent organic molecules (POMs) associated with textile, pulp, paper and pesticide
industries, the removal of sulfur from hydrocarbon fuels132 and the rapid killing of anthrax-
like spores. An extremely powerful oxidant appears relevant to this system and very recently
chemical and spectroscopic evidence has been found for generation of two high valent iron
species consisting of both S = 1 and S = 2 d4 iron(IV) oxo centres133, 132 and, most
interestingly, an S = ½ d3 perferryl iron(V) oxo centre. The S = ½ d3 iron(V) species
[FeV(O)(TAML)]- was only characterised at low temperature in solution (-70oC) following
reaction of the iron(III) complex [FeIII(OH2)(TAML)]- with mCPBA.134 However it proved
stable enough at this temperature to allow its full characterisation by MS, Mössbauer, EPR
and XAS supported by DFT calculations. This S = ½ species represents the first example of a
fully characterized iron(V) oxo complex which is believed to be the active oxidant species in
catalysis of the degradation of numerous environmental POMs by H2O2 in the presence of Fe-
TAML complexes.42 Evidence for the involvement of discrete iron(V) oxo centres in
biological processes is increasing. Following 18O labelling experiments Que and co-workers
have concluded that an iron(V) oxo species formulated as HO-FeV=O is the relevant oxidant
in most enzymatic transformations carried out by the Rieske dioxygenase family.121
Examples of genuine iron(V) complexes are still however rare. Wieghardt et al have
spectroscopically characterized an S = ½ iron(V) complex with a terminal nitrido group
obtained by a photochemical N-N bond cleavage reaction on an iron(III)-azido complex.135
1.3.7 Mimicking the iron oxygenase enzyme macro environment.
Methane monooxygenase and cytochrome P-450 both possess structures wherein the
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non-heme diiron and the heme-iron active sites respectively are embedded within a
hydrophobic pocket, partly to attract (solubilise) the hydrophobic C-H substrate but also to
assist selective uptake and subsequent hydroxylation (oxygenation).136 Both enzymes work in
aqueous media. However the feasibility of creating a local hydrophobic macro environment
within an aqueous soluble lab-based hydroxylating catalyst has received little attention. Fish
et al. have reported studies on alkane functionalization by (tBuOOH)/O2 in aqueous media
using [Fe2O(µ-OAc)(TPA)2]3+ as a pre-catalyst embedded within amorphous silica modified
by alternate incorporation of hydrophilic and hydrophobic polyethylene oxide (PEO) and
polypropylene oxide (PPO) pendant groups. It was observed that this artificial scaffold
mimics the hydrophobic active site of MMO enzyme facilitating the oxidation of alkanes
using t-BuOOH/O2 as oxidant in aqueous medium (pH 4.2). The results of these experiments
are shown in table 1.4137. The products obtained were cyclohexanol, cyclohexanone and
Table 1.4: Oxidation of Alkanes with 1wt% [Fe2O(µ-OAc)(TPA)2]3+, 10% PPO,10% PeO-
SiO2a
Substrate Total TON Products %
cyclohexane 238 cyclohexanone
cyclohexanol
cyclohexyl-tert-butyl peroxide
51
16
33
cycloheptane 146 cycloheptanone
cycloheptanol
cycloheptyl-tert-butyl peroxide
55
16
26
tetrahydronaphthalene 141 α-tetralone
α -tetralol
94
6
ethylbenzene 157 acetophenone
1-phenylethanol
72
28
n-nonane 31 2-,3-,4-nonanone
2-,3-,4-nonanol
68
32
a Reactions were carried out by mixing 0.38 mmol alkane, 3.8 mmol TBHP in 5 cm3 water at pH 4.2, with 0.38
mmol precatalyst (as 1 wt% [Fe2O(µ-OAc)(TPA)2]3+on 10% PPO,10% PEO-SiO2) for 3 h at room temperature.
bProduct as mol % total products. Yields cased on TBHP were 80-90%.
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cyclohexyl-tert-butyl-peroxide with a 1:3:2 ratio when cyclohexane was used as substrate.
The catalytic activity was found to be crucially dependent on the balance between PEO and
PPO tethered on the silica surface. The silica-based assembly showed reactivity somewhat
higher in comparison to an aqueous micelle system utilising cetyltrimethylammonium
hydrogen sulphate as a surfactant.
An alternative way of creating a local hydrophobic microenvironment for the iron-
TPA system is to attach hydrophobic groups to the TPA ligand itself. Possible synthons for
this are tris(6-amino-2-pyridylmethyl)amine (6-(NH2)3-TPA) (attachment via
amide/urea/amine),138 ,139 figure 1.19a, and tris(6-hydroxymethyl-2-pyridylmethyl)amine (6
(a) (b)
Figure 1.19: (a): Iron(III) complexes of (L9) tris(6-neopentylamino-2-pyridylmethyl)amine
(R = C6H5) (a) and (L10) N’,N’’,N’’’-tris(t-butylamidoaminoethyl)amine (b) showing
hydrogen bonding from N-H to stabilize terminal hydroxo and oxo ligands respectively.138, 140
-(OH)3-TPA) (attachment via ether/ester). Studies have shown that when TPA coordinates to
transition metal centres the 6-py positions are orientated along the same direction. Thus
attachment of peralkyl substituents at the 6-position should lead to the creation of a
hydrophobic pocket which moreover might lead to a substrate orientation/proximity effect to
facilitate oxygenation on the usually more inert C-1 position on a linear alkane, figure 1.20.
Metal complexes containing such ligands could also be studied for activity towards alkane
oxygenation in a micellar aqueous system.
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An additional feature of several of the alkane oxygenase enzymes alongside the active
site hydrophobicity is the presence of intra molecular hydrogen-bonding networks which may
regulate the properties/creation of the oxo-metal centres. The X-ray structure of compound I
of cytochrome c peroxidase shows the presence of hydrogen-bonding from an active site
arginine (Arg 48) to the FeIV=O centre141 which may be important in stabilizing (prolonging
the lifetime) of this reactive high valent species as well as tuning its reactivity.
FeN
N
N
O
N
O
O
O
CH3
HO
X
FeN
N
N
O
N
N H
N
NH
H
N
N
O
O
O
CH3
O
X
NH H
H
H
Figure 1.20: Putative hydroperoxo-iron(III) complexes of peralkylated TPA derivatives
tris(6-n-octyloxymethyl-2-pyridylmethyl)amine (a) (see chapter 3) and tris(6-n-octylureayl-2-
pyridylmethyl)amine (b) (see chapter 4) showing hydrogen bonding from urea N-H groups to
stabilize the hydroperoxo group. In both a putative n-heptane molecule is shown orientated in
the pocket in such a way as to facilitate possible oxygenation at the less reactive C-1 position.
In this regard Borovik et al have reported rare examples of mononuclear MnII/III and FeIII/II
complexes containing hydroxo and oxo ligands coordinated within a tripodal TPA-like ligand,
stabilised through intramolecular hydrogen-bonding. Use of the tripodal ligand; (L10)
N’,N’’,N’’’-tris(t-butylamidoaminoethyl)amine , figure 1.19b, creates a protective hydrogen-
bonded cavity around the MIII-O(H) units (MIII = Fe and Mn).140 Here the t-butyl groups are
orientated upwards to encapsulate the hydrogen-bonded Fe(III)-‘O’ centre. Thus one finds the
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intriguing situation of a high valent metal centre located inside a hydrophobic pocket where
the oxo ligand is stabilized through N-H hydrogen bonds. The catalytic behaviour of such
derivatives has yet to be fully explored.
The only 6-py substituted iron-TPA complexes to have received detailed
investigations as to their catalytic alkane hydroxylating ability are those of the 6-Men-TPA (n
= 1-3) derivatives.122 [Fe(6-Me-TPA)(CH3CN)2]2+ shows comparable activity in H2O2
oxygenation catalysis on cyclohexane (A/K = 7.0) and adamantane (3o/2o = 30) to that shown
by [Fe(TPA)(CH3CN)2]2+ and [Fe(BPMEN)(CH3CN)2]2+ implying a metal–based oxidant.
However the presence of 6-Me substituents on two or all three of the pyridines results in high
spin peroxoiron(III); [Fe(L)(OOH)]2+ intermediates and a product profile more consistent
with the involvement of hydroxyl and long lived alkyl radicals (A/K = 1 - 2) despite some
evidence of a higher selectivity than OH radicals towards C-H bond cleavage (cyclohexane
KIE 3.3 – 4.0, adamantane 3o/2o = 15 - 33).122 This shows that some of the selectivity
demonstrated by the iron TPA family of complexes is encouragingly retained upon 6-py
substitution.
1.3.8 Adaptation of iron-TPA based oxidants to the fluorous biphase.
A number of approaches have been devised in homogeneous catalysis to overcome the
problem of catalyst separation from the substrate-product mixture. Use of fluorous biphasic
(FBC) solvent system is one of them wherein a catalyst saturated with fluorous groups is
retained in a perfluorinated solvent while the products and substrate are retained in a different
phase. At low temperature the two phases separate allow easy removal and recovery of the
catalyst.142 It is well known that perfluorohydrocarbons have unusual properties that entail
being extremely hydrophobic and lacking hydrogen bonding capability which renders them to
be relatively insoluble in their hydrocarbon analogues. They also have the propensity to
dissolve various gases very efficiently such as oxygen, hydrogen and carbon dioxide. Fish and
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co-workes have shown how the FBC concept is a practical way to separate the catalyst from
the substrate or product containing phase in the oxidation of alkanes and alkenes using
tBuOOH and O2 gas as oxidating agent.142 The synthesis of Rf-perfluoroalkyl synthons such
as 3-perfluoroctyl-1-iodopropane, 3-perfluorooctyl-1-propanol (Rf =-(CH2)3-(CF2)7-CF3) was
reported along with a variety of new Rf-perfluoroalkylated ligands with amines such as 1,4,7-
triazacyclononane (TACN), bis-picolylamine and bis(1,2-picolylamino)diethylenediamine. It
was found that only 1,4,7-tris-N-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro
undecyl)-1,4,7-triazacyclononane (Rf-TACN) is completely soluble. The ligand must contain
at least 57% of fluorine in order to be fully soluble. The Rf-TACN ligand was combined with
[Mn(O2C(CH2)2C8F17)2] and [Co(O2C(CH2)2C8F17)2] metal complexes with Rf-
perfluoroalkylcarboxylate coordinated to the metal, to produce the corresponding RfMn2+-
RfTACN and RfCo2+-RfTACN pre-catalyst for the oxidation by these metals. Use of Rf-
perfluoroalkyl synthons like 3-perfluoroctyl-1-iodopropane with deprotonated synthons such
as 6-(OH)3-TPA (ether link formation) offers a route to generating interesting hydrophobic
fluorocarbon-soluble perfluoro iron-TPA systems, e.g., figure 1.21, analogous to those in
figure 1.20, for investigating iron-based FBC of peroxide alkane oxygenation.
1.4 Summary and conclusions
The considerable progress in the understanding of the mechanisms underpinning how
iron or copper-based oxygenase enzymes catalyse a variety of C-H bond oxygenation
processes over the last 30 years has motivated the increase of a range of new synthetic
biomimetic systems. A promising number of iron, manganese, nickel and copper complexes
armed with non-porphyrin ligands active in the catalytic oxidation of alkanes and alkenes
with H2O2 or even O2 have been discovered. A recurring theme especially concerning those
reactions utilising H2O2 as oxidant has been to determine the optimum reaction conditions
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Figure 1.21: A putative fluorous-soluble hydroperoxo-iron(III) complex of a tris(6-
perfluoralkyloxymethyl-2-pyridylmethyl)amine ligand.
that prevents generation of OH radicals which are unselective and facilitate the formation of a
high valent oxidant via O-O bond heterolysis of its peroxo precursor. The generation of a
more selective metal-based oxidant makes possible substrate oxidations with noteworthy
chemo-, region- and steroselectivity; and it could be applied in the chemical industry. The
catalytic oxidation of n-alkane C-1 bonds to 1-oxygenates constitute still one of the most
challenging chemical processes. Ultimately the use of O2 as oxidant (source of O) is most
desired from a cost point of view since aqueous H2O2 still remains a relatively expensive
commodity oxidant to both use and transport. Important features in ligand design also need to
be taken in account. The tunnelling effect could be the key factor towards achieving efficient
alkane oxidation and selectivity. It is also important to address what is the best ligand donor
set for generating the right kind of reactive oxygenating species. The role of ancillary ligands,
such as pyridine or carboxylate requires further investigation. Finding a sophisticated ligand
which could facilitate a tunnelling effect and at the same time increase the alkane solubility /
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regioselective reaction is still the goal for future research. Finally adapting the metal-based
oxidant system to work under fluorous biphasic conditions could allow the easy removal and
recycling of catalysts by solubilisation in the fluorous media which could be a key feature for
industrial commercialization.
In the subsequent chapters the chemistry of iron complexes of a number of new 6-py
peralkylated derivatives of TPA is explored with a view to the design of a hydrophobic
catalyst ultimately aimed at enhanced activity for the regioselective H2O2 oxygenation of n-
alkanes at the C-1 position to give 1-oxygenates. In chapter 2 the chemistry of iron(III) and
manganese(II) complexes containing the precursor ligand tris(6-hydroxymethyl-2-
pyridylmethyl)amine ((6-OH)3-TPA) is described, while the iron chemistry of several
completely new tris(6-alkyloxymethyl)TPA derivatives, synthesized from 6-(OH)3-TPA, is
explored in chapter 3. Chapter 4 describes the characterisation and chemistry of iron
complexes of a family of new 6-peralkylureido-TPA ligands, while chapter 5 discusses the
results of catalytic H2O2 oxygenations on cyclohexane carried out by the entire family of new
iron-TPA complexes synthesised in the preceding chapters. The studies with 6-(OH)3-TPA in
chapter 2 have already been published.143
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Chapter 2
Synthesis of Tris(6-hydroxymethyl-2-pyridylmethyl)amine (H3L11)
and a study of its coordination chemistry with CuII, MnII and FeIII.
2.1 Introduction
Transition metal complexes of tris(2-pyridylmethyl)amine (TPA) and its substituted
derivatives have been studied extensively in recent years as providing models for the
active sites of various metalloproteins.1-5 Considerable interest has particularly
surrounded models for a range of non-heme iron1,2 and copper oxygenases as well
as to provide bio-inspired C-H oxidation catalysts.1-3 Several TPA complexes have
moreover been patented as catalysts for alkaline bleaching.6 Further interest stems
from the effects of introducing substituents  to the pyridyl nitrogen which can be
used to provide further functionality and/or to generate steric interactions that modify
the properties such as spin state and redox potentials.7-11 The metal complex
[FeII(TPA)(CH3CN)2]2+ and its corresponding t-butylperoroxoiron(III) derivative are
both low spin, the introduction of only one CH3 at the 6-position of the py ring
originates a significant change, while the t-butylperoxoiron(III) derivative remains low
spin the iron(II) complex [FeII(6-MeTPA)(CH3CN)2]2+ is high spin. The introduction
of two or three 6-Me substituens results exclusively in high spin iron(II) and iron (III)
complexes.7 This has important consequences for subsequent reactions of these
species in the context of H2O2 or tBuOOH-dependent oxidation catalysis. The
introduction of co-ordinating substituents also serves to access multinuclear metal
derivatives.12-15 Colbran et al have described the synthesis of three TPA derivatives
bearing one, two or three hydroxymethyl group(s), respectively, at the 6-position on
the pyridine rings and have described the chemistry of both mono and polynuclear
copper(II) derivatives.16,17 Tris(6-hydroxymethyl-2-pyridylmethyl)amine (H3L11) is
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particularly attractive since unlike TPA itself it is water soluble and stable to alkaline
pH offering potential as a ligand for developing aqueous-based oxygenation
(bleaching) catalysts.6 On the other hand peralkylation of the OH groups (ether
formation) quickly introduces hydrophobicity for the synthesis of hydrocarbon-
soluble/micellar transition metal oxidation catalysts.18 Studies on several alkylated
derivatives of H3L11 are reported in chapter 3. Finally, oxidation of the hydroxymethyl
substituent offers a ready route to the synthesis of further 6-substituted derivatives
having carboxylato17 and carboxamido groups. Previously reported samples of H3L1
were contaminated by the presence of co-crystallised NaBr which led to disordered Cl-
and Br- ion occupancy in the crystal structure of the copper(II) chloride complex C5
[Cu(H3L11)Cl]Cl.16 In this work a bromide-free pure sample of H3L11 has been
prepared which has allowed isolation of a pure sample of the chloride salt;
[Cu(H3L11)Cl]Cl as well as a new structural isomer of the bromide salt; C6
[Cu(H3L11)Br]Br. The coordination chemistry has also been expanded here to include
hepta-co-ordinated manganese(II) and iron(III) derivatives. The iron(III) complex is
linear trinuclear possessing a novel alkoxide-bridged cationic unit with the tightest Fe-
O-Fe angle (87.6o) and shortest Fe…Fe distance (2.834 Å) yet found for a pair of
weakly antiferromagnetically-coupled alkoxide-bridged Fe(III) centres. These findings
have challenged current theories involved in correlating the extent/nature of magnetic
interactions in such species based on Fe-O(bridge) distances and Fe-O-Fe angles. The
Cu(II), Mn(II) and trinuclear Fe(III) complexes of H3L11 have been tested as low
temperature bleaching catalysts in comparison with the patented complexes of TPA.
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2.2 Results and Discussion
2.2.1. Synthesis of Tris(6-hydroxymethyl-2-pyridylmethyl)amine (H3L11). In this
work H3L11 was prepared by a slight modification of the literature method16 following
treatment of 6-(bromomethyl)-2-(hydroxymethyl)pyridine19 in acetonitrile with
ammonium acetate and sodium carbonate. Flash chromatography (35-7060Å silica
gel column) of the filtered and combined acetonitrile fractions ensured no residual
bromide was present which had contaminated previously reported samples.16 The
improvement in purity was illustrated by successful isolation of an analytically pure
sample of the Cu(II) complex [Cu(H3L11)Cl]Cl.
2.2.2. Synthesis and characterisation of monochloro(tris(6-hydroxymethyl-2-
pyridylmethyl)amine)copper(II) chloride, [Cu(H3L11)Cl]Cl. (C5)
Blue-green blocks of [Cu(H3L11)Cl]Cl were obtained after 3 days by diethyl ether
vapour diffusion into a methanol solution of anhydrous copper(II) chloride and H3L11.
Using anhydrous copper(II) chloride we did not encounter the blue oils that had
impaired crystallisation of copper(II) complexes in previous work.16 Figure 2.1
illustrates the molecular structure with relevant bond lengths and angles shown in table
2.1. The molecular structure of [Cu(H3L11)Cl]Cl is very similar to that for the
disordered Br-/Cl- derivative obtained previously16 with a single hydroxymethyl arm
attached to the copper trans to the amine nitrogen along with the other 3 nitrogens and
single chloride. The hydrogen atoms are included in idealised positions apart from on
the co-ordinated hydroxymethyl arm. The co-ordination geometry at copper can be
viewed as 4+2 with a significant tetragonal distortion along two Cu-N bonds to the
two pyridyls that are approximately trans, Cu-N(24) (2.47 Å) and Cu-N(14) (2.57 Å).
The remaining bond lengths from copper(II) to the other two nitrogens,
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hydroxymethyl oxygen and chloride are normal for equatorial plain positioning within
such a tetragonally-distorted structure. As observed previously with co-ordination of
H3L11 versus its mono- and bis-(6-hydroxymethyl) counterparts coordination of the
single hydroxymethyl arm necessitates it to be trans to the amine nitrogen. The single
chloride counter anion is hydrogen-bonded to the acidic hydrogen of the bound
hydroxymethyl group. As a result there is no hydrogen-bonding observed here
between OH groups on adjacent hydroxymethyl arms of the cation as was observed
previously16 showing this to be not a hugely important templating interaction.
Figure 2.1: View of the coordination geometry around Cu(II) in [Cu(H3L11)Cl]Cl
Table 2.1: Selected bond lengths (Å) and angles (°) for [Cu(H3L11)Cl]Cl (esd’s in
parentheses).
Cu(1)-N(4) 1.939(17) Cu(1)-O(9) 2.065(15)
Cu(1)-N(1) 2.096(17) Cu(1)-N(14) 2.567(17)
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Cu(1)-N(24) 2.466(17) Cu(1)-Cl(1) 2.222(5)
N(4)-Cu(1)-O(9) 78.7(6) O(9)-Cu(1)-N(24) 106.9(6)
N(4)-Cu(1)-N(1) 84.2(7) N(1)-Cu(1)-N(24) 74.8(6)
O(9)-Cu(1)-N(1) 162.7(6) Cl(1)-Cu(1)-N(24) 96.5(4)
N(4)-Cu(1)-Cl(1) 173.9(5) O(9)-Cu(1)-Cl(1) 95.5(4)
N(1)-Cu(1)-Cl(1) 101.5(5) N(4)-Cu(1)-N(24) 87.1(6)
__________________________________________________________________________________
2.2.3. Synthesis and characterisation of monobromo(tris(6-hydroxymethyl-2-
pyridylmethyl)amine)copper(II) bromide, [Cu(H3L11)Br]Br. C6
Orange crystals of (C6) [Cu(H3L11)Br]Br were obtained following diethyl ether
vapour diffusion into a solution of anhydrous copper(II) bromide and H3L11 in
methanol. The X-ray structure is shown figure 2.2 with selected bond lengths and
angles shown in table 2.2. In contrast to [Cu(H3L11)Cl]Cl the copper(II) in
[Cu(H3L11)Br]Br is in a distorted square-pyramidal geometry with only two of the
three pyridyl groups coordinated and the copper slightly above the distorted basal
plane. The basal positions are occupied by two pyridines, the tertiary amine and one
of the hydroxymethyl arms. The single coordinated bromide ion is apical. The Cu-N
distance to the third pyridine is 3.130 (4) Å.
The two non-coordinated hydroxymethyl groups are in a hydrogen-bonded network
with the free bromide counter anion located close by (av O---Br 3.26 Å). The co-
ordinated hydroxymethyl arm is further hydrogen-bonded to the hydroxo group of one
of the non co-ordinated arms (O(9)---O(29) 2.62 Å). The important hydrogen-bonding
parameters are shown in table 2.3.
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Figure 2.2: View of the coordination geometry around Cu(II) in
[Cu(H3L11)Br]Br
Table 2.2: Selected bond lengths (Å) and angles (°) for [Cu(H3L11)Br]Br (esd’s in
parentheses).
Cu(1)-N(1) 2.089(4) Cu(1)-O(9) 2.068(4)
Cu(1)-N(4) 1.938(4) Cu(1)-Br(1) 2.4841(7)
Cu(1)-N(14) 1.968(4) Cu(1)-N(24) 3.000(4)
N(4)-Cu(1)-N(14) 164.53(15) N(1)-Cu(1)-O(9) 144.63(13)
N(4)-Cu(1)-N(1) 82.13(15) N(4)-Cu(1)-Br(1) 96.58(11)
N(14)-Cu(1)-N(1) 82.88(14) N(14)-Cu(1)-Br(1) 94.03(10)
N(4)-Cu(1)-O(9) 76.69(14) N(1)-Cu(1)-Br(1) 119.15(10)
CHAPTER 2
61
N(14)-Cu(1)-O(9) 114.34(13) O(9)-Cu(1)-Br(1) 91.42(9)
Table 2.3: Hydrogen-bonding parameters for [Cu(H3L11)Br]Br (esd’s in
parentheses).
D-H--A d(D-H)/ Å d(H--A)/ Å d(D--A)/ Å >(DHA)/o
O(9)-H(9O)--O(29) 0.9800(11) 1.65(2) 2.616(2) 166(8)
O(19)-H(19O)--Br(2) 0.9800(11) 2.35(3) 3.247(4) 152(6)
O(29)-H(29O)--Br(2) 0.9800(11) 2.56(10) 3.282(7) 130(10)
This structure is markedly different to that reported previously16 for the same
compound [Cu(H3L11)Br]Br and illustrates the flexible co-ordination chemistry
apparent for H3L. In Colbran’s structure the copper(II) centre is in a tetragonally-
distorted octahedral geometry, similar to the copper(II) chloride complex here, but
with highly differing Cu-N bonds to the two trans pyridyls (2.32 A and 2.78 A).
However the donor atom positions are completely different to the structure obtained
here with the co-ordinated bromide in an equatorial position cis to long a Cu-N(py)
bond. In the structure here the bromide is cis to both co-ordinated pyridyl groups and
the tetragonal distortion is more extreme leading to a five co-ordinated square-
pyramidal geometry with only two pyridyl groups coordinated and the bromide apical.
It is concluded that these two structural forms for this complex must be very close in
energy given the similar methods of preparation and isolation. The greater degree of
tetragonal distortion towards five co-ordination with bromide as coordinated halogen
compared with chloride could be due to increased steric repulsion from the larger ion.
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2.2.4. Synthesis and characterization of (tris(6-hydroxymethyl-2-pyridylmethyl)
amine)manganese(II) chloride trihydrate, [Mn(H3L1)]Cl2.3H2O. (C7)
Colourless crystals of (C7) [Mn(H3L11)]Cl2.3H2O suitable for X-ray investigation
were obtained following diethyl ether vapour diffusion into a solution of MnCl2.4H2O
and H3L11 in methanol. Here the structure revealed co-ordination of all seven donors
from H3L11 to the Mn(II) centre, figure 2.3, in a distorted capped trigonal prismatic
arrangement. Selected bond lengths and angles are shown in table 2.4. Three
hydroxymethyl arms occupy the basal positions of the distorted trigonal prism with the
longer bond to the tertiary amine nitrogen (2.44Å) capping the expanded triangular
face formed by Mn-N bonds to the three pyridyl nitrogens at the apex of the distorted
prism. Co-ordination of all three hydroxymethyl arms to the metal here is not
unexpected given the higher affinity for oxygen as donor by the hard Mn(II) centre.
The common co-ordination number for Mn(II) is six but the appearance here of a
hepta-co-ordinated complex is not unexpected20 given the high spin d5 configuration,
relatively large radius and zero associated crystal field stabilisation energy.
Figure 2.3: View of the coordination geometry around Mn(II) in [Mn(H3L11)]Cl2.3H2O
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Table 2.4: Selected bond lengths (Å) and angles (°) for [Mn(H3L11)]Cl2.3H2O (esds in
parentheses).
Mn(1)-O(9) 2.253(3) Mn(1)-N(1) 2.440(7)
Mn(1)-N(4) 2.268(4)
N(4a)-Mn(1)-N(4) 108.93(9) O(9a)-Mn(1)-O(9) 81.12(15)
N(4)-Mn(1)-N(1) 69.99(9) O(9)-Mn(1)-N(1) 131.34(10)
O(9)-Mn(1)-N(4a) 98.38(13) O(9a)-Mn(1)-N(4) 150.83(13)
O(9)-Mn(1)-N(4) 70.07(13)
___________________________________________________________________________________
2.2.4. Synthesis and characterization of bis(tris(6-oxymethyl-2-
pyridylmethyl)amine)triiron(III) perchlorate acetonitrile solvate,
[Fe3(L11)2](ClO4)3.nCH3CN (n = 1 or 2). (C8)
The synthesis of [Fe3(L11)2](ClO4)3.nCH3CN followed the procedure of Masuda et al21
for the preparation of the Fe(III) complex of tris(6-pivalamido-2-pyridylmethyl)amine.
Masuda used sodium benzoate to introduce a carboxylate ligand for the purpose of
successfully modelling the active ferric site of soybean lipoxygenase-1.22 We therefore
adopted the same approach in the expectation of making an analogous mononuclear
Fe(III) complex. As in the reported synthesis oxidation of Fe(II) to Fe(III) occurs
spontaneously in the air. However in the case of H3L11 the greater affinity for oxygen
donors by the hard Fe(III) centre leads to coordination of all three hydroxymethyl
arms as in the case of the Mn(II) complex above. Furthermore the increased acidity of
the hydroxyl protons as a result of coordination to Fe(III) leads to deprotonation in the
presence of benzoate (acting here as base) and formation of an alkoxide-bridged linear
trinuclear complex via incorporation of an additional Fe(III) centre. This was further
confirmed by the analytical presence of co-crystallised benzoic acid along with sodium
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perchlorate in the initially analysed yellow-brown solid residue although vapour
diffusion of diethyl ether into an acetonitrile solution of a recrystallised sample gave
X-ray quality crystals solvated by two acetonitriles. The structure of
[Fe3(L11)2](ClO4)3.2CH3CN, figure 2.4, consists of a six-coordinated Fe(III) bound
only to the bridging alkoxide groups flanked by two hepta-coordinated Fe(III) centres
coordinated to the three bridging alkoxides and the four nitrogen donors of L11.
Selected bond lengths and angles are listed in table 2.5. The central hexa-coordinated
iron(III) is distorted from octahedral towards trigonal antiprismatic geometry (range
Fe-O = 1.99-2.10 Å; tight O-Fe-O = ~80o, open O-Fe-O ~100o). The two hepta-
coordinated iron(III)’s are in a distorted capped trigonal prismatic geometry similar to
that found in [Mn(H3L11)]Cl2 with the bond to the tertiary amine distinctly longer (Fe-
N = 2.366 Å) than those to the pyridine nitrogens (av Fe-N = 2.13 Å) and capping the
expanded triangular face of the trigonal prism formed by the latter. Crystal data for all
four complexes reported in this chapter are shown in table 2.6.
Figure 2.4: View of the trinuclear Fe(III) cationic unit of [Fe3(L11)2](ClO4)3.2CH3CN
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Table 2.5: Selected bond lengths (Å) and angles (°) for [Fe3(L11)2](ClO4)3.2CH3CN
(esds in parentheses).
Fe(1)-O(29) 2.102(2) Fe(1)-O(9) 2.082(2)
Fe(2)-O(9) 1.989(2) Fe(1)-O(19) 2.097(2)
Fe(2)-O(19) 2.003(2) Fe(1)-N(4) 2.133(3)
Fe(2)-O(29) 2.010(2) Fe(1)-N(24) 2.143(3)
Fe(2)-Fe(1) 2.8343(5) Fe(1)-N(14) 2.115(2)
Fe(1)-N(1) 2.366(3)
O(29)-Fe(2)-O(29a) 180.000 O(19)-Fe(1)-N(4) 150.30(10)
O(29)-Fe(2)-O(9) 79.62(9) O(9)-Fe(1)-N(4) 75.16(10)
O(29a)-Fe(2)-O(9) 100.38(9) O(29)-Fe(1)-N(24) 74.69(9)
O(9)-Fe(2)-O(9a) 180.000 O(19)-Fe(1)-N(24) 94.59(9)
O(29)-Fe(2)-O(19a) 100.79(9) O(9)-Fe(1)-N(24) 150.05(9)
O(19)-Fe(2)-O(29) 79.21(9) N(4)-Fe(1)-N(24) 109.33(10)
O(9)-Fe(2)-O(19) 79.56(8) O(29)-Fe(1)-N(14) 150.20(9)
O(9a)-Fe(2)-O(19) 100.44(8) O(19)-Fe(1)-N(14) 75.20(9)
O(19a)-Fe(2)-O(19) 180.000 O(9)-Fe(1)-N(14) 95.37(9)
O(29)-Fe(1)-O(9) 75.45(8) N(4)-Fe(1)-N(14) 111.16(10)
O(29)-Fe(1)-O(19) 75.05(8) O(29)-Fe(1)-N(4) 94.09(9)
___________________________________________________________________________________
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Table 2.6: Numerical crystal and refinement data for complexes of H3L11 determined by X-ray crystallography at 93(2)K
__________________________________________________________________________________________________________
[Cu(H3L11)Cl]Cl [Cu(H3L11)Br]Br [Mn(H3L11)]Cl2.3H2O [Fe3(L11)2](ClO4)3.2CH3CN
__________________________________________________________________________________________________________
Formula C21H24Cl2CuN4O3 C21H24Br2CuN4O3 C21H30Cl2MnN4O6 C46H42Cl3Fe3N10O18
M 514.88 603.80 560.33 1296.80
Crystal system Monoclinic Monoclinic Trigonal Monoclinic
Space Group P21/c P21/n R-3c P21/c
a/Å 9.2202(14) 8.6000(13) 13.0839(4) 11.4502(11)
b/Å 25.647(4) 8.2400(13) 13.0839(4) 20.814(2)
c/Å 10.0745(16) 33.120(5) 54.374(2) 11.5548(11)
/o 90 90 90 90
/o 113.014(4) 96.5 90 108.197(2)
/o 90 90 120 90
V/Å3 2192.7(6) 2331.9(6) 8061.1(5) 2616.1(4)
Z 4 4 12 2
/cm-1
Reflections collected 11331 14320 13811 14484
Rint (no. of equivalent reflections) 0.0549 0.0309 0.0406 0.0379
Observed reflections [I/(I) > 2] 3645 3942 1753 4894
Final R, Rw [I/(I) > 2] 0.0629, 0.1395 0.0421, 0.1079 0.0850, 0.2262 0.0551, 0.1115
67
2.2.6. DC Magnetic Susceptibility Studies on [Fe3(L11)2](ClO4)3.2CH3CN.
Direct current magnetic susceptibility studies were performed on a powdered polycrystalline
sample of [Fe3(L11)2](ClO4)3.2CH3CN in the 5 – 300 K range in an applied field of 0.1 T. The
results are plotted as the χMT product versus T in figure 2.5. The room temperature χMT value
of approximately 11.4 cm3 K mol-1 is slightly lower than that expected for three non-
interacting Fe(III) ions (13.125 cm3 K mol-1). Upon cooling, the value of χMT decreases
gradually to approximately 4 cm3 K mol-1 at 5 K. This behaviour is indicative of weak
antiferromagnetic exchange between the metal centres with the low temperature maximum
suggesting an S = 5/2 ground state.
Figure 2.5: Plot of χMT versus T for [Fe3(L11)2](ClO4)3.2CH3CN in the temperature range 5 -
300 K. The solid line is a simulation of the experimental data.
68
Inspection of the molecular structure suggests the presence of only one exchange interaction
(J1) between the central metal ion Fe(2) and the peripheral Fe ions (Fe(1) and symmetry
equivalent) mediated by the µ-bridging alkoxide ligands. However, attempts to simulate the
experimental data with this simple model failed, and so the 2J-model, depicted in figure 2.6,
including the Fe(1)…Fe(1’) interaction (J2) was employed. Using the program MAGPACK23
and employing the Hamiltonian
Ĥ = -2J1(Ŝ1· Ŝ2 + Ŝ2· Ŝ1’) – 2J2(Ŝ1· Ŝ1’)
allowed us to satisfactorily simulate the data with the parameters J1 = - 3.1 cm-1, J2 = + 0.2 cm-
1 and g = 2.00(2). This results in a spin ground state of S = 5/2 with the first S = 3/2 excited
state 17.5 cm-1 higher in energy, and the second excited state, S = 7/2, 22.5 cm-1 higher in
energy.
Figure 2.6: The exchange interaction model employed for the [Fe3(L11)2]3+ core.
The magnetic properties of exchanged coupled dinuclear complexes have, for some
time, been known to depend on the identity of the metal ions, the nature of the bridging
ligands providing the super-exchange pathway, and the bridging geometry, i.e. the angles and
distances. There have been a number of magneto-structural correlations published for the Fe-
O-Fe moiety, which have attempted to describe the relationship between the strength of
interaction (J) and the Fe…Fe distance, the Fe…O distance and the Fe-O-Fe bridging angle,
with, in almost all cases, the central bridging ion being an oxide rather than a hydroxide or
alkoxide. As yet, none have appeared universally correct. For example, Gerloch suggested a
Fe1 Fe2 Fe1’
J1 J1
J2
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rapid decrease in J with decreasing Fe-O-Fe angle, with the maximum value expected for a
bridging angle of 180°.24 Gorun and Lippard suggested the main contribution to the exchange
was the average Fe-O distance25 whilst Güdel and Weihe concluded that both the Fe-(µ-O)
distance and the Fe-(µ-O)-Fe angle were important.26 To our knowledge, the only attempted
magneto-structural correlation for alkoxide-bridged diiron(III) species was published by
Caneschi and co-workers in 1997 who investigated molecules of the type [Fe2(OR)2L12], Table
2.7, where L12 is a β-diketonate ligand.27 Based on their experimental evidence they suggested
a linear dependence of J with the Fe-O-Fe bridging angle (α), expressed as J = 1.48α - 135,
with the switch from antiferromagnetic to ferromagnetic occurring at α = 91°. DFT
calculations later refined the expression to J = 5.0(1)α - 450(10).28 [Fe3(L11)2]3+ with Fe-O-Fe
bridging angles of 87.12, 87.42 and 88.21° (αav = 87.58°), appears not follow these
experimentally or theoretically derived trends. All three bridging angles in [Fe3(L11)2]3+ are
below that expected for a ferromagnetic interaction, and the predicted exchange of +5.4 cm-1
(+12 cm-1 via DFT) is some way off the observed value of -3.1 cm-1. Given that there are only
a few structurally related trinuclear iron complexes reported (see below), and almost none with
reliable magnetic data, it is not possible at this stage to provide a deep understanding of the
origins of these differences, but clearly [Fe3(L11)2]3+ “bucks the trend”. Thus it appears that, as
with the oxo-bridged species before them, there may not be a simple correlation for alkoxo-
bridged Fe clusters between J and any single structural parameter, and that any universal
correlation must invoke other relationships.
2.2.7. Thin-layer Spectroelectrochemistry on [Fe3(L11)2](ClO4)3.2CH3CN.
Cyclic voltammograms of 3.15 x10-4 M solutions of [Fe3(L11)2](ClO4)3.2CH3CN at a Pt
electrode in CH3CN solvent containing 0.1M [nBu4N][BF4] show two clean reversible one-
electron reduction processes to formally [Fe3(L1)2]2+ and [Fe3(L11)2]+ species at +0.36 V and
0.0 V vs Ag/AgCl, figure 2.7. The potentials are invariant with temperature down to 233 K.
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Figure 2.7: Cyclic voltammogram of [Fe3(L11)2](ClO4)3 (3.15 x 10-4 M) in CH3CN at a Pt
electrode containing 0.1M [nBu4N][BF4] (E/V vs AgCl).
The presence of only two relatively close 1e- redox processes29 tentatively suggests that they
are due to successive reduction of the two peripheral hepta-coordinated Fe(III)s to Fe(II) with
the central hexa-coordinated iron(III) stabilised towards reduction as a result of the strong
field of six alkoxide donors, figure 2.8. Subsequent controlled potential spectro-
electrochemistry using an optically transparent thin layer Pt electrode (OTTLE) at +0.3 V and
-0.5 V vs Ag/AgCl reveals distinct UV-vis-NIR spectra for the 1e- reduced [Fe3(L11)2]2+ and
-0.5 0 0.5 1.0
E / V
i /A
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2e- reduced [Fe3(L11)2]+ species for comparison with the spectrum of [Fe3(L11)2]3+, figures. 2.8
and 2.9.
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Figure 2.8: Redox processes involving [Fe3(L11)2]3+ in CH3CN solution.
The reversibility of the two successive 1e- reduction processes was confirmed in each case by
the presence of a well defined isosbestic point. The intensity of the absorption peaks for all
three forms suggests an assignment to charge-transfer transitions. The broad absorption peak
for [Fe3(L11)2]+ at 470nm ( = 3,200 M-1cm-1) , figure 2.9, is tentatively assigned to an
Fe(III)mid-Fe(II)end inter-valence charge transfer transition on the basis of its absence from the
spectrum of [Fe3(L11)2]3+ although further studies would be needed to confirm this especially
in the absence of a similar well defined absorption peak for the 1e- reduced [Fe3(L11)2]2+
complex.
[Fe3(L11)2]3+ is the first example of a six-coordinated Fe(III) centre flanked by two
hepta-coordinated Fe(III) centres and has the tightest Fe-O(bridge)-Fe angle and as a result
shortest Fe….Fe distance (2.8343(5) Å) of all the linear trinuclear Fe(III) complexes so far
characterized (table 2.7, figure 2.11). The only other close structural match is the linear
methoxide-bridged trinuclear Fe(III) complex C11 (figure 2.11) reported in 2005 by Mak et al
via methanolysis of the tripyridine ligand L13 = 2,6-pyridyldiylbis(2-pyridyl)methanone.30
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Figure 2.9: UV/Vis/NIR spectra of [Fe3(L11)2]3+ (blue) and its 1e- reduction product
[Fe3(L11)2]2+ (red) in 0.1 M [nBu4N][BF4] / CH3CN at 233 K showing partially reduced
curves. The potential was held at +0.3 V vs. Ag/AgCl.
Figure 2.10: UV/Vis/NIR spectra for the 1e- reduced species [Fe3(L11)2]2+ (red) and 2e-
reduced species [Fe3(L11)2]+ (green) in 0.1 M [nBu4N][BF4] / CH3CN at 233 K showing
partially reduced curves. The potential was held at -0.5 V vs. Ag/AgCl.
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Figure 2.11: Schematic representation of L12-L14
Complex Single O-bridge CN FeIII-O(bridge) / Å Fe-O-Fe / o a Fe….Fe / Å Ref
linear FeIII3 species
C8 tri-alkoxide 7,6,7 2.047 a 87.6 2.834 a This work
C9 tri-alkoxide 6,8,6 2.090 a 88.5 2.907 a 30
C10 oxide/hydroxide 6,6,6 1.910 a 125.3 3.392(1) 31
C11 hydroxide 6,6,6 1.949 a 123.9 3.440 a 33
FeIII2(OR)2L12
C12 OMe 6,6 1.987 a 102.0 3.087(1) 27
C13 OMe 6,6 1.974 a 103.7 3.105 a “
C14 OEt 6,6 1.965 a 101.8 3.049(3) “
C15 OPrn 6,6 1.974 a 103.1 3.093(3) “
FeIII2(OR)2L13 OMe 6,6 2.002 a 104.6 3.168(1) 39
[FeII,III2L14(O2CPh)2]2+ alkoxide 6,6 1.909(7) 111.2 3.300(2) 40
Table 2.7: Structural data for oxygen-bridged linear triiron(III) and alkoxide-bridged diiron(III) complexes
a-average value
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Figure 2.12: Core Structures of Various Linear Oxygen-bridged Triferric complexes
Here an unusual octa-coordinated central Fe(III) is co-ordinated to six alkoxide/methoxide
oxygen donors and two nitrogen donors from the middle pyridine of both coordinated ligands,
each flanked by two six-coordinated Fe(III)s. The three Fe(III) centres are in a bent
configuration (Fe-Fe-Fe = 152.63(3)o) with the slightly more open angle at the bridging
alkoxide oxygens (av 88.5o) leading to a slightly longer Fe…Fe separation (av 2.907 Å) than
for [Fe3(L11)2]3+.
The only other reported linear triferric complexes have the Fe(III) centres bridged by
two -carboxylates and a single -oxo or hydroxo ligand. Reed and Kitajima et al isolated the
oxo-bridged complex C12, figure 2.12, using the ligand tris(3,5-diisopropylpyrazolyl)borate.31
Here all three Fe(III) centres are hexa-coordinated with the central Fe(III), like in [Fe3(L11)2]3+,
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co-ordinated to only oxygen donors (six); four from -carboxylates and two from disorded -
oxo/-hydroxo ligands. The Fe-O-Fe angle at the bridging oxygen in C12 is much larger (av
125.3o) leading to a larger Fe….Fe separation (3.392(1) Å). A similar linear -oxo, bis--
carboxylato-triiron(III) complex has been characterised using tris(3,5-
dimethylpyrazolyl)borate.32 The -hydroxo,bis--benzoato-triiron(III) complex C13, figure
2.11 has been reported by Kurtz et al using the ligand tris(1,4-dimethylimidazol-2-
yl)phosphine.33 C13 appears to be a rare example of an exclusively hydroxo-bridged linear
triferric complex. The Fe-O-Fe angle (av 125.9o) is similar to that in C12.
[Fe3(L11)2]3+ provides a further relatively rare example of hepta-co-ordinated Fe(III).
Other examples include Fe(dapsox)(H2O)2]+ (H2dapsox = 2,6-diacetylpyridine-
bis(semioxamazide)34 and salts of polyaminocarboxylatoiron(III) complexes obtained with
large radius cations such as Ca[Fe(CDTA)(H2O)]2 (H4CDTA = trans-1,2-
cyclohexanediamminetetraacetic acid)35 and Rb[Fe(EDTA)(H2O)].36 In the latter two
complexes the Fe(III) centre is in a triangular-capped distorted trigonal prismatic geometry
similar to that found in [Fe3(L1)2]3+. Figure 2.13 illustrates the range of coordination
geometries found for H3L11 as ligand.
Finally complexes [Fe3(L11)2]3+ and C11 – C13 can be considered to be putative models
for the triferric site 3 of ferreascidin, a glycoprotein isolated from the blood cells of the
stolidobranch ascidian Pyura stolonifera.37, 38 The site 3 cluster consists of a rare linear unit
containing three antiferromagnetically coupled high-spin Fe(III) centres resulting in a RT
paramagnetic S = 5/2 ground state.37 The absence of sulfur and sulfide in ferreascidin indicates
that the bridging atoms must be oxygen and/or nitrogen atoms.
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Figure 2.13: Ligand co-ordination modes found in metal complexes of H3L11
77
2.3. Experimental
2.3.1. Physical Measurements
X-ray crystallography was carried out at 93(2)K using Mo K radiation from a Rigaku
MM007 rotating anode diffractometer operating with a low temperature attachment, see Table
2.6 for further relevant details. 1H and 13C NMR spectra were recorded on a Bruker Advance
300 Spectrometer (300MHz for 1H, 75.4 MHz for 13C).
Mass spectra were acquired on a Water’s 2795 HPLC with Micromass LCT equipped
with a “lock spray“ for accurate mass measurements.
Elemental analysis for C, H and N were determined on dried samples using a Carlo
Erba CHNS analyser.
Variable-temperature, solid-state direct current (dc) magnetic susceptibility data down
to 5 K were collected on a powdered microcrystalline sample using a Quantum Design
MPMS-XL SQUID magnetometer in an applied field of 0.1 T. Diamagnetic corrections were
applied to the observed paramagnetic susceptibilities using Pascal’s constants.
Electrochemical measurements were carried out on a 3.15 x 10-4 M solution of 2 in
CH3CN containing 0.1M [nBu4N][BF4]. A standard three electrode system was used
comprising a Metrohm 6.1241.060 Pt working electrode, Metrohm 6.0726.100 Ag/AgCl
reference electrode and a Pt wire reference electrode. Data were captured on a DELL Pentium
III desktop PC with General Purpose Electrochemistry system (GPES) version 4.8 connected
to an Autolab PGSTAT30 potentiostat. Quoted data were recorded using a scan rate  = 0.1
Vs-1 and are displayed in the form (Epa + Epc) /2 V (Epa - Epc). Potentals are vs Ag/AgCl
referenced to the ferrocinium/ferrocene couple taken as +0.55 V.
In situ UV/Vis/NIR spectroelectrochemistry was performed on the same solutions of 2
above using an optically transparent thin layer electrode (OTTLE) cell using a Perkin-Elmer
Lambda 9 spectrophotometer. The spectra were captured on a Datalink Pentium desktop PC
running UV Winlab software, version 2.70.01. A platinum gauze working electrode
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(transparency = 40 %) was used in the quartz cell (path length = 0.5 mm). The platinum wire
counter and Ag/AgCl reference electrodes were separated from the test solution by sintered
frits in a quartz reservoir above the flat cell. A tight fitting PTFE lid prevented the oxygen-
purged solutions being exposed to the atmosphere. The assembly was then placed in a PTFE
block fitted with two pairs of quartz windows, inside the spectrometer. Dry, pre-cooled N2
was passed between the cell and the inner pair of quartz windows to cool the solution. Dry,
room temperature N2 was passed between the outer and inner quartz windows of the PTFE
block to prevent frosting of the cell and windows. The spectrometer cavity was kept under
N2. The temperature was monitored using a thermocouple connected to a digital thermometer
and could be controlled by careful adjustment of the N2 flow rate. Potential was applied and
bulk electrolysis performed with UV/Vis/NIR spectra measured every ten minutes.
Conversion of the electroactive species was deemed complete when the spectrum became
constant and current flow ceased. The potential was then set back to re-generate the original
species to ensure reversibility of the redox process.
2.3.2. Materials and Reagents
All metal salts and reagents were used as supplied from Sigma-Aldrich without further
purification. Solvents; acetonitrile, methanol, diethyl ether and dichloromethane were all used
as supplied without further purification. Flash chromatography was carried out using a 30cm x
1cm column of Fluorochem silica gel 35-7060Å.
2.3.3. Tris(6-hydroxymethyl-2-pyridylmethyl)amine (H3L11)
The title compound was prepared by a slight modification of the literature method16 following
treatment of 6-(bromomethyl)-2-(hydroxymethyl)pyridine19 in acetonitrile with ammonium
acetate and sodium carbonate. When no more starting material was evident by 1H NMR and
tlc the solution was filtered, washed with acetonitrile, and the combined acetonitrile fractions
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evaporated to give a white solid which was flash chromatographed on silica gel (eluent
dichloromethane-methanol gradient, 1-10% vv dichloromethane) until pure by 1H NMR. Yield
3.5 g (57%), mp 159-161oC. H (DMSO) 3.37 (6H, s, 3CH2), 4.50 (6H, d 3CH2), 5.42 (3H, br,
3OH), 7.25 (3H, d, 3CH arom), 7.42 (3H, d, 3CHarom), 7.75 (3H, t, 3CH arom). MS: ES+:
m/z: 403 [(M+Na)+ 100%].
2.3.4. [Cu(H3L11)Cl]Cl. (C5)
A green solution of anhydrous copper(II) chloride ( 35,38 mg, 0.236 mmol) in methanol (3
cm3) was added to a solution of H3L1 ( 0.1g, 0.236 mmol) in methanol (12 cm3). The resulting
deep bluish-green solution was placed in an open vial and diethyl ether was allowed to mix in
slowly using vapour diffusion. After 3 days blue-green crystals were obtained which were
found to be suitable for X-ray diffraction. Yield 29 mg, 21.4 %. Found: C, 47,21; H, 4.38; N,
10.51. C21H24Cl2CuN4O3, requires C, 48.98 ; H, 4.69 ; N, 10.88.
2.3.5. [Cu(H3L11)Br]Br. (C6)
A yellow solution of anhydrous copper(II) bromide (58.77 mg, 0.236 mmol) in methanol (3
cm3) was added to a solution of H3L1 (0.1 g, 0.236 mmol) in methanol (12 cm3). The resulting
dark green-brown solution was placed in an open vial and diethyl ether was allowed to mix in
slowly using vapour diffusion. After 3 days a few small orange crystals were obtained which
were found to be suitable for X-ray analysis.
2.3.6. [Mn(H3L11)]Cl2.3H2O. (C7)
A colourless solution of MnCl2.4H2O (0.034 g, 0.236mmol) in methanol (3 cm3) was added to
a solution of H3L1 (0.1g, 0.236mmol) in methanol (12 cm3). The clear colourless solution was
placed in an open vial and diethyl ether was allowed to mix in slowly using vapour diffusion.
After 2 days colourless crystals were obtained. Yield 0.035g (26.3%). Found (%): C, 35.74; H,
80
4.26; N, 7.69. C22H34Cl4.4Mn2.2N4O7 ([Mn(H3L1)]Cl2.(MnCl2)1.2.CH3OH.3H2O) requires (%):
C, 35.52; H, 4.61; N, 7.53. Redissolution in methanol and allowing diethyl ether to mix in by
vapour diffusion eventually produced colourless crystals of the pure chloride trihydrate salt
suitable for X-ray analysis.
2.3.7. [Fe3(L11)2](ClO4)3.nCH3CN (n = 1 or 2) (C8)
The synthesis was based upon that described by Masuda et al for the mononuclear Fe(III)
complex of tris-(6-pivalamido-2-pyridylmethyl)amine.21 A solution of C6H5CO2Na (0.032g,
0.236 mmol) in H2O (2 cm3) was added to a red solution of Fe(ClO4)2.6H2O (0.093 g, 0.236
mmol) and H3L11 (0.1 g, 0.236 mmol) in acetonitrile (20 cm3) giving a yellow solution. The
reaction mixture was stirred for 5 hours after which the solvent was evaporated to leave a
yellow-brown solid which was washed with a small amount of diethyl ether. Dissolution of the
solid in acetonitrile followed by slow precipitation by the addition of diethyl ether gave rise to
a golden brown crystalline solid of the mono acetonitrile solvate, yield 0.088g, (52%). Found
(%): C, 41.36; H, 3.56; N 9.96. C44H45Cl3Fe3N9O18 ([Fe3(L1)2](ClO4)3.CH3CN; Mr 1261.78)
requires (%): C, 41.88; H 3.59; N 9.99. Golden-brown single crystals of the bis acetonitrile
solvate ([Fe3(L11)2](ClO4)3.2CH3CN; Mr = 1302.84) were subsequently obtained by vapour
diffusion of diethyl ether into a dry acetonitrile solution of the above solid and were found
suitable for X-ray structural analysis.
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Chapter 3
Synthesis and Characterisation of a Hydrophobic TPA ligand via O-
alkylation (R = n-octyl or methyl) of tris(6-hydroxymethyl-2-pyridylmethyl)
amine. Characterisation of iron(II) complexes by paramagnetic 1H NMR.
3.1 Introduction
In chapter 2, the synthesis of the TPA derivative, tris(6-hydroxymethyl-2-
pyridylmethyl)amine (H3L11) was described along with the characterisation of a number of
metal complexes with copper(II), manganese(II) and iron(III). It was found that H3L11
possesses a wide and versatile coordination chemistry. H3L11 moreover is water soluble and
stable to alkaline pH and as such may have potential as a bleaching catalyst precursor,
perhaps superior to TPA itself, within a new generation of low temperature detergents
working in alkaline media around pH 10. Several TPA complexes have been patented as
catalysts for alkaline bleaching.1-3 as well as providing models for a range of non-heme iron,4-
9copper oxygenases. and bio-inspired C-H oxidation catalysts.4-9, 16, 17 It has been already
established that the introduction of substituents  to the pyridyl nitrogen leads not only to
further functionality but to additional steric and electronic properties that can modify
properties such as spin state and redox potentials.18-20 For example whereas
[FeII(TPA)(CH3CN)2]2+ and its corresponding t-butylperoxoiron(III) derivative are both low
spin, significant changes occur on introducing a CH3 group at the 6-position on just one of the
pyridine rings. Here while the t-butylperoxoiron(III) complex remains low spin, the
corresponding iron(II) complex is high spin. Finally the introduction of 6-Me substituents on
two or all of the pyridine rings results exclusively in high spin iron(II) and iron(III)
complexes. This has important consequences in the subsequent reactions of these iron TPA-
derived complexes as catalysts of H2O2 or tBuOOH-dependent oxidations.18 Tris(6-
hydroxymethyl-2-pyridylmethyl)amine (H3L11) on the other hand, however, offers the
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opportunity to build hydrophobicity into the ligand backbone via simple alkylation of the
hydroxymethyl groups. Building in hydrophobicity is an aspect that has been little explored to
date in model complexes especially given the evidence now from structural data that
monooxygenase enzymes like cytochrome P-450 and bacterial methane monooxygenase
contain their active iron sites embedded within a deeply hydrophobic region of the protein
enabling the ready uptake, correct orientation and subsequent functionalization
(hydroxylation) of the C-H compound.21 There is evidence from the literature that embedding
biomimetic models within a hydrophobic environment can lead to enhanced activity. By using
the dinuclear iron(III) TPA complex [Fe2O(η1-OAc)(TPA)2]3+ as a close structural model for
MMO Fish et al have described formation of [Fe2O(η1-H2O)(η1-OAc)(TPA)2]3+ in-situ at pH
4.2 from [Fe2O(η1-OAc)(TPA)2]3+ which previously had been determined by UV/VIS and 1H
NMR analysis that [Fe2O(μ-OAc) (TPA)2]3+ was converted to the [Fe2O(η1-H2O)(η1-
OAc)(TPA)2]3+ complex, at pH 4.2 and that, this η1-H2O was thought to be responsible for the
dramatic increase in the oxidation of water soluble alcohols to the corresponding aldehydes
and ketones in the presence of TBHP/ O2.22
The [Fe2O(η1-H2O)(η1-OAc)(TPA)2]3+ complex was embedded in an amorphous silicate
surface modified by a combination of hydrophilic poly(ethylene oxide) and hydrophobic
poly(propylene oxide), figure 3.1.
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Figure 3.1: A schematic representation of in-situ formed [Fe2O(η1-H2O)( η1-OAc)(TPA)2]3+,
embedded in te PEO, PPO derivatized silica, for alkane functionalization in water at pH 4.2
The idea was to simulate the hydrophobic MMO macroenviroment. The resulting assembly
was found to be active towards the catalysis of the oxygenation of cycloalkanes with tert-
butyl hydroperoxide (TBHP)/O2 in an aqueous medium at pH 4.2.23
Even more intriguing was that the silica-based assembly showed higher reactivity when the
[Fe2O(η1-H2O)( η1-OAc)(TPA)2]3+ complex was similarly studied at pH 4.2 within an
aqueous micellar system utilizing the surfactant, cetyltrimethylammonium hydrogen sulfate at
its critical micelle concentration, figure 3.2.23
Figure 3.2: A schematic representation of in-situ formed [Fe2O(η1-H2O)(η1-OAc)(TPA)2]3+
difussing, along with oxidants, TBHP/ O2, into aqueous micelles formed with the surfactant,
cetyltrimethylaamonium hydrogensulfate, for alkane functionalization in water at pH 4.2
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Thus there is much interest and scope in ligands allowing the introduction of a degree of
hydrophobicity into the structure in the expectation of enhancing C-H oxygenating activity.
Such hydrophobicity could be easily introduced into H3L11 via peralkylation (ether formation)
of the hydroxymethyl groups in order to synthesize a new family of possibly hydrocarbon-
soluble/micellar transition metal oxidation catalysts. Similarly functionalisation of the
hydroxymethyl groups with peralkylated substituents containing fluorine could lead to
catalysts soluble in fluorous solvents for oxygenations on hydrocarbons, alkenes and alcohols
under fluorous biphasic conditions (FBC).24 Figure 3.3 below shows a catalytic system based
upon a N-perfluoroalkylated triazacyclononane macrocycle developed by Fish et al for FBC
oxidations of hydrocarbons and olefins with TBHP/O2. Good activity was found and
moreover the presence of the fluorous tails allowed the copper complex to be totally separated
from the organic phase by a simple decantation process and thus recycled three times.24
Figure 3.3: FBC system for oxidations of hydrocarbons and olefins with TBHP/O2 based on
a CuII complex of a tris(N-perfluoroalkyl)triazacyclononane.
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This chapter reports studies on the peralkylation of the hydroxymethyl groups of H3L11 in
order to synthesize and characterise a new family of hydrophobic lipophilic TPA-derived iron
catalysts for C-H oxygenations with H2O2 and t-BuOOH, figure 3.4. Of particular interest was
to create a hydrophobic channel above the active hydroperoxo or oxo iron centre that might
orientate an n-alkane substrate towards C-H oxygenation preferentially at the C-1 position. A
ready cheap supply of medium length (C7-C9) 1-oxygenates (alcohols and aldehydes) is
sought after as plasticizer and detergent additives.25 These are currently made via expensive
catalytic hydroformylation of the corresponding long chain C7-C9 alkenes.26
Figure 3.4: Schematic representation of the hydrophobic pocket generated next to a putative
hydroperoxo-iron(III) centre trapping an alkane and orientating it for C-1 functionalisation.
The use of C7-C9 n-alkanes for this conversion (cheaper - mostly used as additives to petrol)
would be a huge advance. However use of n-alkanes poses huge challenges since there are no
functional groups serving to direct regio reactivity and moreover the internal CH2 bonds are
many times more reactive than those at terminal CH3. The design and use of a catalyst
allowing only the approach of and thus reaction with the terminal CH3 group at the active site
would seem the only way of achieving such regioselective partial 1-oxygenation of n-alkanes
to 1-alcohol/aldehydes in reasonable yield. This might be achievable with restricted substrate
orienation such as within a catalyst containing a hydrophobic channel such as in figure 3.4. In
the sections below the synthesis of two alkylated derivatives of H3L11; tris-(6-methoxymethyl-
2-pyridylmethyl) amine, L15 and tris-(6-n-octyloxymethyl-2-pyridylmethyl)amine, L16 are
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reported along with characterisation of their paramagnetic iron(II) complexes in solution
using NMR. The activity of the iron(II) complexes towards the catalysis of alkane
oxygenation with H2O2 is reported later in chapter 5.
3.2. Results and Discussion.
3.2.1. Synthesis of tris(6-methoxymethyl-2-pyridylmethyl)amine, L2 and of tris-(6-n-
octyloxymethyl-2-pyridylmethyl)amine, L15.
The synthesis of the simpler tris(6-methoxymethyl)TPA derivative, L15 was important for the
purpose of identifying any regioselectivity effect stemming from the introduction of the C8
peralkyl chain in L16 as well as assisting in the assignment of 1H NMR resonances of L16 and
its iron complexes later. The synthesis of L15 and L16 initially followed procedures reported for
the alkylation of 6-hydroxymethylpyridine derivatives27, 28 involving generation of the tris-
alkoxide from H3L11 using sodium hydride (NaH) in the ethereal solvents; tetrahydrofuran
(THF) or dioxane followed by alkylation with the corresponding haloalkane. Use of this
method was not however successful for synthesizing L15 or L16. This was a surprise but
success was eventually achieved on switching to dimethylformamide (DMF) as the solvent as
had been reported in one isolated case.29 The successful synthesis of L15 was achieved by the
addition of a solution of NaH in DMF at 0ºC to a DMF solution of H3L11 followed by addition
of iodomethane after 1 hour stirring, stirring for further 36 h, work up and chromatographic
purification to a yellow oil in 68% yield. A similar procedure but using 1-bromooctane was
used successfully to synthesize L3 in 72% yield after chromatography. Both L15 and L16 have
been fully characterised by 1H NMR and 13C NMR and MS.
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3.2.2. 1H NMR characterisation of tris-(6-methoxymethyl-2-pyridylmethyl)amine, L15
and of tris-(6-n-octyloxymethyl-2-pyridylmethyl)amine, L16.
All 1H NMR spectra were recorded on samples in standard 5mm tubes. The 1H NMR of L15 in
CD3CN, figure 3.5 and 3.6, shows the expected resonances; a singlet at 3.4 ppm for the
methoxy methyl, along with two further singlets at 3.8 ppm and 4.5 ppm for 6-CH2 and 2-CH2
groups respectively on the py ring. The , ’ and  protons of the pyridine ring are seen as the
expected triplet and two doublets at 7.29 ppm, 7.55 ppm and 7.69 ppm respectively, figure 3.6.
 / ppm
Figure 3.5: 1H NMR spectrum of L15 in CD3CN

 / ppm
Figure 3.6: 1H NMR spectrum of L15 in CD3CN, expanded region between 7 - 8 ppm.
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The 1H NMR spectrum of L16 in CD3CN, figure 3.7 and 3.8, shows the β and β’ protons of the
pyridine groups as doublets at 7.22 ppm and 7.42 ppm respectively with the γ proton (triplet)
more downfield at 7.59 ppm. The protons of the methylene group adjacent to the tertiary
 / ppm
Figure 3.7: 1H NMR spectrum for L16 in CD3CN
       

 / ppm
Figure 3.8: 1H NMR spectrum of L16 in CD3CN, expanded region between 7 - 8 ppm.
amine is present as in L15 as a singlet at 4.5 ppm with the -CH2 methylene between the
pyridine and the oxygen assigned to the singlet at 3.7 ppm. The first methylene of the C8 chain
(showing the expected triplet coupling to its neighbour) is apparent at 3.5 ppm well separated
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from the rest of the C8 chain. Finally the terminal CH3 group of the C8 chain is seen most
upfield as expected as a triplet at 0.8 ppm.
3.2.3. Synthesis and characterisation of iron(II) complexes.
Iron(II) complexes of L15 and L16 were prepared by mixing equimolar amounts of the ligand
and either [Fe(H2O)6](ClO4)2 (commercially available) or [Fe(CH3CN)2(O3SCF3)2]
(synthesized in house)30 in either CH3CN or CH2Cl2 solvent. The triflate complex was most
widely employed owing to the small, but real, risk of explosion from handling perchlorate
salts. Vapour diffusion techniques (diffusion of diethyl ether into CH3CN or CH2Cl2
solutions) were used in attempts to grow crystals of the iron(II) complexes as reported for the
complexes with H3L11 in chapter 2. However, in all cases, the iron(II) complexes of L15 and
L16 were obtained as oils and all attempts to grown crystals suitable for X-ray analysis were
unsuccessful.
3.2.4. Bis(acetonitrile)(tris-(6-methoxymethyl-2-pyridylmethyl)amine)iron(II)
perchlorate; (C16) [Fe(L15) (CH3CN)2](ClO4)2 and bis(acetonitrile) (tris- (6-n-octyloxy
methyl- 2-pyridylmethyl)amine)iron(II) perchlorate,(C17) [Fe(L16) (CH3CN)2] (ClO4)2.
A solution of L15 was added under nitrogen to a pale yellow solution of [Fe(H2O)6](ClO4)2 in
CH3CN yielding a reddish-orange solution. The reaction mixture was stirred for 3 h. The
solvent was evaporated yielding [Fe(L15)(CH3CN)2](ClO4)2 as a reddish-orange oil. A similar
procedure was used to prepare [Fe(L16)(CH3CN)2](ClO4)2 again as a reddish-orange oil.
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3.2.5. Bis(acetonitrile)(tris(6-methoxymethyl-2-pyridylmethyl)amine)iron(II) trifluoro
methanesulfonate, (C18) [Fe(L15)(CH3CN)2](CF3SO3)2 and bis(acetonitrile)(tris-(6-
octyloxy methyl-2-pyridylmethyl)amine)iron(II) trifluoromethanesulfonate, (C19)
[Fe(L16)(CH3CN)2](CF3SO3)2.
A solution of L15 was added under nitrogen to a pale yellow solution of
[Fe(CH3CN)2(O3SCF3)2] in THF yielding a reddish-orange solution. The reaction mixture was
stirred for 12 h. The solvent was evaporated to yield [Fe(L15)(CH3CN)2](CF3SO3)2 as a
reddish-orange oil. A similar procedure was used to prepare [Fe(L16)(CH3CN)2](CF3SO3)2
again as a reddish-orange oil.
3.2.6. Characterisation of [Fe(L)(CH3CN)2](CF3SO3)2 (L = L15 or L16) in solution by 1H
NMR.
Each iron(II) complex was prepared in-situ by mixing equimolar quantities of
[Fe(CH3CN)2(O3SCF3)2] and the appropriate ligand in either CD3CN and CD2Cl2. In each case
the solvents were first degassed by 3 freeze-thaw cycles and left under argon.
3.2.6.1. 1H NMR study of [Fe(L15)(CH3CN)2](O3SCF3)2 in CD3CN.
An equimolar amount of L15 in CD3CN or CD2Cl2 under nitrogen atmosphere was added to a
pale yellow deoxygenated solution of [Fe(CH3CN)2(O3SCF3)2] in CD3CN or CD2Cl2 to yield
a reddish-orange solution which was rapidly transferred under nitrogen to a 5mm NMR tube.
1H NMR resonances appear over a range from 0 to +100 ppm, figure 3.9 and 3.10, consistent
with the presence of a high spin iron(II) complex.
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Figure 3.9: 1H NMR spectrum of [Fe(L15)(CH3CN)2](O3SCF3)2 in CD3CN region (0-100
ppm)

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Figure 3.10: 1H NMR spectrum of [Fe(L15)(CH3CN)2](O3SCF3)2 in CD3CN region (0-10
ppm)
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The protons from the methylene group between the tertiary amine and the pyridine rings are
observed very downfield at ~86 ppm, with the two β and β’ protons of the pyridine ring at 43
and 47 ppm respectively. Two well separated peaks are seen at 31 and 41 ppm corresponding
to the methoxy methyl and the methylene between the ether oxygen and pyridine respectively.
This in turn confirms the assignment of the two overlapping methylene peaks at ~35 ppm in
[Fe(L15)(CH3CN)2](O3SCF3)2. In order to confirm the assignment a paramagnetic 1H COSY
NMR spectrum was recorded. This is shown in figure 3.11. Cross peaks are clearly seen in the
spectrum arising from correlation of the broad upfield peak at ~ 5 ppm and the two β and β’
protons of the pyridine ring in the 40-50 ppm region. This assigned the broad upfield
resonance at ~ 5 ppm to the γ proton of the pyridine ring.31 What is also apparent in figure
3.9, are sharp ligand-derived resonances in the normal region 0-10 ppm for a diamagnetic
species. This region is shown clearly in figure 3.10. Three situations could be responsible.
Figure 3.11: 1H COSY NMR spectrum of [Fe(L15)(CH3CN)2](O3SCF3)2 in CD3CN
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(i) the presence of amounts of free uncomplexed ligand L15 as a result of the equimolar Fe:L15
addition not being absolutely exact; (ii) amounts of free or decomposed ligand as a result of
complex degradation or (iii) a small amount of a diamagnetic low spin iron(II) complex in
equilibrium with the high spin form (SC equilibrium). (iii) was ruled out by a temperature
dependent 1H NMR investigation32 which showed no change in relative intensity of the
diamagnetic and paramagnetic features over the range +60oC to -30oC, figure 3.12 (a) and (b).
The resonances assigned to paramagnetic high spin [Fe(L2)(CH3CN)2]2+ gradually became
sharper and shifted upfield while no change was observed to the diamagnetic features. A
further clue as to the origin of the diamagnetic features, figure 3.10, came from re-running the
1H NMR spectrum after standing for a period of 1 month. The 1H NMR spectrum obtained,
(a)
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Figure 3.12: 1H NMR spectrum of [Fe(L15)(CH3CN)2](O3SCF3)2 in CD3CN at (a) -30oC and
(b) + 60oC.
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figure 3.13, shows a clear increase in intensity of the sharp features in the diamagnetic region
in comparison to the paramagnetic features for high spin [Fe(L15)(CH3CN)2]2+. In also ruling
out possibility (i) above it was thus concluded that the diamagnetic features are due to
complex decomposition. Que et al have observed that introducing 6-substituents on the
pyridine rings

 / ppm
Figure 3.13: 1H NMR spectrum of [Fe(L15)(CH3CN)2](O3SCF3)2 in CD3CN re-recorded after
standing at RT for 1 month at 25oC.
of TPA quickly reduces the stability of the corresponding iron(III) complexes.33 Unlike the
high stability of iron(II) and iron(III) complexes of TPA they observed that introducing even
just one 6-Me substituent as in 6-MeTPA reduces the stability such that decomposition is
quickly observed over a period of one month. This indicates that the diamagnetic features,
figures 3.10 and 3.13, are due to free or partly decomposed L2 as a result of complex
degradation involving air oxidation of the iron(II) complexes to iron(III) followed by ligand
dissociation/decomposition.
Chapter 3
99
N -C H 2 P y
β ´ H β H
C H 3 C N
 H
P y C H 2 O ? ?
O C H 2 C 7 H 1 5
3.2.6.2. 1H NMR study of [Fe(L16)(CH3CN)2](O3SCF3)2 in CD3CN.
An equimolar amount of L16 in CD3CN under nitrogen atmosphere was added to a pale
yellow deoxygenated solution of [Fe(CH3CN)2(O3SCF3)2] in CD3CN to yield a reddish-
orange solution which was rapidly transferred under nitrogen to a 5mm NMR tube. The 1H
NMR spectrum, (figure 3.14 and 3.15), is typical of a high-spin iron(II) complex with broad
1H peaks appearing over the range from -5 to +90 ppm. Peaks have been assigned from
comparisons with the spectrum of free L16, (figure 3.7), and other related high spin iron(II)
complexes such as those of 6-Me3TPA (see table 3.2).31 The protons from the methylene
group linking the tertiary amine and pyridine rings are shifted strongly downfield, at ~84 ppm
with the two β and β’ protons of the pyridine appearing at 50 and 43 ppm respectively. The
two broad overlapping resonances seen at 34 and 36 ppm are assigned to the two other
methylenes either side of the ether oxygen with the one at slightly higher chemical shift (36
ppm) assigned to the methylene attached to the pyridyl ring. The protons of the next
methylene group of the n-octyl chain are assigned to the broad resonance at 5 ppm.

 / ppm
Figure 3.14: 1H NMR spectrum of [Fe(L16)(CH3CN)2](O3SCF3)2 in CD3CN region (0-100
ppm)

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Figure 3.15: 1H NMR spectrum of [Fe(L16)(CH3CN)2](O3SCF3)2 in CD3CN region (0-10
ppm)
The γ proton of the pyridine rings of [Fe(L15)(CH3CN)2]2+ were assigned to a broad resonance
at 5ppm. In the case of [Fe(L16)(CH3CN)2]2+ assignment is more difficult within the broad
envelope from -5 to +5 ppm which correspond to protons from CH3CN and the rest of the n-
octyl chain. The entire region between 0-10 ppm was broad with no evidence of the sharp
features that had characterised the spectrum of [Fe(L15)(CH3CN)2]2+.
The paramagnetic nature of the iron(II) complexes of L2 and L3 is apparent from comparisons
with those of the corresponding complexes of TPA and 6-Me substituted derivatives, (Table
3.1). Whereas [Fe(TPA)(CH3CN)2]2+ is low spin the introduction of only one 6-Me pyridyl
substituent as in [Fe(6-MeTPA)(CH3CN)2]2+ is enough to switch the complex to the high spin
form.
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Table 3.1: 1H NMR spectral parameters for the low and high spin iron(II) complexes of TPA
and 6-substituted TPA derivatives (determined in CD3CN).19
Complex CH2-N- -H β,β’-H γ-H -X
[Fe(L15)(CH3CN)2]2+ 86 - 47, 43 5 41 (-CH2O-)
31 (-OCH3)
[Fe(L16)(CH3CN)2]2+ 84 - 50, 43 ~3 36 (-CH2O-)
34 (-OCH2C7H15-n)
[Fe(6-Me3TPA)(CH3CN)2]2+ * 83 - 49, 54 -5 -28 (CH3)
[Fe(6-Me2TPA)(CH3CN)2]2+ * 92
86, 75
106
-
56, 59
52, 57
-11
-6 -25 (CH3)
[Fe(6-MeTPA)(CH3CN)2]2+ * 88
82, 37
95
-
48, 52
50, 51
-7
-6 -24 (CH3)
[Fe(TPA)(CH3CN)2]2+ *
(low spin)
6.3 10.9 8.5, 8.4 7.3 -
3.2.6.3. 19F NMR study of [Fe(L15)(CH3CN)2](O3SCF3)2 in CD3CN.
In the above formulae it is assumed that the trifluoromethane counter anions are
uncoordinated with the octahedral iron(II) coordination sphere completed by two molecules of
CH3CN. Britovsek et al34 have shown that 19F NMR provides a convenient method of
ascertaining the presence of coordinated CF3SO3- groups. Using BPMEN complexes of
iron(II) Britovsek et al showed that in non-coordinating solvents such as CD2Cl2 the 19F
NMR chemical shift of CF3SO3- occurs around +20 ppm, indicative of coordination to the
iron(II) centre. However in coordinating solvent such as CD3CN the chemical shift now
appears around -80 ppm indicating free (uncoordinated) CF3SO3-. The 19F NMR spectra of a
solution of [Fe(L15)(CH3CN)2](O3SCF3)2 in CD3CN, shown in figure 3.16, has a broad feature
at ~ -70 ppm. The same resonance was observed from corresponding solutions in CD2Cl2.
Figure 3.17 It is concluded that in both solvents the two trifluoromethane sulfonate CF3SO3-
ions have been replaced in the iron(II) coordination sphere by CH3CN (either from solvent or
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the starting salt) and so the formula [Fe(L15)(CH3CN)2]2+ for the solution species is assumed
correct. Althought, since the 19F NMR spectrum in CD2Cl2 reveleals uncoordination of the
CF3SO3- ions, it could be also possible that the octanoxy oxygen atom is coordinated to the
iron centre.






19F / ppm
Figure 3.16: 19F NMR spectrum of [Fe(L15)(CH3CN)2](O3SCF3)2 in CD3CN




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19F / pp
Figure 3.17: 19F NMR spectrum of [Fe(L15)(CH3CN)2](O3SCF3)2 in CD2C12
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3.3. Experimental
3.3.1 Instrumental and General Techniques:
NMR spectra were recorded on a Bruker Advance 300 spectrometer (1H 300 MHz, 13C 75.4
MHz. Mass spectra were acquired on a Water’s 2795 HPLC with Micromass LCT equipped
with a “lock spray“ for accurate mass measurements.
3.3.2. Materials and Chemicals:
All chemicals were purchased and used as received from Sigma-Aldrich. DMF and CH3CN
were both dried over CaH2 overnight followed by distillation. [Fe(SO3CF3)2(CH3CN)2] was
prepared by reacting Fe metal and anhydrous CF3SO3H in acetonitrile followed, attempt to
recrystalize in diethyl ether failed. The title compound was obtained as a yellow pale solid in
the ethereal solution. The parent TPA ligand, tris(2-pyridylmethyl)amine was synthesized
according to a literature procedure34. [Fe(TPA)(SO3CF3)2] was synthesized as described by
Diebold and Hagen.15 1H NMR (CD3CN), 300 MHz): 11.59 (br s, 3H, Hα(pyr)), 8.80 (s, 3H, H
β/β’(pyr)), 8.70 (s, 3H, H β/β’(pyr)), 7.34 (t, J = 7.5 Hz, 3H, Hγ(pyr)), 6.75 (s, 6 H, CH2). 19F NMR
(CD3CN), 282 MHz): -79.50 (s,6 F)
3.3.3. Synthesis of Tris-(6-methoxymethyl-2-pyridylmethyl)amine, L15
To a solution of NaH (0.339 g, 14.13 mmol) in DMF (15 cm3) was added a solution of H3L11
(1.3775 g, 3.625 mmol) at 0ºC. The mixture was stirred at 0ºC for 1 h. 1-iodomethane (0.877
cm3, 14.3 mmol) was then added and the reaction mixture allowed to warm up to room
temperature and stirred for 36h. The reaction was quenched by adding 20 cm3 of water. The
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organic phase was extracted with diethyl ether (3x 20 cm3). The combined extracts were
evaporated to give a brown yellow oil which was purified by chromatography (eluent CH2Cl2/
MeOH, 95:5) to yield a yellow oil (yield 1.0378 g, 67.84%).
1H NMR (400.13 MHz, CDCl3, 298 K) H (ppm) = 3.39 (9H, s, 3CH3), 3.81 (6H, s, 3CH2),
4.78 (6H, s, 3CH2), 7.20 (3H, d, 3JHH = 7.7 Hz, 3 H of C5H3N), 7.45 (3H, d, 3JHH = 7.8 Hz, 3 H
of C5H3N), 7.59 (3H, t, 3JHH = 7.7 Hz, 3 H of C5H3N). 13C-{1H} NMR (75.45 MHz, CDCl3,
298 K)C (ppm) = 59.19, 60.57, 119.87, 121.63, 137.44, 158.11, 159.47 MS: ES+: m/z:
423.24 [(M Cl+)+ 100%].
3.3.4. Synthesis of Tris-(6-n-octyloxymethyl-2-pyridylmethyl)amine, L16
To a solution of NaH (0.2848g, 11.8 mmol) in DMF (15 cm3) was added a solution of H3L11
(chapter 2) (1g, 2.62 mmol) at 0ºC. The mixture was stirred at 0ºC for 1 h. 1-bromooctane
(2.045 cm3, 11.8 mmol) was then added and the reaction mixture allowed to warm up to room
temperature and stirred for 36h. The reaction was quenched by adding 20 cm3 of water. The
organic phase was extracted with diethyl ether (3 x 20 cm3). The combined extracts were
evaporated to give brown-yellow oil which was purified by chromatography (eluent CH2Cl2/
MeOH, 95:5) to give a yellow oil, (yield 1.876 g, 72.23%).
1H NMR (300.06 MHz, CDCl3, 298 K), H = 0.80 (9H, t, 3CH3), 1.19 (10H, m, 5CH2), 1.56
(6H, quin, 3CH2), 3.46 (6H, t, 3CH2O), 3.79 (6H, s, 3CH2), 4.52 (6H, s, 3CH2), 7.22 (3H, d,
3JHH = 7.5 Hz, 3 H of C5H3N), 7.43 (3H, d, 3JHH = 7.7 Hz, 3 H of C5H3N), 7.59 (3H, t, 3JHH =
7.7 Hz, 3 H of C5H3N). 13C-{1H} NMR (75.45 MHz, CDCl3, 298 K)C= 14.50, 23.05, 26.57,
29.65, 29.85, 30.15, 32.22, 60.53, 71.63, 74.14, 119.74, 121.51, 137.39, 158.75, 159.24, CHN
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microanalysis: theoretical C 75.37 %, H 10.12 %, N 7.813 %, obtained C 74.24 %, H 10.70 %,
N 8.03 %, MS: ES+: m/z: 739 [(M+Na)+ 100%].
3.3.5. Synthesis of [Fe(L15)(CH3CN)2](ClO4)2. (C16)
CAUTION: Perchlorate salts of metal complexes with organic ligands are potentially
explosive and should be handling with care.
A 2 cm3 solution of L15 (0.1g, 1.39 mmol) in CH3CN was added under nitrogen gas to a pale-
yellow solution of [Fe(H2O)6](ClO4)2 (0.035 g, 1.39 mmol) in CH3CN (2 cm3) yielding a
reddish-orange solution. The reaction mixture was stirred for 3 h. The solvent was evaporated
to yield reddish-orange oil. Attempts to obtain crystals suitable for X-ray analysis were
unsuccessful. A similar method was used to prepare (C17) the iron(II) perchlorate complex of
L16 when again a reddish-orange oil was obtained.
3.3.5. Synthesis of [Fe(CH3CN)2(O3SCF3)2].
The [Fe(CH3CN)2(O3SCF3)2] iron salts was prepared following the reported method.30
To a mixture of (5.58 g, 100 mmol) of finely divided powder in dry CH3CN was added
carefully (32 g, 210 mmol) of triflic acid. The reaction is very exothermic. The flask was fitted
with a cold finger, and after the initial effervescence subsided (about 1 hour), warmed to 60
ºC. When the effervescence has stopped, the unreacted iron was removed by filtration through
a celite pad. The volume of the solution was condensed to approximately 80 ml under vacuum.
Although cooling the pale green solution to -25 ºC overnight we were not successful at
growing crystals. As reported in the literature, after evaporation of the solvent under vacuum.
A pale yellowish solid was obtained. (10.6g, 24.3%).
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3.3.6 Synthesis of [Fe(L15)(CH3CN)2](CF3SO3)2. (C18)
A 2 cm3 solution of L15 (0.250, 0.349 mmol) in THF was added under nitrogen gas to a pale
yellow solution of [Fe(CH3CN)2(O3SCF3)2] (0.1522 g, 0.349 mmol) in THF (2 cm3) yielding a
reddish-orange solution. The reaction mixture was stirred for 12 h. The solvent was
evaporated to yield reddish-orange oil. Attempts to obtain crystals suitable for X-ray analysis
were unsuccessful. A similar method was used to prepare an iron(II) triflate complex of L16
when again a reddish-orange oil was obtained.
3.3.7. Synthesis of iron(II) complexes of L15 and L16 for 1H NMR studies.
Here the iron triflate complexes of L15 and L16 were prepared in-situ in both CD3CN and
CD2C12.
3.3.8. [Fe(L15)(CH3CN)2](CF3SO3)2 in CD3CN.
A 3 cm3 solution of L15 (0.025 g, 0.0349 mmol) in CD3CN was added under a nitrogen
atmosphere to a pale yellow solution of [Fe(CH3CN)2(O3SCF3)2] (0.01522 g, 0.0349 mmol) in
CD3CN (3 cm3) to yield a reddish-orange solution. 1 cm3 of this mixture was then transfer
under nitrogen into a 5 mm o.d. NMR tube.
3.3.9. [Fe(L15)(CH3CN)2](CF3SO3)2 in CD2C12.
A 3 cm3 solution of L15 (0.025 g, 0.0349 mmol) in CD2Cl2 was added under a nitrogen
atmosphere to a pale yellow solution of [Fe(CH3CN)2 (O3SCF3)2] (0.01522 g, 0.0349 mmol)
in CD2Cl2 (3 cm3.) yielding a reddish-orange solution. 1 cm3 of this mixture was then transfer
under nitrogen into a 5 mm o.d. NMR tube.
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3.3.10. [Fe(L16)(CH3CN)2](CF3SO3)2 in CD3CN.
A 3 cm3 solution of L16 (0.0147 g, 0.0349 mmol) in CD3CN was added under a nitrogen
atmosphere to a pale yellow solution of [Fe(CH3CN)2(O3SCF3)2] (0.01522 g, 0.0349 mmol) in
CD3CN (3 cm3) to yield a reddish-orange solution. 1 cm3 of this mixture was then transfer
under nitrogen into a 5 mm o.d. NMR tube.
3.3.11. [Fe(L16)(CH3CN)2](CF3SO3)2 in CD2C12.
A 3 cm3 solution of L16 (0.0147 g, 0.0349 mmol) in CD2Cl2 was added under a nitrogen
atmosphere to a pale yellow solution of [Fe(CH3CN)2(O3SCF3)2] (0.0152 g, 0.0349 mmol) in
CD2Cl2 (3 cm3.) yielding a reddish-orange solution. 1 cm3 of this mixture was then transfer
under nitrogen into a 5 mm o.d. NMR tube.
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3.4. Summary and Conclusions.
Two new derivatives of TPA have been synthesized and characterised and their corresponding
iron(II) complexes characterised by paramagnetic 1H and 19F NMR spectroscopy in CD3CN
and CD2C12 solution. Attempts to obtain crystals suitable for X-ray analysis were
unsuccessful and only reddish-orange oils were obtained. 19F NMR spectroscopy confirmed
that the CF3SO3- ions in the triflate complexes are not coordinated to iron(II) with the
remaining two coordination sites occupied by acetonitrile molecules as observed previously in
the cases of iron(II) complexes of TPA, 6-MeTPA, 6-Me2TPA, 6-Me3TPA and BPMEN. The
synthesis and characterisation of [Fe(L15)(CH3CN)2]2+ with a simpler 6-methoxymethyl-
pyridine substituent helped in the assignment of the paramagnetic resonances for the 6-n-
octyloxymethyl-pyridine complex [Fe(L16)(CH3CN)2]2+, confirmed by a 2D COSY
experiment which in turn identified the upfield shifted γ proton of the pyridine. The iron(II)
complexes were exclusively high spin with no evidence from variable temperature NMR
studies of a Spin-Crossover equilibrium. A degree of spontaneous decomposition is apparent
in the paramagnetic NMR spectra of the two iron(II) complexes in CD3CN at RT with the
presence of diamagnetic resonances for free or decomposed (modified) ligand.
The catalytic activity of both [Fe(L15)(CH3CN)2]2+ and [Fe(L16)(CH3CN)2]2+ towards H2O2
oxygenation on alkane substrates is explored in chapter 5 along with a detailed X-band EPR
spectroscopy investigation at low temperature (100K) of the reaction products obtained from
treatment of both [Fe(L15)(CH3CN)2]2+ and [Fe(L16)(CH3CN)2]2+ separately with H2O2 and t-
BuOOH in CH3CN solvent.
.
A different method for attaching 6-peralkyl and ultimately 6- perfluoroalkyl substituents to
TPA, which it is hoped could lead to potentially more oxidatively-robust iron complexes, is
now explored in chapter 4.
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Chapter 4
Synthesis and Characterisation of Mono and Bis(6-(n-hexylureyl)pyridine)
Derivatives of TPA: Building Blocks to Superior Hydrophobic Iron-Based
Catalysts for the 1-Oxygenation of n-Alkanes.
4.1. Introduction
In chapter 3 the synthesis and characterisation of high spin iron(II) complexes of two O-
alkylated derivatives of tris(6-hydroxymethyl-2-pyridylmethyl)amine (H3L11) was described.
The n-octyloxymethylpyridine derivative (L16) was synthesized to examine the effect of
creating a putative 8 carbon hydrophobic channel above the active iron-hydroperoxo centre
towards the catalysis of regioselective 1-oxygenation of n-alkane substrates using H2O2 and it
will be examined in chapter 5. While synthetically L16 and its simpler methoxymethyl
counterpart L15 were readily synthesized via alkylation of the alkoxide of H3L11 the presence
of a reactive benzylic methylene group adjacent to the active iron site makes these TPA
derivatives potentially prone to oxidative degradation. This became apparent upon monitoring
the 1H NMR spectra of the high spin iron(II) species over time. Masuda at al have reported
the synthesis of another family of iron-TPA derivatives which contain alkylated amide/amine
groups attached at the 6-position. The initial driving force for synthesizing these was to model
the active site of iron dependent non-heme monooxygenase enzymes such as soybean
lipoxygenase-1 (SLO-1). Lipoxygenases (LOs) are found in animals and plants and catalyze
the regiospecific and stereospecific hydroperoxidation of 1,4-Z,Z-pentadiene-containing
polyunsaturated carboxylic acids such as linoleic and linolenic acids, important species on the
biosynthetic path to plant growth hormones and other products aiding response to infection.1-4
The X-ray crystal structures of several soybean lipoxygenases have been determined. Each
one sharing a common high spin iron(II) centre, in a distorted octahedral geometry.5-9 The
iron(II) centre is coordinated by three imidazoles from histidine, a carboxylate from the C-
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terminal isoleucine, a carboxamidato carbonyl oxygen from asparagine and a single water
molecule.5-9 In the catalytic cycle of SLO-1, the proposed active species consists of an
iron(III) centre coordinated to a hydrogen-bonded hydroxide ligand, figure 4.1, termed ferric-
SLO.5
Figure 4.1: Schematic representation of the active ferric form of SLO-1
A number of mononuclear six-coordinate iron(III) complexes with oxygen donor ligands such
as methoxo, ethoxo, carboxylato or carboxamidato, and several dinuclear iron(III) complexes
with terminal or bridging hydroxo ligands have been characterized as possible models for
ferric SLO.6-11 Of these only one structural model containing a mononuclear iron(III) centre
coordinated to a hydrogen-bonded terminal hydroxo ligand has been structurally
characterized, [Fe(TNPA)(PhCO2)(OH)]ClO4, figure 4.2a.5 The similarities to the active site
of ferric-SLO are clear. The iron complex [Fe(TNPA)(PhCO2)(OH)]ClO4 has also been
characterized by UV/VIS and EPR spectroscopy and by electrospray ionization mass
spectrometry (ESI-MS). In related work Masuda et al also reported a thermodynamically
stable iron(III) complex with an alkylperoxide ligand attached in an end-on fashion, whose
spectral behaviour was moreover comparable to that of the ‘purple’ form of SLO-1.12-15,16
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Figure 4.2: Schematic representation of (a) [Fe(TNPA)(PhCO2)(OH)](ClO4) (model for
SLO-1) and (b) [Cu(BPPA)(OOH)](ClO4). TNPA = tris(6-neopentylamino-2-
pyridylmethyl)amine, (L17); BPPA = bis(6-pivaloylamido-2-pyridylmethyl)-2’-
pyridylmethylamine, (L18).
The LCu(II)-OH and LCu(II)-OOH(R) complexes (L18 = bis(6-pivaloylamido-2-
pyridylmethyl)-2’-pyridylmethylamine (BPPA)) have also been synthesized, figure 4.2b.17, 18
An interesting feature of both complexes is the hydrogen-bonding from the amine/amido N-H
groups to the hydroxo/hydroperoxo ligand which results in the t-butyl substituents all pointing
upwards above the metal coordination centre.12-15, 19 Thus one could envisage replacing the
neopentyl groups in figure 4.2a with long peralkyl chain substituents in order to create a
hydrophobic channel which would moreover self-assemble around the iron(III) centre via
hydrogen-bonding to a bound H2O2 ligand. Finally, 6-amine/amido substituents attached to
pyridine should be more oxidatively robust compared to the benzylic methylenes present in
ligands L15 and L16 (chapter 3). This is an important consideration in the ligand design for a
powerful oxidation catalyst.
Finally, in considering the optimum spacer group for attaching the peralkyl
substituents at the three 6-py positions of TPA the use of a urea group has particular
attractions. Borovik and co-workers have reported the reaction of t-butyl isocyanate with tren
(tris(aminoethyl)amine) to give tris(t-butylureylethyl)amine (TBUA) (L10), which in the
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presence of a strong base (NaH) combines with iron(II) under oxidative conditions to give the
first structurally characterised mononuclear iron(III) complex attached to a single terminal
oxo ligand, figure 4.3.20 Strong hydrogen-bonding from the urea N-H groups to the oxo ligand
is an important feature in stabilising this moiety. It is believed that initial formation of a high
valent iron(IV) or iron(V) species is followed by reduction back to iron(III). Although one
could envisage the iron(III) centre in [(H-3TBUA)FeIII=O] as Fe(III)-O2- or Fe(III)-OH2
hydrogen-bonded to two doubly-deprotonated urea groups the unusually short Fe(III)-O
distance suggests an assignment to the former Fe(III)=O2- representation.20
Figure 4.3: Schematic representation of the formation of [(H-3TBUA)FeIII=O] in the presence
of a strong base (NaH) and O2.
Our approach here has been to combine the features of the iron complexes of Masuda and
Borovik above by synthesizing a new family of iron-TPA complexes with peralkylurea
groups attached at the 6-position on each of the three pyridines. These putative ligands
possess many of the important features needed for the design of the optimal iron-based n-
alkane oxidation catalyst.
(i) Iron-TPA complexes have already demonstrated activity in the catalysis of
H2O2 oxygenation on various C-H substrates (see chapter 1)
(ii) The binding of OH2, OH- or OOH- to the iron centre will induce strong and
effective hydrogen-bonding from the urea groups at the 6-py position
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leading to orientation of the peralkyl substituents upwards above the iron
centre (self-assembly) thus creating a hydrophobic channel for both
solublisation and orientation of the n-alkane substrate to induce C-1
oxygenation.
(iii) Strong hydrogen-bonding from the remote N-H group of the urea will
promote heterolytic O-OH cleavage, figure 4.4, of the Fe(III)-OOH
precursor facilitating access to formally iron(V) (perferryl) as representing
the optimal and most potent catalytic centre for oxidative reaction at the
most inert of C-H substrates like n-alkanes.
(iv) Introducing electron-withdrawing hexylurea groups on the pyridine rings
should lower the basicity of the pyridine nitrogens contributing to the
thermodynamic stabilization of any mononuclear alkylperoxo iron (III)
complex.19
Figure 4.4: Schematic representation of how hydrogen-bonding within a hydroperoxo
iron(III) complex of putative tris(6-n-hexylureyl-2-pyridylmethyl)amine could facilitate
heterolytic O-O cleavage (abstraction of OH-) to generate a high valent ‘perferryl’ iron(V)
intermediate.
The use of urea groups might circumvent the behaviour of [Fe(BPPA)(O2CBut)]2+ which
possesses an interesting seven-coordinated iron centre bound to the four nitrogens of TPA, a
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pivalate carboxylate and two amide carbonyls, figure 4.5a. Treatment of
[Fe(BPPA)(O2CBut)]2+ with tBuOOH is believed to give rise to seven-coordinated
[Fe(BPPA)(OOBut)]2+, figure 4.5b, on the basis of retention of the same low field EPR signal,
figure 4.5c. [Fe(BPPA)(OOR)]2+ is remarkably long lived for a alkylperoxo-iron(III) complex
and is reported to persist for 5 h at 25oC.21
tBuOOH
(a) (b)
(c)
Figure 4.5: (a) Schematic representation of the structure of [Fe(BPPA)(O2CBut)]2+; (b)
putative [Fe(BPPA)(OOBut)]2+ and (c) EPR signal from [Fe(BPPA)(OOBut)]2+ at 77K.
This is believed to be attributable to a degree of electronic and/or steric control by the BPPA
ligand.18 A low field EPR signal, similar to that in figure 4.5(c), is obtained on treating the
iron(III) formate complex; [Fe(BPPA)(O2CH)]2+ with H2O2.27 This has been assigned to the
seven-coordinated hydroperoxo complex; [Fe(BPPA)(OOH)]2+. It was hoped that the use of
urea spacer groups could discourage carbonyl binding to iron in favour of hydrogen bonding
from both the proximal and remote N-H hydrogens of the urea to bound hydroxo/oxo or
hydroperoxo species, see figure 4.4.
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There are only brief reports as to the behaviour of iron-BPPA complexes, such as
those in figure 4.5, towards oxidation catalysis on C-H substrates. The reactivity towards
cyclohexene and cyclohexane in single turnover reactions (high selectivity for hydroxylation
over ketonization) is similar to that found in heme iron-based oxidations22-25 and is not consist
with Haber-Weiss26 or Russell27 termination radical processes. The reactive species was
proposed to be a nucleophilic iron(IV)-oxo based reactant, formulated as (H2BPPA)Fe(IV)O,
deriving from O-O homolysis of a (H2BPPA)Fe(III)-OOH precursor.21
A desirable precursor for the synthesis of a whole range of 6-N-substituted TPA
ligands is L20 = tris(6-amino-2-pyridylmethyl)amine, figure 4.6, reported by Masuda via
hydrolysis of tris(6-pivalamido-2-pyridylmethyl)amine.28, 29 In the sections below possible
new routes to tris(6-amino-2-pyridylmethyl)amine using tris(6-bromo-2-pyridylmethyl)amine
Figure 4.6: Structure of tris(6-amino-2-pyridylmethyl)amine, L20
are described along with the successful synthesis and characterisation of two 6-n-hexylureyl
substituted TPA derivatives; L21 and L22, figure 4.7. Complexes of L21 and L22 with iron(II)
have been characterised in acetonitrile solution by paramagnetic 1H NMR. The structure of
the iron(II) complex of L22 has also been characterised by X-ray crystallography. Attempts at
making L23, figure 4.7, (unsuccessful to date) are also described.
Figure 4.7: Structures of the 6-(n-hexylureyl)-substituted TPA ligands L21 – L23.
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4.2. Results and discussion:
4.2.1. Attempted Synthesis of tris-(6-amino-2-pyridylmethyl)amine L20 from tris-(6-
bromo-2-pyridylmethyl)amine, L24.
The published route involves acid hydrolysis of tris-(6-pivaloylamino-2-
pyridylmethyl)amine.28,29 However synthesis of this precursor required an NBS radical
bromination on 6-pivaloylamino-2-picoline to activate the methyl group followed by a two
step amination.29 However such NBS activated radical brominations on picolines are well
documented as favouring preferential reaction on the aromatic ring with monobromination at
methyl proceeding only in 10% yield. Although the final amination step involving various 6-
N-protected-2-bromomethylpyridines has been recently improved by Berreau et al,30 using
ammonium acetate as ammonium source, potassium carbonate and tetrabutylammonium
bromide as phase transfer agent, the problem of obtaining good yields of the 2-
bromomethylpyridine precursors remains. Subsequently it was reported that a detectable
(usable) yield of radical side chain (methyl) mono-bromination products only results in the
case of the 6-N-acetyl or 6-N-pivaloyl-2-picolines.31 Initial attempts to radical
monobromination of the methyl groups of a range of other 6-N-protected amino-2-picolines
such as with boc or more desirably n-alkylureyl groups resulted only in ring bromination
products.29 We therefore decided to use a different strategy involving direct amination of the
6-bromoTPA precursor; tris(6-bromo-2-pyridylmethyl)amine. This seemed potentially
attractive since the reaction works well for simpler 6-bromopyridine analogues and tris-(6-
bromo-2-pyridylmethyl amine is obtainable in very good yield. Moreover it is known that the
6-position can be easily modified for example via Suzuki coupling as reported by Canary et
al.32 Tris(6-bromo-2-pyridylmethyl)amine (L24) is prepared from 2,6-dibromopyridine via
monolithiation and reaction with DMF followed by NaBH4 reduction to 6-bromo-2-
hydroxymethylpyridine which is then brominated with HBr and finally reacted with
ammonium acetate/sodium carbonate to give the TPA. Four methods were then employed for
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the direct amination of tris-(6-bromo-2-pyridylmethyl)amine involving (i) potassium in liquid
ammonia (KNH2),33 (ii) copper-catalyzed reaction with liquid ammonia,34 and finally (iii)
palladium-catalysed reaction with benzophenone imine35 or (iv) with lithium
bis(trimethylsilyl)amide36 as ammonia equivalents. However, despite repeated attempts, none
of these direct amination methods proved successful for the synthesis of tris-(6-amino-2-
pyridylmethyl)amine. Therefore, an alternative method to the use of radical bromination for
activating the methyl group of a range of 6-N-protected amino-2-picolines was investigated.
The method of choice proved to be that reported in 2007 by Berlin et al involving treatment
with BuLi to deprotonate the 2-methyl group followed by reaction with dioxygen and
reduction of the resulting 6-N-protected-2-hydroperoxomethylpyridine to the 2-
hydroxymethylpyridine, O-tosylation and finally amination to the TPA (see below).
4.2.2. Synthesis of [6-(n-hexylureyl)-2-pyridylmethyl)-bis-(2-pyridylmethyl)]amine, L21.
In 2007 a new method for the oxidation of 4-methyl heteroaryls with molecular oxygen was
reported by Berlin et al37 as part of a facile multigram synthesis of 2-[t-
butoxycarbonyl)amino]-4-pyridinecarbaldehyde, a versatile pharmaceutical intermediate. This
involved conversion of side chain methyl to hydroxymethyl. This, as an alternative to
generating a bromomethyl substituent for the final amination step, seemed to be generally
applicable to a wide variety of methyl heteroaryls and there was no reason to suppose that it
would not proceed in good yield on a variety of 6-N-substituted amino-2-picolines. Following
the same strategy, firstly 6-amino-2-picoline 1 is converted into the 6-N-boc and 6-N-n-
hexylureyl derivatives with di-tert-butyl dicarbonate or hexyl isocyanate 2 respectively in dry
THF. Both of these reactions proceed in good yield and are described briefly below for L21,
figure 4.8. The next step was the activation of the methyl group. This is carried out by firstly
deprotonating it with butyl lithium at -78° C (3.3 equivalents in the case of the reaction for the
N-hexylureyl but only 2.2 equivalents for N-Boc protected to ensure that all NH’s are
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deprotonated). The efficiency of the reaction at this point was tested by quenching the product
with D2O wherein 1H NMR revealed evidence of the single deuteration of the methyl group in
high yield. Pre-dried molecular oxygen was passed through the -78° C suspension of the
trianion wherein the dark orange colour quickly changed to bright yellow.
Figure 4.8: Synthesis of [6-(hexylureyl)-2-pyridylmethyl)-bis-(2-pyridylmethyl)]amine, L21
After several hours, the reaction mixture was quenched with two equivalents of acetic acid
together with an excess of dimethyl sulfide. The crude mixture was stirred for an additional
48 hours at room temperature since it appeared from TLC that formation of the alcohol 4 via
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3, presumed to occur via the hydroperoxide intermediate, was not very complete at this time.
The desired alcohol 4 was subsequently isolated in 43 % yield. To activate the alcohol group,
it was tosylated with p-toluenesulfonyl chloride in the presence of triethylamine to give 5,
yield 64%. Finally reaction of 5 with 1.1 equivalents of bis(2-picolyl)amine 6 using K2CO3 as
a base and tetrabutylammonium bromide as a phase transfer agent30 gave L21 as a colourless
solid in 19% yield.
Figure 4.9: Synthesis of [Bis-(6-(hexylureyl)-2-pyridylmethyl)-2-pyridylmethyl]amine, L22
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equivalents of 5 with 2-aminomethylpyridine 7 using K2CO3 as a base and
tetrabutylammonium bromide as a phase transfer agent gave the desired ligand L22 as a
colourless solid in an overall 48% yield.
4.2.4. Attempted synthesis of Tris-(6-(hexylureyl)-2-pyridylmethyl)amine, L23.
The synthesis of L6 was attempted before knowledge of Berreau’s improved method for
amination involving use of ammonia acetate and potassium carbonate with
tetrabutylammonium bromide as phase transfer agent. Conversion of the tosylated alcohol 5
into the corresponding tripodal ligand L6 was thus carried out using a Gabriel Synthesis29,
figure 4.10. Firstly, 5 was treated with potassium phthalimide to give 8, and afterwards
reaction with hydrazine in ethanol under reflux gives 9. However, reaction between 9 and two
equivalents of 5 did not occur probably because of the absence of tetrabutylammonium
bromide which appeared to be crucial. Unfortunately, there was not sufficient time available
to reinvestigate this reaction in the presence of tetrabutylammonium bromide. Nonetheless,
the successful synthesis of L4 and L5 has allowed a detailed investigation of the influence of
having one or more 6-N-hexylureyl-pyridine substituents on the subsequent properties and
catalytic activity of the corresponding iron complexes.
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Figure 4.10: Synthetic route to tris-(6-(hexylureyl)-2-pyridylmethyl)amine L23
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4.3. Synthesis of Iron(II) complexes:
The 6-N-hexylureyl-TPA ligands, L21 and L22 were each reacted with 1 equivalent of the
iron(II) salt; [Fe(CH3CN)2(O3SCF3)2] in CH3CN solvent. The method of vapour diffusion
using diethyl ether was employed to grow crystals suitable for X-ray diffraction as described
in chapter 2. However only the crystals obtained from the reaction of [Fe(CH3CN)2(O3SCF3)2]
with L5 were suitable for X-ray determination.
4.3.1. Reaction of [Fe(CH3CN)2(O3SCF3)2] with L22.
An X-ray structure investigation of the crystalline product revealed it to contain the iron(II)
bistriflate salt [Fe(L22)](O2SCF3)2, C21, figure 4.11.
Figure 4.11: Molecular structure of [Fe(L22)](O3SCF3)2 , C21
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The iron(II) centre is in a distorted octahedral geometry coordinated to all four nitrogen
donors of L22, plus two carbonyl oxygens from the 6-N-hexylureyl substituent. As a result of
coordination of the two urea carbonyls to iron(II) the n-hexyl substituents are orientated out
on one side of the complex forming a hydrophobic channel adjacent to the iron coordination
centre. Coordination of amide carbonyl oxygens is not unusual for iron(II) and indeed the
structure of [Fe(L22)](O3SCF3)2 is very similar to that of the iron(II) complex [Fe(BPPA)]2+
reported by Masuda et al.19 Selected bond lengths and angles are listed in table 4.1.
Table 4.1: Selected bond lengths (Å) and angles (°) for [Fe(L22)](O3SCF3)2 (esds in
parentheses).
Fe(1)-O(9) 2.018(4) Fe(1)-O(29) 2.185(4)
Fe(1)-N(43) 2.127(5) Fe(1)-N(1) 2.232(5)
Fe(1)-N(23) 2.139(5) Fe(1)-N(3) 2.239(5)
O(9)-Fe(1)-O(43) 109.36(17) O(9)-Fe(1)-N(43) 114.44(18)
N(9)-Fe(1)-O(23) 127.83(17) O(9)-Fe(1)-O(29) 81.31(15)
N(43)-Fe(1)-O(29) 81.81(16) N(23)-Fe(1)-O(29) 78.25(17)
O(9)-Fe(1-N(1) 155.98(17) N(43)-Fe(1)-N(1) 76.27(17)
N(23)-Fe(1)-N(1) 75.20(18) O(29)-Fe(1)-N(1) 122.69(16)
O(9)-Fe(1)-O(3) 80.28(16) N(43)-Fe(1)-N(3) 109.14(18)
N(23)-Fe(1)-N(3) 104.95(17) O(29)-Fe(1)-N(3) 160.91(16)
N(1)-Fe(1)-N(3) 75.88(17) C(21)-Fe(1)-N(14) 112.2(4)
___________________________________________________________________________________
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The octahedral geometry is highly distorted with distinctly different Fe-O bond lengths,
2.018(4) and 2.185(4) to the two-urea carbonyls. There was no evidence of the uniquely long
Fe-N bond to the tertiary amine nitrogen that characterises seven coordinate iron(III)-TPA
centres such as those present in [Fe3(L11)2](ClO4)3 (H3L11 = tris(6-hydroxymethyl)-2-
pyridylymethyl)amine (chapter 2). This is presumably as a result of binding to iron(II) in this
case. Indeed the longest Fe-N bond is to a nitrogen atom of one of the pyridines carrying a 6-
N-hexylureyl substituent. Finally, the two-urea N-H groups are in a hydrogen-bonded
arrangement with the two trifluoromethanesulfonate anions. It is hoped that subsequent
reaction with H2O2 to form peroxo-iron(III) complexes will lead to dissociation of urea
oxygen facilitating the intended hydrogen-bonded interactions of urea N-H with the
hydroperoxo groups, figure 4.4 rather than amide oxygen coordination as in [Fe(BPPA)]2+
and [Fe(BPPA)(O2CBut)]2+, figure 4.5.18 This is explored in the next chapter.
4.3.2. Characterisation of high spin [Fe(L21)(CH3CN)](O3SCF3)2 C20, and
[Fe(L22)](O3SCF3)2 C21 in solution by 1H NMR spectroscopy.
[Fe(L22)](O3SCF3)2. Figure 4.12 shows a 1H NMR spectrum of a solution of
[Fe(L22)](O3SCF3)2 in CD3CN. The spectrum taken over a wide sweep from -5 to +100 ppm
shows broad signals corresponding to a high spin iron(II) complex. The resonances at 110,
53.5 and 56 ppm are assigned to the and  and ’ protons respectively of the unsubstituted
pyridine ring with its tertiary amine methylene assigned to the resonance at 99 ppm. The 
and ’ protons of the substituted pyridine ring appear at 40 and 46 ppm along with two
resonances for tertiary amine methylene at 68 and 58 ppm. The upfield resonances at 32, 8.7,
3.8 and 2.5 ppm are assigned to the first and the subsequent methylenes of the n-hexyl chain.
Finally, the upfield resonances at 0.8 and 1.1 ppm are assigned to the  protons respectively
on the two types of pyridine ring. These assignments, listed below in table 4.2, are based upon
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Figure 4.12: 1H NMR spectrum of [Fe(L22)](O3SCF3)2 in CD3CN, C21.
comparisons with the 1H NMR spectrum of [Fe(6-Me2TPA)(CH3CN)2]2+.18 Further
confirmation would have required a 1H COSY NMR experiment. However, this was not
possible due to lack of material available and the poor quality noisy spectrum obtained.
[Fe(L21)(CH3CN)](O3SCF3)2.
Figure 4.13 shows a 1H NMR spectrum of a solution of [Fe(L21)(CH3CN)](O3SCF3)2
recorded in CD3CN. In the absence of further X-ray characterisation it has been assumed that
one acetonitrile molecule remains coordinated to the iron(II) centre as L21 only contains one 6-
N-n-hexylureyl substituent on one of the pyridine rings presumed coordinated through oxygen
as in [Fe(L22)](O3SCF3)2 . The resonances at 131, 47 and 48 ppm are assigned to the and the
 and ’ protons of the two unsubstituted pyridine rings with the tertiary amine methylene
assigned at 72 ppm. The  and ’ protons of the substituted pyridine ring appear at 23 and 35
ppm along with two resonances for tertiary amine methylene at 67 and 37 ppm. The
resonances at 18.4 and 2.5 ppm are assigned to the first and subsequent methylenes of the n-
hexyl chain; the rest presumed to be amongst the large solvent peaks around 2 ppm. Finally,
the two highly upfield broad resonances around 0 and -1 ppm are assigned to the upfield
shifted  protons respectively on the two types of pyridine ring. These assignments, listed
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below in table 4.2 are based upon comparisons with the 1H NMR spectrum of [Fe(6-
MeTPA)(CH3CN)2]2+ 18 and would require a 1H COSY experiment for confirmation.
However, this was not possible due to lack of material available and the poor quality noisy
spectra obtained.





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Figure 4.13: 1H NMR spectrum of [Fe(L21)(CH3CN)](O3SCF3)2 in CD3CN.
Table 4.2: 1H NMR parameters (in CD3CN) for high spin iron(II) complexes of L21 and L22
along with those for high spin [Fe(6-MeTPA)(CH3CN)2]2+ and [Fe(6-Me2TPA)(CH3CN)2]2+.9
Complex CH2-N- -H β,β’-H γ-H -X
[Fe(L21)(CH3CN)]2+ 72
67, 37
131
-
35, 23
47, 48
-1
0 18.5 (X = NHCONHCH2C5H11-n)
[Fe(6-MeTPA)(CH3CN)2]2+ * 88
82, 37
95
-
48, 52
50, 51
-7
-6 -24 (X = CH3)
[Fe(L22)]2+ 99
68, 58
110
-
53.5, 56
40, 46
0.8
1.1 32 (X = NHCONHCH2C5H11-n)
[Fe(6-Me2TPA)(CH3CN)2]2+
*
92
86, 75
106
-
56, 59
52, 57
-11
-6 -25 (X = CH3)
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4.4. Experimental:
4.4.1. Synthesis of tris(6-bromo-2-pyridylmethyl)amine and attempted synthesis of
tris(6-amino-2-pyridylmethyl)amine via direct amination:
4.4.1.1. Synthesis of 2-bromo-6-hydroxymethylpyridine:
To a solution of n-BuLi (15.625 cm3, 25 mmol, 1.6 mol dm-3 in hexane) in THF (30 cm3) at -
78ºC was added dropwise a solution of 2,6-dibromopyridine (5.925 g, 25 mmol) in THF (70
cm3). The internal temperature was kept below -78ºC during the addition. After mixing the
resulting green solution was stirred for additional 15 minutes then neat DMF (3.0 cm3, 38.75
mmol) was added over a period of 30 s. The reaction was stirred at -78 for 15 min. followed
by the addition of methanol (25 cm3) and acetic acid (1.6 cm3) and finally NaBH4 (0.95 g, 25
mmol). The cooling bath was removed and the reaction solution carefully warmed up to room
temperature. The reaction mixture was carefully quenched with a saturated aqueous solution
of ammonium chloride (75 cm3) and then extracted with ethyl acetate (100 cm3 followed by
50 cm3 respectively). The combined organic layers were washed with brine (50 cm3) dried
over Na2SO4, and concentrated giving 2-bromo-6-hydroxymethylpyridine as a pale-yellow oil
(4.01 g, 85%).
1H NMR (CDCl3) 7.54 (t,1H), 7.36 (d,1H), 7.29 (d,1H), 4.73 (s,2H), 3.64 (br,1H)
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4.4.1.2. Synthesis of 2-bromo-6-bromomethylpyridine:
2-bromo-6-hydroxymethylpyridine (9.43 g. 50 mmol) was added to 100 cm3 of 48%
hydrobromic acid, and the reaction was heated at reflux for 12 h. The reaction solution was
neutralized carefully with 1 mol dm-3 sodium hydroxide and then extracted with CH2Cl2. The
combined organic layers were dried over Na2SO4 and evaporated. Flash chromatography
(hexane/ethyl acetate; 4:1) and evaporation gave 2-bromo-6-bromomethylpyridine as a
colourless solid (8.52 g, 67.85 %).
1H NMR (CDCl3) 7.58 (t,1H), 7.44 (d,2H), 4.53 (s,2H)
4.4.1.3. Synthesis of tris(6-bromo-2-pyridylmethyl)amine, L24:
2-bromo-6-bromomethylpyridine (8.5 g, 33 mmol) was dissolved in dry CH3CN (15 cm3) and
ammonium acetate (0.870, 11.29 mmol) and sodium carbonate (2.39g, 22.58 mmol) added
under nitrogen gas and the reaction mixture stirred for 3 d at room temperature. The reaction
was followed by TLC (DCM) and additional portion of sodium carbonate (1.12 g, 11.29
mmol) was added after three days. The mixture was filtered to remove the salts and the filtrate
was dried under vacuum to give tris(6-bromo-2-pyridylmethyl)amine as a white solid.
Recrystallisation was carried out by dissolving the compound in warm diethyl ether and
storing the solution in the freezer, white needles of pure product were obtained (2.76 g, 46.37
%) 1H NMR (CDCl3) 7.58 (d,3H), 7.55 (t,3H), 7.38 (d,3H), 3.96 (s,6H) MS: ES+: m/z:
550.95 [(M+Na)+ 100%]
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4.4.1.4. Synthesis of tris(6-amino-2-pyridylmethyl)amine via direct amination of tris(6-
bromo-2-pyridylmethyl)amine, L20.
Method 1. Tris(6-bromo-2-pyridylmethyl)amine (200 mg, 0.38 mmol) was added to a
solution of potassium amide prepared from (166.9 mg, 4.26 mmol) of metallic potassium in
100 cm3 of NH3 in a foil-wrapped flask. The mixture was then quenched after 15 min. with
excess of ammonium bromide. Diethyl ether (100 cm3) was added while the ammonia was
evaporated. The ethereal mixture was filtered and the residual salts triturated with diethyl
ether (4 x 50 cm3). The combined ethereal extracts were concentrated to yield a brown solid
(0.123 g) which was not soluble in any solvent.
Method 2. A 500 cm3 pressure tested autoclave was charged with Cu2O (1 mg), then a
solution of tris(6-bromo-2-pyridylmethyl)amine (200 mg, 0.38 mmol) in ethylene glycol (5
cm3). The mixture was cooled to 0ºC and liquid ammonia was added over a 30 min. period.
The autoclave was then sealed and the reaction mixture heated at 80ºC for 16 h. at a pressure
of ~ 50 psi. The reaction mixture cooled down to room temperature and drained into a beaker.
The pH was adjusted to 10.5 with 2 mol dm-3 H2SO4 solution and the mixture extracted with
EtOAc to give a brown solid (0.1271 g). The 1H NMR spectrum shows only broad peaks
which could match with the data reported in literature.28 However, the MS does not match
with the entitle compound.
1H NMR (CDCl3) 7.31 (br,3H), 6.73 (br,3H), 6.24 (br,3H), 5.77 (br,6H), 3.36 (br,50 H)
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Method 3. In a screw-capped vial in a dry box under argon gas containing (0.527g, 1 mmol)
of tris(6-bromo-2-pyridylmethyl)amine was placed tri(t-butyl)phosphine (10.116 mg, 0.05
mmol), Pd(dba)2 (22.875 mg, 0.025 mmol) (dba = dibenzylideneacetone) and LiHMDS
(0.1840 g, 1.1 mmol) (HMDS = hexamethyldisilazane, followed by toluene (2.5 cm3). The
vial was sealed with a cap that fitted a PTFE septum and removed from the dry box for
heating at 70ºC. The crude mixture was diluted with diethyl ether (20 cm3) and the silylamide
deprotected by adding a drop of 1 mol dm-3 HCl. The mixture was transferred to a separating
funnel with aqueous 1 mol dm-3 NaOH (20 cm3). The organic layer was dried over anhydrous
MgSO4, filtered and then concentrated under reduced pressure. A brown solution was
obtained from which a brown solid precipitated. The 1H NMR spectrum in (d6-DMSO) did
not match with the literature values.
Method 4. Dry toluene (10 cm3) was introduced into a 25 cm3 Schlenk tube and the mixture
was degassed, (vacuum/N2 cycle, three times). Tris(6-bromo-2-pyridylmethyl)amine (0.572 g,
1 mmol), dppf ( dppf = bis(diphenylphosphine) ferrocene) (83.15 mg, 0,15 mmol), sodium t-
butoxide (0.37 g, 3.30 mmol), palladium(II) acetate (16.8 mg, 0.075 mmol) and
benzophenone imine (0.609 g, 3.36 mmol) were then charged and the mixture heated at such
rate that the inner temperature rose to 78-82 ºC within 30-60 min. The reaction mixture
agitated for 1 h at 78-82 ºC and then allowed to cool to room temperature and stand for 10
min. Tri(n-butyl)phosphine (0.326 g, 1.611 mmol) was then added to the mixture which was
allowed to stand at ambient temperature for a further 10 min. The toluene solution was
poured for into 5 % aqueous solution of citric acid (100 cm3) and allowed to stand for a
further 30 min. at room temperature. The aqueous layer was then washed with iPrOAc (50
cm3) and the organic layer discarded. The citric acid layer was washed with 5 mol dm-3 NaOH
solution (10 cm3) keeping the temperature between 15 - 20ºC. The aqueous layer contained a
precipitate. A yellow solid (91 mg) was obtained upon evaporation of the solvent. The solid
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was soluble in DMSO and CDCl3. The 1H NMR spectrum in (d6-DMSO) did not match with
the literature values.
4.4.2. Synthesis of [(6-(n-hexylureyl)-2-pyridylmethyl)-2-bis(pyridylmethyl)]amine, L21,
[bis-(6-(n-hexylureyl)-2-pyridylmethyl)-2-pyridylmethyl]amine, L22 and attempted
synthesis of tris[(6-n-hexylureyl)-2-(pyridylmethyl)]amine, L23:
4.4.2.1. Synthesis of 6-(n-hexylureyl)-2-methylpyridine:
To a solution of 6-amino-2-methylpyridine (1.72 g, 15.7 mmol) in THF (15 cm3) was added
n-hexylisocyanate (2.00 g, 1.57 mmol). The reaction mixture was stirred overnight for 16 h at
RT. The white product was removed by filtration, washed with THF, then with diethyl ether,
before being dried under vacuum to give 6-(n-hexylureyl)-2-methylpyridine as a white
powder (2.20 g, 59.4%).
1H NMR (300.06 MHz, CDCl3, 298 K): δ= 9.64 (1H, br, s, NH), 8.01 (1H, br, s, NH), 7.48
(1H, t, 3JHH = 7.4 Hz, 1H of C5H3N), 6.73 (1H, d, 3JHH = 7.5 Hz, 1H of C5H3N), 5.57, (1H, d,
3JHH = 8.01 Hz, 1H of C5H3N), 3.41 (2 H q, 3JHH = 5.63 Hz, CH2), 2.47 (3 H s , CH3), 1.64 (m
, CH2), 1.36 (m,3 CH2), 0.92 (3H, t, 3JHH = 6.6 Hz, CH3).
13C-{1H} NMR (75.45 MHz, CDCl3, 298 K)C= 14.48, 23.07, 24.49, 27.25, 30.18, 31.98,
40.18, 108.93, 116.18, 138,94, 153.24, 156.40, 157.49
MS: ES+: m/z: 258.16 [(M+Na)+ 100%].
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4.4.2.2. Synthesis of 6-(n-hexylureyl)-2-hydroxymethylpyridine:
To a solution of 6-(n-hexylureyl)-2-methylpyridine (3 g, 12.75 mmol) in THF (150 cm3) -
78ºC (acetone/dry ice bath) was added a solution of n-butyl lithium (2.5 mol dm-3) in hexane
(19.13 cm3, 48.84 mmol). The mixture was warmed up and stirred for 2 h at room temperature
resulting in the formation of an orange solution. The mixture was cooled to -78ºC and pre-
dried O2 (passed through a Drierite column) was bubbled through the suspension for 6 h. The
reaction was quenched by adding (6.48 cm3, 34.4 mmol) of Me2S at -78ºC, followed by
glacial acetic acid (2.76 cm3, 19.28 mmol). The reaction mixture was warmed and stirred for
48 h at RT. Dilution with water and extraction with ethyl acetate was followed by
concentration and flash chromatography of the residue (dichloromethane/acetone; 6:1).
Evaporation gave 6-(n-hexylureyl)-2-hydroxymethylpyridine as a pale yellow solid (1.07g, 43
%).
1H NMR (300.06 MHz, CDCl3, 298 K): δ= 9.30 (1H,br, s, NH), 8.98 (1H, br, s, NH), 7.57
(1H, t, 3JHH = 7.7 Hz, 1H of C5H3N), 6.98 (1H, d, 3JHH = 7.7 Hz, 1H of C5H3N), 6.68, (1H, d,
3JHH = 8.0 Hz, 1H of C5H3N), 4.70 (2H s , HOCH2), 3.38 (2H q, 3JHH = 5.8 Hz, 3JHH = 7.7 Hz,
CH2), 3.00 (1H, br , OH), 1.64 (2H, m , CH2), 1.36 (6H, m, 3 CH2), 0.91 (3H, t, 3JHH = 6.6 Hz,
CH3).
13C-{1H} NMR (75.45 MHz, CDCl3, 298 K)C= 14.46, 23.02, 27.21, 30.13, 31.93, 31.93,
40.23, 65.61, 110.00, 113.57, 139.13, 153.21, 157.03, 157.75.
MS: ES+: m/z: 274.15 [(M+Na)+ 100%].
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4.4.2.3. Synthesis of 6-(n-hexylureyl)-2-(p-toluenesulfonoxymethyl)pyridine:
To a solution of 6-(n-hexylureyl)-2-hydroxymethylpyridine (261.18 mg, 1.04 mmol) and Et3N
(0.45ml, 3.24 mmol) in ethyl acetate (10 cm3), was added p-toluenesulfonyl chloride (59.086
mg, 3.10 mmol) at 0 ºC. The mixture was warmed to room temperature and stirred for 24 h;
then quenched by the addition of saturated aqueous NaHCO3. The organic layer was
separated, washed with H2O and brine, dried (anhydrous MgSO4) and evaporated. The crude
residue was purified by flash chromatography (CH2Cl2/acetone; 4:1) to yield the pure tosylate
product as a colourless solid (270 mg, 64 %).
1H NMR (300.06 MHz, CDCl3, 298 K): δ= 9.21 (1H,br, s, NH), 8.92 (1H, br, s, NH), 7.82
(1H, d, 3JHH = 8.3 Hz, 1H of C6H4), 7.56 (1H, t, 3JHH = 7.8 Hz, 1H of C5H3N), 7.35 (1H, d,
3JHH = 7.9 Hz, 1H of C6H4), 6.89 (1H, d, 3JHH = 7.5 Hz, 1H of C5H3N), 6.78, (1H, d, 3JHH =
8.7 Hz, 1H of C5H3N), 5.06 (2H s , TsOCH2), 3.38 (2H q, 3JHH = 5.8 Hz, 3JHH = 6.6 Hz, CH2),
2.46 (1H, s , CH3), 1.62 (2H, m , CH2), 1.36 (6H, m, 3 CH2), 0.92 (3H, t, 3JHH = 6.6 Hz, CH3).
13C-{1H} NMR (75.45 MHz, CDCl3, 298 K)C= 14.11, 21.66, 22.64, 26.79, 29.83, 31.54,
39.91, 71.04, 111.87, 114.86, 127.91, 129.87, 138.90, 145.06, 149.99, 153.20, 155.73, 155.95.
MS: ES+: m/z: 428.16 [(M+Na)+ 100%].
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4.4.2.4. Synthesis of 6-(n-hexylureyl)-2-pyridylmethyl-N-isoindole-1,3-dione:
Potassium phthalimide (388.2 mg, 2.09 mmol) was suspended in a solution of 6-(n-
hexylureyl)-2-(p-toluenesulfonoxymethyl)pyridine (850 mg, 2.09 mmol) in DMF (50 cm3),
and the mixture stirred at 80ºC overnight. Following evaporation of the DMF, water was
added to precipitate the crude product. This was extracted with dichloromethane and dried
over anhydrous MgSO4. Following evaporation the resulting solid residue was washed with
diethyl ether to give 6-(n-hexylureyl)-2-pyridylmethyl-N-isoindole-1,3-dione as a colourless
solid (143.5mg 18.05 %).
1H NMR (300.06 MHz, CDCl3, 298 K): δ= 9.14 (1H,br, s, NH), 8.79 (1H, br, s, NH), 7.79
(1H, d, 3JHH = 2.4 Hz, 3JHH = 3 Hz 1H of C6H4), 7.66 (1H, d, 3JHH = 2.4 Hz, 3JHH = 3 Hz 1H
of C6H4), 7.44 (1H, t, 3JHH = 7.8 Hz, 1H of C5H3N), 6.84 (1H, d, 3JHH = 7.5 Hz, 1H of
C5H3N), 6.64, (1H, d, 3JHH = 8.7 Hz, 1H of C5H3N), 4.79 (2H s , NCH2), 3.18 (2H q, 3JHH = 7
Hz, 3JHH = 6.6 Hz, CH2), 1.45 (2H, m , CH2), 1.22 (6H, m, 3 CH2), 0.81 (3H, t, 3JHH = 6.6 Hz,
CH3).
13C-{1H} NMR (75.45 MHz, CDCl3, 298 K)C= 14.14, 22.65, 26.75, 30.25, 31.68, 39.96,
42.51, 111.24, 115.01, 123.16, 123.48, 132.03, 133.85, 134.18, 138.84, 153.53, 156.09,
167.93.
MS: ES+: m/z: 428.16 [(M+Na)+ 100%].
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4.4.2.5. Synthesis of 6-(n-hexylureyl)-2-aminomethylpyridine:
A mixture of 6-(n-hexylureyl)-2-pyridylmethyl-N-isoindole-1,3-dione (140 mg, 368 mmol)
and hydrazine hydrate (17,9 cm3, 368 µmol) in of ethanol (5 cm3) was heated under reflux
overnight. The white precipitate was removed by filtration and the filtrate evaporated.
Recrystallization of the residue from ethanol gave 6-(n-hexylureyl)-2-aminomethylpyridine as
a white solid (18.9 mg 20.5 %).
1H NMR (300.06 MHz, CDCl3, 298 K) δ= 9.18 (1H,br, s, NH), 7.37 (1H, t, 3JHH = 7.8 Hz,
1H of C5H3N), 6.75 (1H, br, s, NH), 6.70 (1H, d, 3JHH = 7.7 Hz, 1H of C5H3N), 6.32, (1H, d,
3JHH = 8.1 Hz, 1H of C5H3N), 4.70 (2H s , NH2CH2), 3.19 (2H q, 3JHH = 5.6 Hz, 3JHH = 7.2
Hz, CH2), 1.40 (2H, m , CH2), 1.14 (6H, m, 3 CH2), 0.71 (3H, t, 3JHH = 6.6 Hz, CH3)
MS: ES+: m/z: 251.19[(M+Na)+ 100%].
13C NMR (75 MHz, CDCl3): δ = 28.29, 63.65, 80.89, 109.60, 115.67, 147.60, 152.66, 152.73,
152.91.
4.4.2.6. Synthesis of [bis(2-pyridylmethyl)-6-(n-hexylureyl)-2-pyridylmethyl)]amine, L21:
L21
Bis(2-picolyl)amine (0.111 cm3, 0.617 mmol) and 6-(n-hexylureyl)-2-(p-toluenesulfonoxy
methyl)pyridine (0.250 g, 0.617 mmol) were dissolved in CH3CN (25 cm3) under N2 gas.
Following addition of Na2CO3 (0.327 g, 3.086 mmol) and 5 mg Bu4NBr, the mixture was
heated in a nitrogen atmosphere under reflux for 21 hours. The reaction mixture was cooled to
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RT wherein 10 ml of distilled water and aqueous 1 mol dm-3 sodium hydroxide (1.6 cm3)
were added. Following extraction with CH2Cl2 (3 x 20 cm3), the combined organic extracts
were dried over anhydrous Na2SO4 and then evaporated under reduced pressure to give a
yellow oil. The oil was dissolved in diethyl ether and after the addition of hexane was kept in
the freezer for several days depositing L4 as a white solid, yield 50 mg (19 %).
1H NMR (300.06 MHz, CDCl3, 298 K) δ= 9.48 (1H,br, s, NH), 8.45 (2H, d, 3JHH = 7.8 Hz,
1H of C5H3N), 8.15 (1H, br, s, NH), 7.6 (2H, t, 3JHH = 7.7 Hz, 1H of C5H3N), 7.48 (2H, t, 3JHH
= 7.7 Hz, 1H of C5H3N), 7.42 (1H, d, 3JHH = 7.7 Hz, 1H of C5H3N), 7.10 (1H, d, 3JHH = 7.7?
Hz, 1H of C5H3N), 7.05 (1H, d, 3JHH = 7.7? Hz, 1H of C5H3N), 6.5, (1H, d, 3JHH = 8.1 Hz, 1H
of C5H3N), 3.80 (4H s , NH2CH2), 3.70 (2H s , NH2CH2), 3.3 (2H q, 3JHH = 5.6 Hz, 3JHH = 7.2
Hz, CH2), 1.50 (2H, m , CH2), 1.14 (6H, m, 3 CH2), 0.80 (3H, t, 3JHH = 6.6 Hz, CH3).
13C NMR (75 MHz, CDCl3): δ = 14,11, 22.63, 26.82, 30.00, 31.56, 39.40, 59.92, 60.35,
110.04, 115.48, 122.09, 122.78, 136.45, 138.64, 149.14, 152.93, 156.05, 159.30.
MS: ES+: m/z: 495.19[(M+Na)+ 100%].
4.4.2.7. Synthesis of [Bis-(6-(hexylureyl)-2-pyridylmethyl)-2-pyridylmethyl]amine, L22:
L22
Under N2 atmosphere 2-aminomethylpyridine (0.032 cm3, 0.308 mmol) was mixed with 6-(n-
hexylureyl)-2-(p-toluenesulfonoxymethyl)pyridine (0.250 g, 0.6128 mmol) in CH3CN (25
cm3). Following addition of Na2CO3 (0.654 mg, 6.17 mmol) and 5 mg of NBu4Br, the
reaction mixture was heated under reflux for 21 hours. The mixture was cooled to room
temperature wherein 10 cm3 of distilled water and aqueous 1 mol dm-3 sodium hydroxide (3.2
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cm3) were added. After extraction with dichloromethane and the combined organic extracts
were dried over anhydrous Na2SO4 and evaporated to dryness under reduced pressure to yield
an orange-brown oil, to which acetone was added. After storing at -18oC for two days, L5 was
obtained as a white precipitate, yield 81 mg (48 %).
1H NMR (300.06 MHz, CDCl3, 298 K) δ= 9.48 (2H, br, s, NH), 8.45 (1H, d, 3JHH = 7.8 Hz,
1H of C5H3N), 8.15 (2H, br, s, NH), 7.6 (2H, t, 3JHH = 7.7 Hz, 1H of C5H3N), 7.48 (1H, t, 3JHH
= 7.7 Hz, 1H of C5H3N), 7.42 (2H, d, 3JHH = 7.8 Hz, 1H of C5H3N), 7.10 (1H, t, 3JHH = 7.8
Hz, 1H of C5H3N), 7.05 (2H, d, 3JHH = 7.7 Hz, 1H of C5H3N), 6.5 (2H, d, 3JHH = 8.1 Hz, 1H
of C5H3N), 3.80 (2H s , NH2CH2), 3.70 (4H s , NH2CH2), 3.3 (4H q, 3JHH = 5.6 Hz, 3JHH = 7.2
Hz, CH2), 1.50 (4H, m , CH2), 1.14 (12H, m, 3 CH2), 0.80 (6H, t, 3JHH = 6.6 Hz, CH3). MS:
13C NMR (75 MHz, CDCl3): δ = 14,10, 22.64, 26.82, 29.99, 31.55, 39.87, 60.05, 60.46,
110.14, 115.23, 122.19, 122.64, 136.50, 138.66, 149.16, 153.01, 156.05, 159.30.
ES+: m/z: 597.36 [(M+Na)+ 100%].
4.4.2.8. Attempted synthesis of tris-(6-(n-hexylureyl)-2-pyridylmethyl)amine, L23:
L23
Under N2 6-(n-hexylureyl)-2-aminomethylpyridine (19 mg, 7.59 µmol) was reacted with a 2
fold excess of 6-(n-hexylureyl)-2-(p-toluenesulfonoxymethyl)pyridine (67.6 mg, 0.167 mmol)
in CH2Cl2 (10 cm3) under reflux overnight at 40ºC. The solvent was evaporated and the 1H
NMR of the crude residue was recorded to look for evidence of the required TPA product.
Three different species appeared to be present but none consistent with the presence of a TPA
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derivative (no resonance for methylene between tertiary amine and pyridine observed around
4 ppm).
4.4.3. Synthesis of iron(II) complexes:
The iron(II) salt [Fe(CH3CN)2(O3SCF3)2] was utilised as the iron precursor in the preparation
of the iron(II) complexes of L21 and L22.
4.4.3.1. [Fe(L21)(CH3CN)](O2SCF3)2. To a solution of [Fe(CH3CN)2(O3SCF3)2] (4.36 mg,
0.01 mmol) in CH3CN (4 cm3) was added a solution of L21 (4.32 mg, 0.01 mmol) in CH3CN
(4 cm3). The mixture was stirred in an open vial for 1 h. Diethyl ether was then mixed in
slowly using vapour diffusion. After 2 days, orange crystals were obtained (2.1mg, 23.2 %)
which were found to be unsuitable for X-ray diffraction.
4.4.3.2. [Fe(L22)](O3SCF3)2. To a solution of [Fe(CH3CN)2(O3SCF3)2] (4.36 mg, 0.01 mmol )
in CH3CN (4 cm3) was added a solution of L22 (5.74 mg, 0.01 mmol ) in CH3CN (4 cm3). The
mixture was stirred in an open vial for 1 h. Diethyl ether was then mixed in slowly using
vapour diffusion. After two days, orange crystals were obtained (2.5mg, 14.85 %) which were
found to be suitable for X-ray diffraction.
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4.5. Summary and Conclusions.
A new synthetic route for the synthesis of 6-N-amino-TPA derivatives has been developed via
lithiation of the methyl group of N-protected 6-amino-2-picoline followed by reaction with O2
to generate the 2-hydroxymethylpyridine derivative under reducing work up conditions. This
reaction goes in high yield, works on a variety of N-protected 6-amino-2-picolines and bastly
superior in every way to radical bromination, which gives much, poorer yields and exhaustive
chromatography due to preferential bromination on the pyridine ring. Tosylation of the
hydroxymethyl group allows the TPA framework to be synthesised using the recently
modified amine coupling method of Berreau in the presence of the mass transfer agent
nBu4NBr. As a result we have synthesized and fully characterised two new 6-substituted TPA
ligand derivatives, L21 and L22 possessing respectively N-ureyl substituents at the 6-position
on one and two of the pyridine moieties. Unfortunately due to lack of time and material the
synthesis of L23 with all three pyridine rings substituted using Berreau’s method was not
achieved, the initial attempts without the presence of nBu4NBr being unsuccessful. High spin
iron(II) complexes of L21 and L22 have however been successfully isolated and suitable
crystals for X-ray diffraction were obtained for the iron(II) triflate complex of L22. The iron(II)
centre is in a distorted octahedral environment coordinated to both urea carbonyl groups along
with the four nitrogens of the TPA moiety. It represents the first such structurally
characterised iron(II) complex coordinated to two urea amido-type carbonyl oxygens in this
family of TPA derivatives. The activity of high spin [Fe(L21)(CH3CN)](O3SCF3)2 and
[Fe(L22)](O3SCF3)2 towards the catalysis of alkane oxygenation with H2O2 was evaluated and
is reported in chapter 5. Along with a study of the reaction products of
[Fe(L21)(CH3CN)](O3SCF3)2 and [Fe(L22)](O3SCF3)2 with both H2O2 and t-BuOOH in CH3CN
solvent which were examined at low temperature (100K) by X-band EPR spectroscopy and at
RT by UV-visible spectrophotometry.
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Chapter Five
Catalysis of H2O2 oxygenation of cyclohexane by hydrophobic iron(II)-TPA
derivative complexes in acetonitrile solvent. GC and time resolved EPR and
UV-VIS studies.
5.1. Introduction
Hydrocarbons, especially saturated hydrocarbons, are the main constituents of oil and natural
gases, the feedstocks for the chemical industry. Selective transformation of saturated
hydrocarbons constitutes an extremely important field of contemporary chemistry from an
economic point of view, since their oxidation products are versatile intermediates for the
further synthesis of a wide range of chemicals.1, 2 New selective routes from hydrocarbons to
valuable products such as alcohols, ketones, acids and peroxides would be hugely beneficial
to sustaining existing large scale chemical synthesis from the dwindling crude oil supply3 but
remains highly challenging as described in chapter 1. H2O2 and O2 remain the desired
oxidizing agents for large-scale industrial applications and the achievement of selective
oxidation of hydrocarbons by these oxidants catalyzed by transition metal species remains the
target of much contemporary research.4, 5 Non-heme iron complexes of tetradentate pyridine-
based ligands such as [Fe(TPA)(CH3CN)2]2+ and [Fe(BPMEN)(CH3CN)2]2+ have shown
significant activity towards the H2O2 oxygenation of hydrocarbons in CH3CN solvent
principally from studies on cyclohexane.6, 7, 8 These catalyst give significantly high A:K ratios
compared to those based on radical intermediates implying the involvement of high valent
metal-oxo based reactive species. Radical based processes give much lower A:K ratios which
under certain conditions, like in Gif chemistry in pyridine, can fall well below unity favouring
the ketone as product. [Fe(BPMEN)(CH3CN)2]2+ is the most active and efficient of the
polypyridine chelate-based non-heme iron catalysts investigated so far.6 Catalysis of
stereospecific hydroxylation has been observed with a prochiral substrate9, 10 which has been
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used as further evidence for metal-oxo based processes involving either iron(IV)-oxo or
iron(V)-oxo species.6 The existence of such high-valent iron-oxo species as intermediates is
supported by recent crystallographic characterisation of two non-heme Fe(IV)=O
complexes.11, 12
As a result of the successes with iron(II)-TPA and related complexes as providing a
template for significant alkane oxygenation activity with H2O2 it was decided to structurally
modify the properties of the TPA ligand with the aim of further enhancing the catalytic
activity and selectivity. At the focus of this work were attempts to improve selectivity towards
the 1-oxygenation of linear n-alkanes by restricting the approach of the internal CH2 groups at
the active iron centre. To achieve this, several TPA ligand derivatives were synthesized
modified at the 6-position of the pyridine ring with alkyl chains. The aim was to create a
narrow hydrophobic channel adjacent to the iron centre that might restrict access to the active
oxo-iron centre of only the end CH3 group of the n-alkane substrate. The synthesis and
characterisation of a number of these derivatives (see figure 5.1 below) was reported in
chapters 2, 3 and 4. In this chapter the results of a study of the catalytic activity of their
iron(II) complexes towards the selective H2O2 oxygenation of cyclohexane is reported.
N
N N
N
R1
R2
R3 L4: R1 = HN
O
N
H
R2 = R3 = H
L5: R1 = R2 = HN
O
N
H
R3 = H
L3: R1 = R2 = R3 = O
L2: R1 = R2 = R3 = O
L1: R1 = R2 = R3 = OH
L7: R1 = R2 = R3 = Br
L6: R1 = R2 = R3 = HN
O
N
H
Figure 5.1: Modified 6-substituted TPA ligands used in the studies in this chapter
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Cyclohexane was chosen as the initial substrate of study (rather than using a linear alkane
from the outset) since the measurement of the A:K ratio offers a quick benchmark comparison
with the behaviour of [Fe(TPA)(CH3CN)2]2+ and [Fe(BPMEN)(CH3CN)2]2+ under identical
experimental conditions. Reactions of the iron(II) complexes; [Fe(L)(CH3CN)x]2+ (L =
L15,16,21 – L23) towards H2O2 and tBuOOH in CH3CN solution have also been followed by X-
band EPR spectroscopy at 110 K and time-resolved UV-VIS spectrophotometry. Low spin
purple species such as Fe(III)-hydroperoxo Fe(III)-η2-peroxo derived from the reaction of
[(trispicMeen)FeCl]Cl (trispicMeen = N-methyl-N´, N´, N´-tris(pyridylmethyl)ethane-1,2-
diamine)) with H2O2 have been studied in detail by Bill et al and characterized by EPR and
Mössbauer spectropscopy.13 A quantitative information about low spin [(TPA)LFe(III)-OOH]
and [(TPA)LFe(III)-OOtBu] in terms of stability and reactivity were obtained from a study
carried out by Talsi et al,(Talsi et al Reference) where the nature of the sixth ligand L could
be determined by EPR.
A correlation between the observed catalytic activity and the nature of the FeIII(L)-OOR
intermediates generated has become apparent. As a result a number of important
consequences for future directions of this research are discussed.
5.2 Results and Discussion
5.2.1 EPR studies of reactions of [Fe(L)(CH3CN)x]2+ (L = L15,16,21 – L23) with H2O2 or
tBuOOH. General procedure:
A 1 cm3 stock solution (3 x 10-4 mol dm-3) of each iron(II) complex in acetonitrile was
prepared. A 0.3 cm3 aliquot of this was then transferred to a quartz EPR tube, (12cm length x
0.4cm i.d.) which was then immersed in a Dewar of liquid nitrogen. The frozen iron(II)
sample was then rapidly transferred to a cooled sample holder within the EPR spectrometer
whose cavity was maintained at 110 K. The EPR spectrum was then acquired. Following data
acquisition the tube was removed from the frozen sample holder of the spectrometer and kept
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frozen in a separate dewar of liquid nitrogen. An aliquot of H2O2 or tBuOOH was then added
from a small syringe to the frozen EPR tube of the iron(II) complex. The tube was then
thawed enough so as to permit mixing of the two solutions over ~ 2 minutes before rapidly
refreezing and re-introduced into the frozen cavity of the EPR spectrometer. The spectrum
was then re-acquired. The aim was to observe the appearance and then decay of the reactive
paramagnetic peroxo-iron(III) species for each ligand. The partial re-thawing (over 2 min
intervals) and refreezing procedure were repeated at few times with the spectrum acquired.
Finally the solution was allowed to warm up and stand for up to 1-5 hours depending upon the
system before re-acquiring the spectrum of the final product of the reaction. The exact
procedure followed varied slightly from sample to sample as required.
5.2.1.1 Reaction of [Fe(L15)(CH3CN)x]2+ with H2O2
The frozen solution of [Fe(L15)(CH3CN)x]2+ obtained via dissolution of
[Fe(L15)(CH3CN)2](O3SCF3)2 in CH3CN, figure 5.2(a), was EPR silent as expected for a
paramagnetic high spin iron(II) complex. An aliquot of aqueous H2O2 representing 170
equivalents was then added to the frozen iron(II) solution. Following partial hand thawing to
allow some mixing a deep purple colouration was observed to form at the mixing interface of
the two solutions. After 2 minutes had elapsed the mixture was quickly re-frozen and its EPR
spectrum acquired, figure. 5.2(b). A single isotropic high-spin g = 4.4 signal was present
indicative of a high spin (S = 5/2) iron(III) complex in a rhombic environment, whose
sharpness and intensity may result from an increase in molecular symmetry in the oxidized
complex compared with that of [Fe(L15)(CH3CN)x]2+ itself. A second 2 minute thawing –
refreezing procedure resulted in an increase in the intensity of the purple colour paralleling a
further growth in the intensity of the g = 4.4 signal, figure 5.2(c). Finally the solution was re-
thawed and allowed to stand for 5 hours at room temperature before being refrozen and the
spectrum acquired for a final time. After this time the purple colour had long vanished and the
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(a)
(b)
(c)
(d)
solution was now yellow-brown. The EPR spectrum, figure 5.2(d), had a noticeably smaller g
= 4.4 feature signal which was considerably different in appearance to that characterising the
purple intermediate in figure 5.2 (c), and (d) possessed two broad features either side of the
main g = 4.4 line. It is believed that further reactions of the purple iron(III) species had given
rise to two iron species, a new mononuclear high spin iron(III) complex accompanied by an
EPR silent iron species. Clues as to the nature of these species resulted from the study of the
corresponding reaction with tBuOOH.
Figure 5.2: X-band EPR spectra at 110 K for a 3 x 10-4 mol dm3 CH3CN solution of (a)
[Fe(L15)(CH3CN)x]2+; (b) after thawing 2 mins/refreeze following addition of 170-fold excess
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of H2O2 (purple colour at interface); (c) after further thawing 2 mins/refreeze (homogeneous
purple colour) and (d) allowed to stand at room temperature for 5 hours and then refrozen
(yellow- brown).
5.2.1.2 Reaction of [Fe(L15)(CH3CN)x]2+ with tBuOOH.
The reaction of [Fe(L15)(CH3CN)x]2+ with 170 equivalents of an aqueous solution of tBuOOH
was carried out in an identical fashion to the study with H2O2. Following partial hand thawing
to allow some mixing a deep purple colouration was again observed to form at the mixing
interface of the two solutions. After 2 minutes had elapsed the mixture was quickly re-frozen
and its EPR spectrum acquired. As with H2O2 a distinct low field EPR signal appeared upon
development of the purple colour but it was noticeably different in appearance to that
obtained from the H2O2 generated purple species, this time having three distinct features
around g = 7.5, 5.0 and 4.4, figure 5.3 (b). The sample was again removed from the
spectrometer, thawed for 2 min and then refrozen and the spectrum re-acquired. After this
process the solution was homogeneously purple in colour. In this case several thawing-
refreezing cycles up to ~ 20 mins total incubation, resulted in the same EPR features for the
resulting purple solution, figure 5.2(c). The three low field EPR features seen in figure 5.2(b)
were again observed but this time accompanied by a strong sharp resonance at ~ g = 2 which
is assigned to the tBuOO˙ radical.14-16 The tBuOO˙ radical has a half life of ~1 hour below
40oC and so is trappable under these conditions unlike HOO˙ which may have formed
similarly in the reaction with H2O2. The tBuOO˙ signal accompanied a decrease in intensity of
the high spin iron(III) low field EPR features and is attributed to steps (5.1) and (5.2)
involving initial formation of a high spin t-butylperoxoiron(III) complex
[Fe(L15)(CH3CN)x(OOBut)]2+ followed by homolytic Fe-O cleavage giving tBuOO˙ and a new
EPR silent iron(II) species.
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(b)
(c)
(d)
(e)
Figure 5.3: X-band EPR spectra at 110 K for a 3 x 10-4 mol dm3 CH3CN solution of (a)
[Fe(L15)(CH3CN)x]2+; (b), (a) with 170-fold excess of tBuOOH after 2 minutes (purple colour
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at interface); (c), (b) warmed to RT for 20 minutes and refrozen (purple); (d), (c) after
standing at RT for 1 hour then refrozen (yellow) and (e), (d) after standing at RT for 5 hours
then refrozen (yellow –brown).
The presence of steps (5.1) and (5.2) was further confirmed by thawing and then refreezing
after 1 hour incubation wherein only the residual signal of tBuOO˙ remained, figure 5.3(d)
which will slowly decompose via Russel-type reaction. Further standing at room temperature
for 5 hours and then refreezing resulted in the EPR spectrum shown in figure 5.3(e). The
signal for tBuOO˙ was now absent and the only signal which is present corresponds to the
high spin iron(III) signal around g = 4.4, probably obtained from the oxidation of iron (II)
oxidadized by the oxygen present in the solution originated in the decomposition of tBuOO˙.
This signal was identical to the final yellow-brown product obtained in the reaction with
H2O2, Figure 5.2(d) possessing two broad features either side of the main g = 4.4 line. It is
known from previous work in our own laboratory17 and the work of Que18 and others19 that
high spin tBuOOFe(III) complexes are susceptible to homolytic Fe-O cleavage. However,
further proofs are needed to rule out whether it is Fe-O cleavage or O-O cleavage. Scheme 5.1
attempts to explain the sequence of reactions resulting from reaction of [Fe(L15)(CH3CN)2]2+
with the two hydroperoxides. The similarity of the EPR features of the purple tBuOOFe(III)
intermediate here to the distinctly rhombic signals characterising the seven-coordinated
iron(III) complexes; [Fe(BPPA)(OOBut)]2+ and [Fe(BPPA)(OOCBut)]2+, obtained by Masuda
et al (chapter 4, figure 4.5)20 suggests assignment to a similar low symmetry seven-coordinate
high spin iron(III) species with two of the ether oxygen donors coordinated, figure 5.4.
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[Fe(BPPA)(OOBut)]2+ 20 [Fe(L15)(OOBut)]2+ (this work)
Figure 5.4: Structures of high spin seven-coordinated t-butylperoxoiron(III) intermediates
of 6-substituted TPA ligands deduced from X-band EPR studies at 110K.
This then undergoes homolytic Fe-O cleavage to generate a different iron(II) complex to that
initially present which is then slowly oxidised by the excess tBuOOH or by oxygen (air) to
give the final (stable) high spin iron(III) species.
The nature of this final iron(III) product has not thus far been ascertained. However the lower
intensity of its EPR signal compared to that from the purple peroxoiron(III) intermediate,
particularly apparent in the H2O2 reaction, figures 5.2(c) and (d), and the fact that once
formed further treatment with tBuOOH fails to restore the purple colour, suggests assignment
to an unreactive stable high spin iron(III) product possibly a hydroxo(aqua) complex involved
in an equilibrium to form an unreactive -oxo dimer, scheme 5.1.
The reason why the purple alkylperoxo or hydroperoxo iron(III) [Fe(L15)(OOR)]3+
intermediate deriving from H2O2 (R = H) is different (more symmetric) that for R = But is not
obvious. One idea is that the slightly
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Scheme 5.1
more hydrophobic nature of tBuOOH may lead to a greater interaction with the methyl groups
of the MeO substituents hence favouring the seven coordinated alkylperoxo iron(III)
intermediate with two of the ether groups coordinated whereas the presence of proton on the
OOH group may lead to hydrogen bonding with the ether oxygen thus leading to a more
symmetric 6-coordinated hydroperoxoiron(III) species, figure 5.5, with coordination of only
one ether oxygen to iron(III).
Figure 5.5: Possible hydrogen-bonding interaction from OOH leading to a more symmetric
6- coordinated complex for putative purple [Fe(L15)(OOH)]2+ having only one ether oxygen
coordinated to iron(III).
5.2.1.3 Reaction of [Fe(L16)(CH3CN)x]2+ with H2O2
The reaction of the octyloxymethyl TPA derivative complex [Fe(L16)(CH3CN)x]2+ with 170
equivalents of H2O2 in CH3CN was carried out in an identical fashion to the study of the
reaction of [Fe(L16)(CH3CN)x]2+. The frozen solution of [Fe(L16)(CH3CN)x]2+ in CH3CN,
figure 5.6(a), was EPR silent as expected for a paramagnetic high spin iron(II) complex. An
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(a)
(b)
(c)
aliquot of aqueous H2O2 representing 170 equivalents was then added to the frozen iron(II)
solution. Following partial hand thawing to allow some mixing a deep purple colouration was
observed to form at the mixing interface of the two solutions. After 2 minutes had elapsed the
mixture was quickly re-frozen and its EPR spectrum acquired, figure 5.6(b). A single
isotropic high-spin g = 4.4 signal was present similar to that formed with
[Fe(L15)(CH3CN)x]2+ indicative of a high spin (S = 5/2) iron(III) complex in a high symmetry
rhombic environment. A second 2 minute thawing – refreezing procedure resulted in an
increase in the intensity of the purple colour paralleling a further growth in the intensity of the
g = 4.4 signal, not shown.
Figure 5.6: X-band EPR spectra at 110 K for a 3 x 10-4 mol dm3 CH3CN solution of (a)
[Fe(L16)(CH3CN)x]2+; (b) following addition of 170-fold excess of H2O2 after 2 minutes
(purple colour at interface); (c) allowed to stand at room temperature for 5 hours and then
refrozen (yellow-brown).
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Finally the solution was re-thawed and allowed to stand for 5 hours at room temperature
before being refrozen and the spectrum acquired for a final time. After this time the purple
colour had long vanished and the solution was now yellow-brown. The EPR spectrum, figure
5.6(c), was virtually identical to that obtained from reaction with [Fe(L15)(CH3CN)x]2+ with
H2O2 after 5 h with a noticeably smaller g = 4.4 feature signal considerably different in
appearance (more rhombic) to that characterising the purple intermediate, figure 5.2(b),
possessing two broad feature either side of the main g = 4.4 line. It is believed that further
reactions of the purple iron(III) species had given rise to two iron species, a new mononuclear
high spin iron(III) complex accompanied by an EPR silent iron species. Clues as to the nature
of these species again resulted from the study of the corresponding reaction of
[Fe(L16)(CH3CN)x]2+ with tBuOOH.
5.2.1.4 Reaction of [Fe(L16)(CH3CN)x]2+ with tBuOOH
The reaction of [Fe(L16)(CH3CN)x]2+ with 170 equivalents of an aqueous solution of tBuOOH
was carried out in an identical fashion to the reaction of [Fe(L15)(CH3CN)x]2+. In this case,
however, the solution of [Fe(L16)(CH3CN)x]2+ already possessed a weak g = 4 signal, figure
5.7(a). Following partial hand thawing to allow some mixing a deep purple colouration was
again observed to form at the mixing interface of the two solutions. After 2 minutes had
elapsed the mixture was quickly re-frozen and its EPR spectrum acquired. As with H2O2 a
distinct low field EPR signal appeared upon development of the purple colour which was
noticeably different in appearance to that obtained from the H2O2 generated purple species
and as with [Fe(L15)(CH3CN)x]2+ possessed three distinct low field features around g = 7.5,
5.0 and 4.4, figure 5.7(b). The sample was again removed from the spectrometer, thawed for
15 min and then refrozen and the spectrum re-acquired. After this process the solution was
homogeneously purple in colour. The three low field EPR features seen in figure 5.7(b) were
again observed, figure 5.7(c), but this time lower in intensity accompanied by a strong sharp
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resonance at ~ g = 2 assigned to the tBuOO˙ radical. It is believed that steps (5.1) and (5.2)
take place as for the methoxymethyl L1 derivative involving initial formation of the high spin
iron(III) complex [Fe(L16)(OOBut)]2+ followed by homolytic Fe-O cleavage giving tBuOO˙
and a new EPR silent iron(II) species.
Figure 5.7: X-band EPR spectra at 110 K for a 3 x 10-4 mol dm3 CH3CN solution of (a)
[Fe(L16)(CH3CN)x]2+; (b), (a) with 170-fold excess of tBuOOH after 2 minutes (purple colour
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at interface); (c), (b) warmed to RT for 15 mins and the refrozen (purple); (d), (c) after
standing at RT for 5 hours then refrozen (yellow–brown).
Further standing at room temperature for 5 hours and then refreezing resulted in the EPR
spectrum shown in figure 5.7(d). The signal of tBuOO˙ had now vanished and was replaced by
a new narrower rhombic high spin iron(III) signal around g = 4.4 with distinct broad features
either side of the main g = 4.4. line. The spectrum was identical to that obtained from the
reaction of [Fe(L15)(CH3CN)x]2+ with tBuOOH after 5 h, figure 5.3(e). The behaviour overall
paralleled that observed with the methoxymethyl derivative L2 suggesting that introduction of
the longer n-octyl groups did not have a significant effect on the overall scheme of reactions
of the iron(II) complexes with either hydroperoxide.
The detection of largely Haber-Weiss-Fenton behaviour in the reactions of both
[Fe(L15)(CH3CN)x]2+ and [Fe(L16)(CH3CN)x]2+ with H2O2 and tBuOOH, as has been observed
previously with e.g. trispicolinatoiron(III) in pyridine,17 with little evidence of high valent
iron intermediates, was a little disappointing. The reactivity pathways are believed to reflect
the high spin nature of the peroxoiron(III) intermediates favouring Fe-O, rather than O-O,
cleavage pathways. As a result interest turned to corresponding experiments with the iron(II)
complexes of the n-hexylurea-substituted TPA ligands; L21 and L22. The synthesis and
characterisation of the iron(II) complexes of these ligands was reported in chapter 4. Here the
reactivity of [Fe(L21)(CH3CN)x]2+ and [Fe(L22)(CH3CN)x]2+ with H2O2 and tBuOOH in
CH3CN solvent is explored by X-band EPR accompanied in this case by time-resolved UV-
VIS studies.
5.2.1.5 Reaction of [Fe(L21)(CH3CN)x]2+ with H2O2
The reactivity of the iron(II) complex of L21, carrying only one 6-n-hexylurea substituent, is
of interest in that reaction of peroxides with [Fe(6-MeTPA)(CH3CN)2]2+ (only one 6-Me
substituent) form predominantly low spin peroxoiron(III) complexes albeit in equilibrium
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with small quantities of high spin forms.21, 22 Low spin peroxoiron(III) intermediate are more
likely than high spin forms at promoting O-O rather than Fe-O cleavage reactions and are thus
more likely to give rise to the desirable high
Figure 5.8: X-band EPR spectra at 110 K for a 3 x 10-4 mol dm3 CH3CN solution of (a)
[Fe(L21)(CH3CN)x]2+; (b) following addition of 170-fold excess of H2O2, thaw/refreeze after 4
minutes (pinkish-brown colour at interface) and (c) allowed to stand at room temperature for
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1 hour and then refreeze (yellow-brown). Runs (d) – (e) are for a repeat experiment with fresh
[Fe(L21)(CH3CN)x]2+.
valent iron intermediate oxidants. The X-band EPR study of the reaction of H2O2 with
[Fe(L21)(CH3CN)x]2+ was carried out in identical fashion to that for [Fe(L15)(CH3CN)x]2+ and
[Fe(L16)(CH3CN)x]2+. The results are shown in figure 5.8. [Fe(L21)(CH3CN)x]2+ differed from
[Fe(L15)(CH3CN)x]2+ and [Fe(L16)(CH3CN)x]2+ in being noticeably air-sensitive. Despite
attempts to make up the iron(II) solutions under air-free conditions, fresh frozen yellow
solutions of [Fe(L21)(CH3CN)x]2+ in CH3CN always showed a weak rhombic signal in the
region around g = 2 attributable to a low spin iron(III) species in equilibrium with a very
small amount of a high spin species (weak g = 4.5 signal), figure 5.8(a) and (d). Following
addition of 170 equivalents of aqueous H2O2 to the CH3CN solution of [Fe(L21)(CH3CN)x]2+
with partial thawing to mix and then refreezing after 2-4 minutes incubation the solution did
not exhibit a distinct purple colour this time at the interface but revealed a faint pinkish-brown
colour which turned brownish with time. The acquired EPR spectrum showed an increase in
the rhombic low spin feature followed by its collapse (4 mins) to reveal a growing low field
signal at g = 4.5 attributable to a high spin iron(III) species. When the solution was allowed to
stand for 1 hour and then re-frozen the pinkish brown colour persisted as did the low spin
feature around g = 2 only slowly fading away over a period of 1 day to leave behind the low
field high spin iron(III) signal. In order to understand what was being formed here it was
decided to following the corresponding reaction of [Fe(L21)(CH3CN)x]2+ with tBuOOH.
5.2.1.6 Reaction of [Fe(L21)(CH3CN)x]2+ with tBuOOH.
A yellow CH3CN solution of [Fe(L21)(CH3CN)x]2+ was frozen and into this was syringed a
small aliquot representing 170 equivalents of aqueous tBuOOH. Following partial hand
thawing to allow solution mixing a deep blue colouration was observed to form at the mixing
interface of the two solutions.
Chapter 5
162
(a)
(b)
(c)
(d)
Figure 5.9: X-band EPR spectra at 110 K for a 3 x 10-4 mol dm3 CH3CN solution of (a)
[Fe(L21)(CH3CN)x]2+; (b), (a) with 170-fold excess of tBuOOH after 2 minutes (deep blue
colour at interface); (c), (b) warmed to RT for 2 mins and the refrozen (homogeneous deep
blue); (d), (c) after standing at RT for 1 hour then refrozen (yellow–brown).
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After 2 minutes had elapsed the mixture was quickly re-frozen and its EPR spectrum
acquired. Unlike the reaction with H2O2, above here the changes were more distinct. A
distinct rhombic low spin iron(III) signal appeared in the g = 2 region accompanied by a
strong sharp feature around g = 2 corresponding to the tBuOO˙ radical, figure 5.9 (b). There
was little change in the high spin region apart from the presence of a small residual g = 4.5
signal. The sample was again removed from the spectrometer, thawed for another 2 min and
then refrozen and the spectrum re-acquired. After this process the solution was
homogeneously deep-blue in colour. The resulting EPR spectrum, figure 5.9(c), showed a
decrease in the intensity of both the rhombic low spin iron(III) feature and the g = 2 signal for
tBuOO˙ accompanied by the appearance of a strong isotropic high spin signal at ~ g = 4.4.
Warming for 1 hour then refreezing completely removed both of the features in the ~g = 2
region with the only feature remaining being the now quite intense isotropic g = 4.4 signal
attributable to a high spin iron(III) centre in a fairly high symmetry environment, figure
5.9(d).
The big difference between [Fe(L21)(CH3CN)x]2+ and both [Fe(L15)(CH3CN)x]2+ and
[Fe(L16)(CH3CN)x]2+, which have all three py rings 6-substituted, is the formation of a deep
blue low spin t-butylperoxo-iron(III) intermediate even if the final product again is a yellow-
brown high spin iron(III) species. The formation of the low spin peroxoiron(III) complexes
with L21 is attributed to the maintenance of a reasonably strong ligand field around the iron
centre as a result of the presence of only one 6-alkyl-py substituent. Similar behaviour has
been observed with the monomethylated TPA complex; [Fe(6-MeTPA)(CH3CN)2]2+. Low
spin t-butylperoxoiron(III) complex tend to react on via O-O cleavage processes which if so
would generate the putative EPR silent high valent intermediate complex
[FeIV(L21)(O)(CH3CN)x]2+ and tBuO˙ radical (5.3). The formation here of some tBuOO˙ could
then be as a result of rapid C-H abstraction on the excess tBuOOH by tBuO˙ radical (5.4).
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So the observation here of some tBuOO˙ radical is not necessarily an indication of the
operation of Haber-Weiss Fe-O cleavage as far as low spin peroxoiron(III) complexes are
concerned although further independant proof of the O-O cleavage reaction (5.3) is required.
Formation of the final iron(III) product could be as a result of further oxidative reactions
involving reduction of putative [FeIV(L21)(O)(CH3CN)x]2+ or via oxidation (via O2, tBuOOH
or FeIVO) of the iron(II) species generated via Haber-Weiss Fe-O cleavage as for L15 and L16.
5.2.1.7 Reaction of [Fe(L22)(CH3CN)x]2+ with H2O2.
The reaction of the bis(6-n-hexylurea substituted TPA complex; [Fe(L22)(CH3CN)x]2+ with
170 equivalents of H2O2 in CH3CN was carried out in an identical fashion to the study of the
reaction of [Fe(L21)(CH3CN)x]2+. The frozen solution of [Fe(L22)(CH3CN)x]2+ in CH3CN,
Figure 5.10 (a), was EPR silent as expected for a paramagnetic high spin iron(II) complex. An
aliquot of aqueous H2O2 representing 170 equivalents was then added to the frozen iron(II)
solution. Following partial hand thawing to allow some mixing a faint purple-brown
colouration was observed to form at the mixing interface of the two solutions. After 2 minutes
had elapsed the mixture was quickly re-frozen and its EPR spectrum acquired, figure 5.10 (b).
A very weak isotropic high-spin g = 4.4 signal was now present in the spectrum. A second 2
minute thawing – refreezing procedure resulted in bleaching of the purple-brown colour to
give a yellow solution which paralleled the appearance now of an intense isotropic signal at g
= 4.4, figure 5.10 (c), similar to that formed with [Fe(L15)(CH3CN)x]2+ and indicative of a
high spin (S = 5/2) iron(III) complex in a high symmetry environment. The spectrum obtained
was unchanged on further standing at RT for 1 hour. Clues as to the nature of the species
being generated came from a study of the corresponding reaction of [Fe(L22)(CH3CN)x]2+ with
tBuOOH.
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Figure 5.10: X-band EPR spectra at 110 K for a 3 x 10-4 mol dm3 CH3CN solution of (a)
[Fe(L22)(CH3CN)x]2+; (b) thawing 2 mins/refreeze following addition of 170-fold excess of
H2O2 (pale-purple colour at interface); (c) (b) after thawing 2 mins/refreeze (yellow). (d) and
(e) are from a repeat experiment.
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5.2.1.8 Reaction of [Fe(L22)(CH3CN)x]2+ with tBuOOH
The reaction of [Fe(L22)(CH3CN)x]2+ with 170 equivalents of an aqueous solution of tBuOOH
was carried out in an identical fashion to the study with H2O2. An aliquot of aqueous tBuOOH
representing 170 equivalents was added to the frozen yellow iron(II) solution. Following
partial hand thawing to allow some mixing a deep blue colouration was observed to form at
the mixing interface of the two solutions. After 2 minutes had elapsed the mixture was
quickly re-frozen and its EPR spectrum acquired. As with H2O2 a distinct low field EPR
signal appeared upon development of the blue colour but it was noticeably different in
appearance to that obtained from reaction with H2O2. A highly asymmetric rhombic high spin
signal was obtained reminiscent of that obtained with [Fe(L15)(CH3CN)x]2+ and
[Fe(L16)(CH3CN)x]2+. Three distinct rhombic features were observed at g = 8.5, 6.0 and 4.4,
figure 5.10(b), along with a weak g = 2 signal for tBuOO˙. The sample was again removed
from the spectrometer, thawed for 2 min and then refrozen and the spectrum re-acquired.
After this process the solution was homogeneously deep blue in colour. The spectrum, figure
5.11 (c), was similar to that in Figure 5.11(b) except for an increase in all the observed
features. A further thaw for 5 minutes and refreeze resulted in a slight drop in the intensity of
the low field signals at the expense of an increase in the intensity of the g = 2 signal of
tBuOO˙. After warming to RT and standing for 1 hour remarkably the solution was still deep
blue in colour. The acquired EPR spectrum upon freezing still showed that the low field
features were very slowly disappearing while the g = 2 signal of tBuOO˙ was still in evidence.
This is the longest time after standing at RT that some tBuOO˙ could still be detectable in
these Fe(II)(L)/tBuOOH mixtures by EPR indicating that it must be being continuously
produced via the slow collapsed of the species responsible for the low field EPR features and
the intense blue colour, the high spin t-butylperoxoiron(III) species, [Fe(L22)(OOBut)]2+.
[Fe(L22)(OOBut)]2+ is by far the longest lived of all the t-butylperoxoiron(III) complexes
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studied in this work with its mode of decay being an incredibly slow (Haber-Weiss) Fe-O
cleavage process generating a steady flux of tBuOO˙ radical.
Figure 5.11: X-band EPR spectra at 110 K for a 3 x 10-4 mol dm3 CH3CN solution of (a)
[Fe(L22)(CH3CN)x]2+; (b), (a) with 170-fold excess of tBuOOH after 2 minutes (deep purple
colour at interface); (c), (b) thaw 2 minutes/refreeze (homogeneous deep purple); (d), (c) thaw
5 minutes/refreeze (homogeneous deep purple); (e) (d) warm to RT for 1 hour then refreeze
(still purple!!).
Chapter 5
168
This prompted a time-resolved UV-VIS spectrophotometric study at 25oC of the decay of
both [Fe(L21)(OOBut)]2+ and [Fe(L22)(OOBut)]2+ in CH3CN solution under different
conditions for comparisons with other known ROOFe(III)(L) species reported in the
literature.
5.2.2. Time-resolved UV-VIS spectrophotometric studies of the reactions of
[Fe(L)(CH3CN)x]2+ species with H2O2 and tBuOOH in CH3CN solvent at 25oC.
5.2.2.1 Reaction of [Fe(L21)(CH3CN)x]2+ with H2O2.
Figure 5.12 shows a UV-visible spectrum for a 2.5 x 10-3 mol dm-3 solution of
[Fe(L21)(CH3CN)x]2+ in CH3CN following the addition of 100 fold excess of H2O2 at 25oC
(spectrum A) and after completion of the reaction (spectrum B). Spectrum A corresponds to
the maximum amount of the hydroperoxoiron(III) complex; [Fe(L21)(OOH)]2+ (sh = 530 nm)
generated under these conditions.
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Figure 5.12: UV-VIS spectra in CH3CN following the addition of a 100 fold excess of H2O2
to a solution of [Fe(L21)(CH3CN)x]2+ (2.5 x 10-3 mol dm-3) at 25oC (spectrum A) and at the
completion of the decay (spectrum B).
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Figure 5.13 shows a plot of the decay in the absorbance of the hydroperoxoiron(III) complex
at 530 nm versus time at 25oC. Each data point was taken at 5 minute intervals. The data was
fitted successfully to a single exponential decay corresponding to a rate constant of (3.80 ±
0.02) x 10-2 min-1. It cannot be ascertained from the UV-VIS data whether the decay of
[Fe(L21)(OOH)]2+ is due to homolytic Fe-O or O-O cleavage since if formed in the latter
process the putative oxoiron(IV) species; [Fe(L21)(O)(CH3CN)x]2+ would decay rapidly at
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Figure 5.13: Plot of the decay in the absorbance at 530nm (data at 5 minute intervals)
following the addition of a 100 fold excess of H2O2 to a solution of [Fe(L21)(CH3CN)x]2+ (2.5
x 10-3 mol dm-3) in CH3CN at 25oC. The solid line is a least square fit to a single exponential
decay.
temperatures ~ 25oC as observed from the reactions of H2O2 with [Fe(TPA)(CH3CN)2]2+ and
[Fe(6-MeTPA)(CH3CN)2]2+ 8 Here the oxoiron(IV) species [Fe(L)(O)(CH3CN)x]2+ can only be
trapped in CH3CN at temperatures below -40oC. Indications as to which process may be
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responsible for the absorbance changes in figure 5.13 however are apparent from studies of
the catalysis by [Fe(L21)(CH3CN)x]2+ of H2O2 oxygenation on cyclohexane reported at the end
of this chapter, section 5.3.
5.2.2.2 Reaction of [Fe(L21)(CH3CN)x]2+ with tBuOOH
Initial investigations at 25oC showed that the putative blue t-butylperoxoiron(III) complex
[Fe(L21)OOBut]2+ decayed away too rapidly for a kinetic study to be undertaken since it was
not available a low temperature cryostatic kinetic capability. Nonetheless the observed rate of
decay was reminiscent of the reactions of tBuOOH with [Fe(TPA)(CH3CN)2]2+ and [Fe(6-
MeTPA)(CH3CN)2]2+ wherein temperatures of at least -40oC are required to detect the blue t-
butylperoxoiron(III) intermediate and observe its decay. In this regard the much slower decay
of the [Fe(L21)(OOH)]2+ is interesting and may be as a result of a hydrogen-bonded
stabilisation via the single n-hexylurea substituent group, figure 5.14. Such hydrogen–
bonding will be absent in the corresponding t-butylperoxoiron(III) intermediate.
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Figure 5.14: Structures of putative peroxoiron(III) intermediates deriving from reaction of
[Fe(L21)(CH3CN)x]2+ in CH3CN with H2O2 (A) and tBuOOH (B).
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5.2.2.3 Reaction of [Fe(L22)(CH3CN)x]2+ with H2O2
Initial investigations at 25oC showed that the purple-brown hydroperoxoiron(III) intermediate
[Fe(L22)OOH]2+ seen in the low temperature EPR experiments decayed away too rapidly for a
kinetic study to be undertaken since it was not available a low temperature cryostatic kinetic
capability. Nonetheless the observed rate of decay was reminiscent of the reactions of H2O2
with [Fe(TPA)(CH3CN)2]2+ wherein temperatures of at <-40oC are required to follow the
appearance and decay of the corresponding purple hydroperoxoiron(III) intermediate.
5.2.2.4 Reaction of [Fe(L22)(CH3CN)x]2+ with tBuOOH
Figure 5.15 shows a UV-visible spectrum for (a) 7 x 10-4 mol dm-3 [Fe(L22)(CH3CN)x]2+ in
CH3CN (spectrum A); (b) following
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Figure 5.15: UV-VIS spectra for [Fe(L22)(CH3CN)x]2+ (7 x 10-4 mol dm-3) in CH3CN
(spectrum A); (b) following the addition of an 18 fold excess of tBuOOH in CH3CN at 25oC,
[Fe(L22)(OOBut)]2+ (spectrum B); (c) after completion of the first stage (spectrum C) and (d)
at the completion of the second stage (spectrum D).
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Figure 5.16: Plot of the decay in the absorbance at the 603 nm peak maximum versus time (2
min intervals) following the reaction of [Fe(L22)(CH3CN)x]2+ (7 x 10-4 mol dm-3) with an 18
fold excess of tBuOOH in CH3CN at 25oC (the solid line represents a non-linear least squares
fit to two exponential decays, BC and CD).
the addition of an 18 fold excess of tBuOOH in CH3CN at 25oC, the t-butylperoxoiron(III)
intermediate (spectrum B); (c) after completion of the first stage (spectrum C) and (d) at the
end of the final second stage of the reaction (spectrum D). Spectrum B corresponds to the
amount of [Fe(L22)(OOBut)]2+ (max = 603 nm) generated at its maximum. Figure 5.16 shows
a plot of the decay in the absorbance at the 603 nm peak maximum versus time at 25oC. Each
data point was taken at 2 minute intervals. The data was fitted to two successive exponential
decays corresponding to rate constants k1 (BC) and k2 (CD) with values respectively; k1
= (2.80 ± 0.06) x 10-1 min-1 and k2 = (7.28 ± 0.02) x 10-2 min-1.
The reaction was then repeated but this time with a much larger 350 fold excess of
tBuOOH. The UV-VIS spectra for this experiment are shown in figure 5.17. As before
spectrum
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Figure 5.17: UV-VIS spectra for [Fe(L22)(CH3CN)x]2+ (7 x 10-4 mol dm-3) in CH3CN
(spectrum A); (b) following the addition of an 350 fold excess of tBuOOH in CH3CN at 25oC,
[Fe(L22)(OOBut)]2+ (spectrum B); (c) after completion of the first stage (spectrum C) and (d)
at the completion of the second stage (spectrum D).
A corresponds to [Fe(L22)(CH3CN)x]2+ before peroxide addition. Spectrum B corresponds to
[Fe(L22)(OOBut)]2+ at its maximum absorbance with its subsequent decay characterised by
two distinct stages to spectrum C and finally to spectrum D. The biphasic nature of the decay
is clearly apparent in a plot of absorbance at the 603 nm peak maximum, figure 5.18, as a
function of time. Each data point was this time taken at 10 min intervals. An initial fast stage,
complete in less that 100 minutes, is followed by a very slow decay taking place over 14
hours. A least squares fit to two exponentials k3 (BC) and k4 (CD) with values
respectively; k3 = (6.84 ± 0.16) x 10-2 min-1 and k4 = (2.4 ± 0.1) x 10-3 min-1. It is noted that
the value of k3 is identical
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Figure 5.18: Plot of the decay in the absorbance at the 603 nm peak maximum versus time
(10 min intervals) following the reaction of [Fe(L22)(CH3CN)x]2+ (7 x 10-4 mol dm-3) with an
350 fold excess of tBuOOH in CH3CN at 25oC (the solid line represents a non-linear least
squares fit to two exponential decays, BC and CD).
within experimental error to that of k2 (the second stage when using only an 18 fold excess of
tBuOOH). No new species is detectable in the spectral changes with time and it appears that
the decay behaviour is due to different processes affecting the observed rate of decay of the
same species namely [Fe(L22)(OOBut)]2+ to the final iron(III) product. The persistence of both
the blue [Fe(L22)(OOBut)]2+ intermediate and its decay product tBuOO. in these solutions over
some considerable time when a large excess (>100 fold) of tBuOOH is explained here by the
slow rate of the second stage process here (k4 = (2.4 ± 0.1) x 10-3 min-1) the conditions of
which are quite close to those used for the EPR experiments. The observation of this very
slow rate of decay when a large excess of tBuOOH is present suggests that there are rate
defined processes involving tBuOOH that are competing to replenish [Fe(L22)(OOBut)]2+
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while it decays. Unlike in the case of high spin [Fe(L16)(OOBut)]2+ and [Fe(L21)(OOBut)]2+
and the reaction of [Fe(L22)(CH3CN)x]2+ with H2O2 it appears that the iron(II) product formed
via the Fe-O homolytic decay process on [Fe(L22)(OOBut)]2+ behaves like
[Fe(L22)(CH3CN)x]2+ reacting with excess tBuOOH to regenerate [Fe(L22)(OOBut)]2+ leading
to a steady flux of tBuOO. radical. These competing replenishing reactions are less efficient
at lower excesses of tBuOOH so the observed rate of decay of [Fe(L22)(OOBut)]2+ is faster.
Steps 5.5 – 5.9 attempt to explain the sequence of reactions taking place.
The basic process is catalysis of the reaction of three equivalents of tBuOOH to give two
equivalents of tBuOO. radical, tBuOH and water (5.10). The faster observed rate of decay of
[Fe(L22)(OOBut)]2+ under lower concentrations of tBuOOH suggests that the replenishing
steps 5.6 – 5.9, involving consumption of three equivalents of tBuOOH, are not rapid
processes and are therefore rate determining to some extent dependant upon (the order of)
[tBuOOH]. Thus we assign the fastest process governed by k1 (2.80 ± 0.06) x 10-1 min-1) as
representing step 5.5 the intrinsic rate of decay of [Fe(L22)(OOBut)]2+. This decay process is
never observed using larger (350 fold) equivalents of tBuOOH since steps 5.6 – 5.9 are now
efficient at replenishing the t-butylperoxo complex as it decays.
Masuda reported a relatively slow decay (t1/2 ~ 30 mins at 25oC) for the t-butylperoxo
complex of BPPA23 similar to that observed for [Fe(L22)(OOBut)]2+. Since the X-ray
structural study on [Fe(L22)](O3SCF3)2 (chapter 4) showed coordination of both urea carbonyl
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oxygen donors it is likely that similar urea carbonyl oxygen coordination will occur at the
relatively harder iron(III) centre in [Fe(L22)(OOBut)]2+. Moreover the EPR study reveals
evidence of a very low symmetry rhombic environment for high spin iron(III) centre in
[Fe(L22)(OOBut)]2+ similar to that observed for [Fe(L15)(OOBut)]2+ (coordination by two ether
oxygens) and hepta coordinated [Fe(BPPA)(OOBut)]2+ and [Fe(BPPA)(O2CBut)]2+
(coordinated by two amide oxygens). Thus as for [Fe(L15)(OOBut)]2+ we assign the hepta
coordinated structure in figure. 5.19
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Figure 5.19: Structures of hepta coordinated FeIII(L)OOBut)]2+ complexes
to [Fe(L22)(OOBut)]2+ with its slow decay due to sterically-restricted dissociation of the
tBuOO. radical moiety. Interestingly this is the first evidence of an influence on the properties
these iron-TPA derivatives by the introduction of a long alkyl chain.
5.2.3. Study of the catalysis of H2O2 oxygenation on alkanes by [Fe(L)(CH3CN)x]2+ (L =
L11,15,16, 21 ,22 and L24)
Since cyclohexane is a benchmark substrate for investigations of metal-oxo versus radical
based oxygenation process with H2O2 it was decided to investigate catalysis of cyclohexane
oxygenation, figure 5.20, by [Fe(L)(CH3CN)x]2+ (L = L11,15,16,21 ,22 and L24) as a first
screening of any enhanced activity versus those of TPA and other related derivatives. The
results are compared with the catalytic behaviour of a range of iron polypyridine systems
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towards the H2O2 and m-chloro-perbenzoic acid (mCPBA) oxygenation of both cyclohexane
and adamanatane. Some definitive conclusions have been reached.
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Figure 5.20: Products of cyclohexane oxygenation.
The preparation of iron(II) complexes of the 6-py substituted TPA ligands; L11, 15,16,21 and L22
has been described in chapters 2, 3 and 4. The formation and decay of peroxoiron(III)
derivatives with L15,16,21 and L22 has been discussed earlier in this chapter. Each of the iron(II)
complexes has been prepared using [Fe(O3SCF3)2(CH3CN)2] which is air stable, can be easily
made anhydrous, contains a weakly coordinating anion, and is a safe substitute for perchlorate
salts.24
.
5.2.3.1 Methodology
The oxygenation reactions were carried out in acetonitrile as the solvent at room temperature
under air. Aqueous solutions of 30% w/w hydrogen peroxide were standardised by titration
with potassium permanganate as described in Vogel.25 To start the reaction the hydrogen
peroxide solution (70 mM, 10 equiv or 700 mM, 100 equiv) was added by means of a syringe
pump over a 30 min period at 25°C to an acetonitrile solution containing the iron(II) catalyst
(2.1 µmol, 1 equiv) and cyclohexane (2.1 mmol, 1000 equiv). A large excess of substrate was
used in order to minimize over-oxidation of cyclohexanol (A) to cyclohexanone (K). Use of
the syringe pump ensured that decomposition of H2O2 was minimised. After syringe pump
addition the solution was stirred for another 5 min before work up. The iron(II) catalyst was
removed by passing the solution through silica gel followed by elution with 3 ml of CH3CN.10
An internal standard (toluene) was added at this point, and the solution was subjected to GC
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analysis. The organic products were identified by GC-MS comparison with authentic
compounds. All reactions were run at least in duplicate, and the data reported was the average
of two runs. The yields were based on the amount of oxidant (H2O2) converted into
oxygenated products. Two series of catalytic experiments were carried out initially, using
both 10 and 100 equivalents of H2O2 following the methodology previously reported by
Que9,26 and Britovsek.27
5.2.3.2 Catalysis by the iron(II) complexes of L11,15,16,21,22 and, L24
Table 5.5 summarizes the results of catalytic H2O2 oxygenations on cyclohexane by the
iron(II) complexes of L11,15,16,21,22 and L24.
The main observations are as follows:
(i) The catalytic efficiency (moles oxidation products/mole of oxidant) decreases as
the amount of H2O2 used is increased from 10 equivalents to 100 equivalents.
Even using 10 equivalents of H2O2 none of the six iron catalysts achieves an
efficiency of greater than 7%.
(ii) The A/K (cyclohexanol/cyclohexanone) ratio increases when the equivalents of
H2O2 used are increased from 10 to 100 fold.
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(iii) Only the complexes [Fe(L21)(CH3CN)x]2+, [Fe(L22)(CH3CN)x]2+ and
[Fe(L24)(CH3CN)2]2+ give rise to an A/K ratio >2 when using 100 equivalents of
H2O2. Only those for [Fe(L22)(CH3CN)x]2+ and [Fe(L24)(CH3CN)2]2+ are above 3.0.
The higher the A/K ratio the more likely metal oxo species may be involved in the
cyclohexane oxygenation.
(iv) The highest turnover number (moles of oxidised products/mol catalyst - relevant
for the runs using 100 equivalents of H2O2) was 4.6 for the 35 minute incubation
time using the 6-Br3-TPA derivative complex, [Fe(L24)(CH3CN)2]2+.
These findings show that these iron-TPA derivative complexes show somewhat disappointing
activity compared to that shown by the parent TPA complex; [Fe(TPA)(CH3CN)2]2+ and also
[Fe(BPMEN)(CH3CN)2]2+.28 The A/K ratios are similar to those obtained using the 6-Me
substituted complexes; [Fe(6-Me2TPA)(CH3CN)2]2+ and [Fe(6-Me3TPA)(CH3CN)2]2+ both of
which generate high spin peroxo intermediates. These results indicate products stemming
largely from OH radical based processes. It is particularly noticable how inferior the mono-6-
hexylurea TPA derivative complex [Fe(L21)(CH3CN)x]2+ is compared with the mono-6-
methylated TPA complex [Fe(6-MeTPA)(CH3CN)2]2+ despite the fact that low spin peroxo
intermediates are formed in both cases. Here it is believed that the low activity of
[Fe(L21)(CH3CN)x]2+ stems from the presence of only one vacant site in the iron complexes
due to likely coordination of the urea carbonyl oxygen in the hydroperoxo complex
[FeIII(L21)OOH]2+. Thus L21 effectively behaves as a pentadentate ligand (x = 1), figure 5.14,
like N4py in the complex [Fe(N4py)(CH3CN)]2+.28 [Fe(N4py)(CH3CN)]2+, which despite
forming low spin peroxo intermediates, shows poor activity in the air towards H2O2
oxygenation of cyclohexane (at 10 equivalents) with a turnover number of only 3.1 and an
A/K ratio of 1.4 implying products deriving from OH radical based processes. The urea
groups were introduced in the hope of triggering hydrogen bonding from N-H to the bound
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OOH group on the hydroperoxoiron(III) complex to hopefully promote heterolytic cleavage
of the O-O bond to generate the powerful iron(V) oxidant. However, it appears in these
systems that coordination of the urea carbonyl rather occurs limiting the number of available
coordination sites for reactivity. The low activity of Masuda’s pivaloylamido complexes such
as, [Fe(BPPA)(OOBut], figure 5.4, towards catalysis of alkane oxygenation is believed to be
the result of similar amido oxygen coordination.20 Finally, the expected strong coordination of
the hydroxymethyl groups to iron(III) in the complex of H3L11 (chapter 2) results in saturation
of the coordination sphere so that a hydroperoxo complex intermediate is unable to form. The
result is a complete shut down of the catalytic oxygenation activity, table 5.1. These findings
provide strong support to Que’s assertion22 that the presence of both a low spin iron centre
and of two labile and available cis sites are required for the facilitation of selective metal-oxo
based processes in alkane oxygenation catalysts by these families of non-heme iron
polypyridine systems.
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Table 5.1: Results of catalytic H2O2 oxygenations on cyclohexane by iron(II) complexes of L1 – L5 and L7
-
Conditions: Iron catalyst:H2O2:alkane = 1:10:1000 (cyclohexane), 1:100:1000 (cyclohexane), and 1:10:10 (adamantane).
Solvent – acetonitrile H2O2 added by syringe pump in the air at 25oC over 30mins, total incubation time 35 mins before work up.
Eff. (cyclohexanol+cyclohexanone):H2O2/100 in the oxidation of cyclohexane.
TN - mols oxidised products:mols cat. in the oxidation of cyclohexane
A:K - cyclohexanol:cyclohexanone in the oxidation of cyclohexane.
KIE - kinetic isotope effect of cyclohexanol formation in the oxidation of cyclohexane and cyclohexane-d12
3°:2° - 1-adamantanol:(2-adamantanol+2-adamantanone) in the oxidation of adamantane taking into account of the correction
for a number of C-H bonds in a group.
nr – no products detected.
*This work
Oxidations with H2O2 Eq.H2O2 Eq. C 6H10 Eff TN. A:K KIE 3°:2° Ref.
[Fe(H3L11)(CH3CN)x]2+ 100 1000 nr nr nr - - *
[Fe(L15)(CH3CN)x]2+ 10 1000 6.4 0.6 1.6 - - *
[Fe(L15)(CH3CN)x]2+ 100 1000 1.8 1.8 1.6 - - *
[Fe(L16)(CH3CN)x]2+ 100 1000 3.0 3.0 1.2 - - *
[Fe(L21)(CH3CN)x]2+ 10 1000 5.1 0.5 0.8 - - *
[Fe(L21)(CH3CN)x]2+ 100 1000 2.3 2.3 2.1 - - *
[Fe(L22)(CH3CN)x]2+ 100 1000 1.4 1.4 3.3 - - *
[Fe(L24)(CH3CN)2]2+ 100 1000 4.6 4.6 3.1 - - *
[Fe(6-Me2TPA)(CH3CN)2]2+ 10 1000 29 2.9 2.0 4.0 33 10, 29
[Fe(6-Me3TPA)(CH3CN)2]2+ 10 1000 14 1.4 1.0 3.3 15 10, 29
[Fe(6-MeTPA)(CH3CN)2]2+ 10 1000 40 4.0 7.0 3.6 30 10, 29
Simple Fe salts
[Fe(CH3CN)4]2+ 10 1000 10 1.0 1.0 1.8 -
30
Fe(ClO4)3 10 1000 37 3.7 1.9 1.5 3.3
31
Free OH. radical 10 1000 1.0 1-2 2 2.0 32-35
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5.2.3.3 Survey of H2O2 and mCPBA oxygenations on cyclohexane and adamantane by
iron(II) polypyridine complexes
It order to draw detailed conclusions of how the iron(II) complexes of ligands L11,15,16,21,22 and
L24 compare to the range of other reported iron catalysts it was decided to review the literature
data available on iron polypyridine complex catalysis of H2O2 oxygenation of cyclohexane
and adamantane in CH3CN solvent to see if any patterns in activity with ligand type and
design were emerging and what lessons could be learnt. A number of systems using m-
chloroperbenzoic acid (mCPBA) as the oxidant will also be commented on for comparison.
The survey is broken down into two classes of ligand; TPA-like and BPMEN-like and
whether the starting iron(II) complexes are low spin or high spin. Figure 5.21 shows the range
of literature polypyridine-based ligands employed in the various studies reviewed.
Figure 5.21: TPA and related polypyridine-based ligands used in the iron catalysis of H2O2
oxygenations on cyclohexane and adamantane in CH3CN solvent.
Based upon A/K ratios and KIE values for oxygenations on cyclohexane and 3o/2o ratios for
oxygenations on adamantane (where available) an attempt has been made to come up with a
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set of completely empirical and subjective criteria for deciding on the nature of the active
ROO-FeIII derived oxidant for ROOH oxidations of alkanes, table 5.2, based on a survey of
the behaviour of the literature systems. The criteria are based on the three ways that a
hydro(alkyl)peroxo-iron(III) complex can subsequently react, see discussion in chapter 1, (i)
via Fe-O bond homolysis – generating iron(II) and OH˙ radical; (ii), via O-O bond homolysis
generating a high valent FeIV=O species and OH˙ radical and finally (iii) via O-O bond
heterolysis generating FeV=O (or FeIV-O.) and OH-.
Table 5.2: Criteria for deciding on the active ROO-FeIII-derived oxidant for ROOH oxidations
on cycloalkanes (R = H, tBu, m-ClC6H4C(=O))
cyclohexane adamantane ROO-FeIII
cleavage process
proposed active
oxidant
A/K KIE 3o/2o
≤2.4 (≤2) (<10) Fe-O homolysis OH.
≤2.4 (2<4) - O-O homolysis FeIV=O, OH.
≤2.4 (2<4) (≥10) O-O homolysis FeIV=O, OH.
>4 (>3) (>4) O-O heterolysis FeV=O (FeIV-O.)
Tables 5.3 and 5.4 summarize data for the catalysis of H2O2 oxygenation on cyclohexane and
adamantane catalysed respectively by high spin and low spin iron(II) polypyridine (TPA-like)
complexes along with data for simple high spin iron salts; [Fe(CH3CN)4]2+, Fe(ClO4)2/3,
Fe(OPPh3)4]2+ and [Fe(bipy)2]2+. Based on the criteria proposed in table 5.2 virtually all the
high spin iron(II) catalysts in table 5.3 fall into the category suggesting that the primary
reaction of the hydroperoxoiron(III) intermediate is Fe-O homolysis to generate OH. radicals
as the active oxidant. All have A/K ratios <2.4 with KIE values (where available) also <2.
The exceptions are [Fe(6-Me2TPA)(CH3CN)2]2+ and [Fe(6-Me3TPA)(CH3CN)2]2+ which
exhibit KIE values of >3 and [Fe(HBPClNOL)Cl2] which has an A/K ratio >2.4.
[Fe(BIPBMP)(CH3CN)n]2+ is a highly efficient catalyst but the small A/K ratio (close to
unity) suggests OH. radical based processes. [Fe(6-Me2TPA)(CH3CN)2]2+ stands out as having
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a high 3o/2o ratio (33) for adamantane oxygenation whilst satisfying the other criteria for
homolytic O-O cleavage suggesting that a high valent oxo species (possibly LFeIV=O?) is
formed and may be active in the subsequent oxygenation chemistry. For the ultra high valent
oxidant FeV=O (or FeIV-O.) to be proposed as an active species however a set of extreme
criteria must be satisfied comprising an A/K ratio of >4 coupled with a KIE value of >4 and a
3o/2o ratio (adamantane) of >4. None of the high spin iron(II) catalysts listed in table 5.3 come
anywhere near satisfying all of these empirical criteria for proposal of an active FeV=O
oxidant.
The situation for low spin iron(II) catalysts, table 5.4, is however somewhat different.
Here there is tentative evidence under the empirical criteria for the involvement of high valent
FeV=O centres. Indeed all the low spin TPA derivatives satisfy the criteria for a FeV=O
oxidant being involved via O-O bond heterolysis of the hydroperoxoiron(III) precursor. Only
the BISP complexes of Comba et al,36 Feringa’s [Fe(N4py)(CH3CN)]2+ complex37,38 and
[FeIII2(-O)(TPOEN)2]4+ 39 fail to satisfy all the criteria with the low A/K ratios and KIE
values (both <2) implying OH radical based processes (Fe-O homolysis). The latter dimer
complex is moreover anomalously termed ‘low spin’ because of antiferromagnetic coupling
between two high spin FeIII centres.
Table 5.5 shows data for corresponding catalytic oxygenations using a number of the
iron-polypyridine (TPA-like) catalysts with the oxidant mCPBA. In the reactions with mCPBA
even some high spin iron complexes satisfy the criteria for the proposal of a high valent iron
oxidant being involved. Both high spin [Fe(TPOEN)Cl]+ and [Fe(TPOEN)Cl3] exhibit A/K
ratios of >3 with a 3o/2o ratio (adamantane) of ~19 implying O-O bond homolysis to give
LFeIV=O and m-chlorobenzoyloxo radical (mCBPO.). [Fe(N4py)(CH3CN)]2+,37,38
[Fe(TPA)(OAc)(H2O)]+ 40 and [FeIII2(-O)(L1)2] (H2L1 shown in figure 5.21), (each under N2 or
Ar gas) exhibit A/K ratios of >4 (in the case of [FeIII2(-O)(L1)2] a value of >12 and a 3o/2o of
5.3) and for [Fe(N4py)(CH3CN)]2+ a KIE of 4.5 satisfying the criteria for heterolytic O-O
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cleavage of the hydroperoxo species. However what is significant is when the catalysis by
[Fe(N4py)(CH3CN)]2+ is carried out in the air wherein the A/K ratio drops sharply to 1.3 and
the efficiency reduces by a third. Unfortuntely no KIE data is available but the above data
suggests that a dominant radical based pathway is now involved. Finally the runs with the
acetato-TPA complex; [Fe(TPA)(OAc)(H2O)]+ are of interest in that quenching with PPh3 was
performed prior to GC analysis to reduce out any cyclohexylhydroperoxide (H) present to
cyclohexanol (A). [Fe(TPA)(OAc)(H2O)]+ is a highly efficient catalyst towards mCPBA
oxygenation (Eff 46%, 460 turnovers/hr) although data on [Fe(TPA)(CH3CN)2]2+ under the
same conditions are not available for comparison. The A/K ratio following PPh3 quenching is
6.4. The possible promoting effect of acetate was discussed in chapter 1.
Quenching the final product solution with PPh3 is standard practice for many reported
studies of iron-heme based alkane oxygenation catalysts such as [Fe(F20TPP)Cl].41 This
treatment can have the effect of increasing quite dramatically the apparent A/K ratio if a
significant amount of H is formed as a co-product. Thus the efficient catalysis (91% based on
oxidant) of mCPBA oxygenation of cyclohexane by [FeIII(F20TPP)Cl] in 1:1
acetonitrile:CH2Cl2 exhibits an A/K ratio of 44.5 with a KIE of 5.2. 41
Catalytic cycloalkane oxygenations carried out with mCPBA generally give
significantly higher A/K ratios and higher efficiencies for a particular catalyst than those
observed with H2O2 or tBuOOH (even for cases where PPh3 quenching has not been
employed). This implies an increased tendency towards heterolytic O-O cleavage for m-Cl-
C6H4C(O)OOFe(III) intermediates. This phenomenon has been reviewed and discussed by Que
et al42 and may simply be a reflection of m-Cl-C6H4C(O)O- being a better leaving group than
either OH- or tBuO- rather than any virtuous property of the iron-ligand system. Unfortunately
mCPBA is a somewhat exotic oxidant and although good for mechanistic study it is not a
viable reagent for commercial scale reaction which remains the domain of H2O2 or better still
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Table 5.3 A Survey of H2O2 oxygenation on alkanes catalysed in CH3CN by high spin iron-TPA and TPA-like complexes.
Conditions: Iron catalyst:H2O2:alkane = 1:10:1000 (cyclohexane) and 1:10:10 (adamantane). H2O2 added by syringe pump in air, 25oC, 30mins, total time 35 mins.
Eff. - (cyclohexanol+cyclohexanone):H2O2/100 in the oxidation of cyclohexane.
TN - mols total oxidised products:mols cat. in the oxidation of cyclohexane.
A:K - cyclohexanol:cyclohexanone in the oxidation of cyclohexane. KIE - kinetic isotope effect of cyclohexanol formation in the oxidation of C6H12 and C6D12.
3°:2° - 1-adamantanol:(2-adamantanol+2-adamantanone) in the oxidation of adamantane correcting for the number of C-H bonds in a group.
*Conditions: Iron catalyst:H2O2:alkane = 1:150:100 (cyclohexane), 50oC, 3h in air. + after 7h, ++ after 23h. £ 25oC for 18h in air $ 22h in air. “ 23h in air, “” 2h under
Ar, % 19h in acetone.
** Conditions: iron catalysts:H2O2:alkane = 1:1000:1000 (cyclohexane), 25oC 24h, + 50oC 24h
****** Conditions: Iron catalyst:H2O2:alkane = 1:100:500 (cyclohexane) in acetonitrile 25oC, 3h under N2.
*** Conditions: Iron catalyst:H2O2:alkane = 1:200:1000 in acetonitrile 20oC, 90mins under N2.
Catalyst eq. H2O2 eq. C6H10 Eff. TN. A:K KIE 3°:2° cleavage process oxidising
species
Ref.
Fe(ClO4)3 10 1000 37 3.7 1.9 1.5 3.3 Fe-O homolysis O 31
Fe(ClO4)3 * £ 150 1000 37 63 2.3 - - Fe-O homolysis OH. 31
Fe(ClO4)3 * $ 150 1000 78 99 0.6 - - Fe-O homolysis OH. 31
Fe(ClO4)2 * “ 150 1000 87 100 0.5 - - Fe-O homolysis OH. 31
Fe(ClO4)2 * “” 150 1000 87 100 1.1 - - Fe-O homolysis OH. 31
Fe(ClO4)2 * % 150 1000 37 37 0.1 - - Fe-O homolysis OH. 31
[Fe(OPPh3)4]2+ 10 1000 13 1.3 1.2 1.9 - Fe-O homolysis OH. 30
[Fe(CH3CN)4]2+ 10 1000 10 1.0 1.0 1.8 - Fe-O homolysis OH. 30
[Fe(bpy)2]2+ 10 1000 9 0.9 0.8 1.4 - Fe-O homolysis OH. 30
[Fe(6-Me2TPA)(CH3CN)2]2+ 10 1000 29 2.9 2.0 4.0 33 O-O homolysis FeIV=O, OH. 10, 29
[Fe(6-Me3TPA)(CH3CN)2]2+ 10 1000 14 1.4 1.0 3.3 15 O-O homolysis FeIV=O, OH. 10, 29
[Fe(BIPBMP)(CH3CN)n]2+ * 150 100 51 100 0.3 - - Fe-O homolysis OH. (Gif-like) 43
[Fe(BIPBMP)(CH3CN)n]2+ * 150 100 99 100 1.1+ - - Fe-O homolysis OH. 43
[Fe(BIPBMP)(CH3CN)n]2+ * 150 100 81 100 0.8++ - - Fe-O homolysis OH. 43
[Fe(HBPClNOL)Cl2] ** 1000 1000 2.2 140 2.7 - - O-O homolysis FeIV=O, OH. 44
[Fe(HBPClNOL)Cl2] ** + 1000 1000 6.0 269 3.0 - - O-O homolysis FeIV=O, OH. 44
[Fe(TPOEN)Cl]+ *** 200 1000 12.2 24.4 2.4 - 3.2 Fe-O homolysis OH. 39
[Fe(TPOEN)Cl3] *** 200 1000 18.1 36.1 2.3 - 3.0 Fe-O homolysis OH. 39
[Fe(MPZPBY)(CH3CN)3]2+ ****** 100 1000 2.9 2.9 1.6 Fe-O homolysis OH. 45
Chapter 5
187
Table 5.4: A Survey of H2O2 oxygenation on alkanes catalysed in CH3CN by low spin iron-TPA and TPA-like complexes.
Conditions: Iron catalyst:H2O2:alkane = 1:10:1000 (cyclohexane) and 1:10:10 (adamantane).
H2O2 added by syringe pump in the air at 25oC over 30mins, total incubation time 35 mins before work up.
Eff. - (cyclohexanol+cyclohexanone):H2O2/100 in the oxidation of cyclohexane.
TN - mols total oxidised products:mols cat. in the oxidation of cyclohexane
A:K - cyclohexanol:cyclohexanone in the oxidation of cyclohexane.
KIE - kinetic isotope effect of cyclohexanol formation in the oxidation of cyclohexane and cyclohexane-d12.
3°:2° - 1-adamantanol:(2-adamantanol+2-adamantanone) in the oxidation of adamantane correcting
for the number of C-H bonds in a group.
****Conditions: Iron catalyst:H2O2:alkane = 1:400:1000 in acetonitrile 20oC, 90mins under N2.
***** Conditions: Iron catalyst:H2O2:alkane = 1:100:1000 (cyclohexane) in acetonitrile 25oC, 35mins under N2. + in the air
5-(ME)2TPA = bis(5-methoxycarbonyl-2-pyridylmethyl)-2’-pyridylmethylamine, 6-MeTPA = 6-methyl-2-pyridylmethyl-bis(2’-pyridylmethyl)amine
5-Me3TPA = tris(5-methyl-2-pyridylmethyl)amine; 3-Me3TPA = tris(3-methyl-2-pyridylmethyl)amine;
Catalyst eq.H2O2 eq. C6H10 Eff
.
TN. A:K KIE 3°:2° cleavage process oxidising
species
Ref.
[Fe(TPA)(CH3CN)2]2+ 10 1000 37 3.7 5.0 3.5 17 O-O heterolysis FeV=O 46
[Fe(3-Me3TPA)(CH3CN)2]2+ 10 1000 45 4.5 14 3.7 27 O-O heterolysis FeV=O 10, 29
[Fe(5-(Me)2TPA)(CH3CN)2]2+ 10 1000 23 2.3 19 3.7 15 O-O heterolysis FeV=O 10, 29
[Fe(5-Me3TPA)(CH3CN)2]2+ 10 1000 40 4.0 9.0 3.8 21 O-O heterolysis FeV=O 10, 29
[Fe(6-MeTPA)(CH3CN)2]2+ 10 1000 40 4.0 7.0 3.6 30 O-O heterolysis FeV=O 10, 29
[Fe(BISP)(CH3CN)2]2+ ***** 400 1000 34 34 1.4 Fe-O homolysis OH. 36
[Fe(BISP)(CH3CN)2]2+ ***** + 100 1000 25 25 1.1 Fe-O homolysis OH. 36
[Fe(N4py)(CH3CN)]2+ 10 1000 31 3.1 1.4 1.5 3.3 Fe-O homolysis OH. 37,38
[FeIII2(-O)(TPOEN)2]4+ **** 400 1000 6 24 1.9 - 3.1 Fe-O homolysis OH
. 39
Free OH. radical 10 1000 1.0 1-2 2 2.0 OH. 22
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Table 5.5: A Survey of mCPBA oxygenation on alkanes catalysed in CH3CN by low spin iron-TPA and TPA-like complexes
a - Conditions: Iron catalyst:mCPBA:alkane = 1:100:1000 under N2 at 25oC, total incubation time 1h before work up. b – in air.
Eff. - 100 x (cyclohexanol+cyclohexanone):mCPBA in the oxidation of cyclohexane.
TN - mols oxidised products:mols cat. in the oxidation of cyclohexane
A:K - cyclohexanol:cyclohexanone in the oxidation of cyclohexane
KIE - kinetic isotope effect of cyclohexanol formation in the oxidation of cyclohexane and cyclohexane-d12.
c - Conditions: Iron catalyst:mCPBA:alkane = 1:1000:7576 (cyclohexane) in CH2Cl2-CH3CN 3:1 at 25oC for 1h under Ar. PPh3 used to quench
Eff. - 100 x (cyclohexanol+cyclohexanone):mCPBA in the oxidation of cyclohexane.
TN - mols oxidised products:mols cat. in the oxidation of cyclohexane
A:K - cyclohexanol:cyclohexanone in the oxidation of cyclohexane.
3°:2° - 1-adamantanol:(2-adamantanol+2-adamantanone) in the oxidation of adamantane correcting for
the number of C-H bonds in a group.
**Conditions: Iron catalyst:mCPBA:alkane = 1:200:1000 in acetonitrile 20oC, 90mins under N2.
***Conditions: Iron catalyst: mCPBA:alkane = 1:400:1000 in acetonitrile 20oC, 90mins under N2.
d – Conditions: Iron catalyst:mCPBA:alkane = 1:500:2000 in acetonitrile, total incubation time 6h at 25oC under N2.
Catalysts eq.mCPBA eq. C 6H10 Eff. TN. A:K KIE 3°:2° cleavage
process
oxidising species Ref.
High spin Fe species
[Fe(TPOEN)Cl]+ ** 200 1000 24.9 49.7 3.2 18.5 O-O homolysis FeIV=O, mCPBO. 39
[Fe(TPOEN)Cl3] ** 200 1000 36.2 72.4 3.0 19.4 O-O homolysis FeIV=O, mCPBO. 39
Low spin Fe species
[Fe(N4py)(CH3CN)]2+ a 100 1000 33 33 5.6 4.5 - O-O heterolysis FeV=O 47
[Fe(N4py)(CH3CN)]2+ b 100 1000 9.6 9.6 1.3 - - Fe-O homolysis mCPBO. 47
[Fe(TPA)(OAc)(H2O)]+ c 1000 7576 45.8 458 6.4 - O-O heterolysis FeV=O 40
[FeIII(L1)Cl] d 500 2000 5.6 27.8 1.7 - 2.2 Fe-O homolysis mCPBO. 48
[FeIII2(-O)(L1)2] d 500 2000 2.6 13.2 12.2 - 5.3 O-O heterolysis Fe
V=O 48
[FeIII2(-O)(TPOEN)2]4+ *** 400 1000 26 104 2.9 30.3 O-O homolysis Fe
IV=O, mCPBO. 39
Free OH. radical 10 1000 1.0 1-2 2 2.0 OH. 22
Chapter 5
189
O2. Therfore catalytic systems employing H2O2 and/or O2 remain the benchmark for
exploitable study.
The final series of iron polypyridine complexes that have received detailed study
towards the catalytic H2O2 oxygenations on cyclohexane and adamantane are those
employing the family of tetradentate BPMEN and related ligands. The
[Fe(BPMEN)(CH3CN)2]2+/H2O2 catalytic system reported by Que et al6 and Britovsek26, 49, 50
is so far the most active and selective catalyst using H2O2 as the oxygen source. Britovsek et
al have carried out a detailed study of various BPMEN derivatives looking at the ligand
topology.26, 49, 50 These are summarized in figure 5.22. table 5.6 summarizes the results of
catalytic studies obtained with BPMEN and ligands L25 – L31.
Figure 5.22: BPMEN and related tetradentate ligands.26, 49, 50
The most active ligands were BPMEN itself, L29 and L30. Each of these systems satisfied the
criteria for O-O heterolysis to generate an active FeV=O catalyst when using 10 equivalents
of H2O2 and each was unique in exhibiting an A/K ratio of >4. However using the larger 100
fold excess of H2O2 the A/K ratio dropped in all cases to values <3 implying products
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deriving from homolytic O-O cleavage of the hydroperoxoiron(III) intermediate. Under all
conditions the systems exhibited KIE values in the range 2.5 – 4.5 with 3o/2o values of
between 10 and 16, each supportive of O-O bond breaking processes, and for BPMEN, L29
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Table 5.6: A Survey of H2O2 oxygenation on alkanes catalysed in CH3CN by the family of iron-BPMEN complexes
Conditions: Iron catalyst:H2O2:alkane = 1:10:1000 (cyclohexane) and 1:10:10 (adamantane). H2O2 added by syringe pump, air at 25oC, 25mins, total time 40 mins. av. of 2 runs.
Eff. - (cyclohexanol+cyclohexanone):H2O2/100 in the oxidation of cyclohexane. TN - mols oxidised products:mols cat. in the oxidation of cyclohexane.
A:K - cyclohexanol:cyclohexanone in the oxidation of cyclohexane. KIE -kinetic isotope effect of cyclohexanol formation in the oxidation of cyclohexane and cyclohexane-d12.
3°:2° - 1-adamantanol:(2-adamantanol+2-adamantanone) in the oxidation of adamantane taking into account of the correction for a number of C-H bonds in a group.
Catalyst eq.H2O2 eq. C 6H10 Eff. TN. A:K KIE 3°:2° cleavage process oxidising species Ref.
[Fe(BPMEN)(CH3CN)2]2+ 10 1000 65 6.5 9.5 2.5 – 4.5 10-16 O-O heterolysis FeV=O 16, 51
[Fe(BPMEN)(CH3CN)2]2+ f 100 1000 48 48 2.5 “ “ O-O homolysis FeIV=O, OH. 16, 27
[Fe(L25)(CH3CN)2]2+ 10 1000 62 6.2 2.4 “ “ O-O homolysis FeIV=O, OH. 52
[Fe(L25)(CH3CN)2]2+ f 100 1000 23 23 2.2 “ “ O-O homolysis FeIV=O, OH. 52
[Fe(L26)(CH3CN)2]2+ 10 1000 18 1.8 1.2 “ “ Fe-O homolysis OH. 50
[Fe(L26)(CH3CN)2]2+ f 100 1000 6 6 2.3 “ “ O-O homolysis FeIV=O, OH. 50
[Fe(L27)(CH3CN)2]2+ 10 1000 42 4.2 1.4 “ “ Fe-O homolysis OH. 50
[Fe(L27)(CH3CN)2]2+ f 100 1000 6 6 1.4 “ “ Fe-O homolysis OH. 50
[Fe(L28)(CH3CN)2]2+ 10 1000 n r n r n r “ “ - - 50
[Fe(L28)(CH3CN)2]2+ f 100 1000 0.9 0.9 1.1 “ “ Fe-O homolysis OH. 50
[Fe(L29)(CH3CN)2]2+ 10 1000 51 5.1 5.0 “ “ O-O heterolysis FeV=O 49
[Fe(L29)(CH3CN)2]2+ f 100 1000 30 30 2.3 “ “ O-O homolysis FeIV=O, OH. 49
[Fe(L30)(CH3CN)2]2+ 10 1000 49 4.9 4.4 “ “ O-O heterolysis FeV=O 49
[Fe(L30)(CH3CN)2]2+ f 100 1000 15 15 2.9 “ “ O-O homolysis FeIV=O, OH. 49
[Fe(L31)(CH3CN)2]2+ 10 1000 34 3.4 2.1 “ “ O-O homolysis FeIV=O, OH. 49
[Fe(L31)(CH3CN)2]2+ f 100 1000 9 9 1.8 “ “ Fe-O homolysis OH. 49
Simple Fe salts
[Fe(CH3CN)4]2+ 10 1000 10 1 1.0 1.8 - Fe-O homolysis OH.
30
Fe(ClO4)3 10 1000 37 3.7 1.9 1.5 3.3 Fe-O homolysis OH. 31
Free OH. radical 10 1000 1.0 1-2 2 2.0 OH. 22
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and L30 evidence of heterolytic O-O cleavage when using 10 equivalents of H2O2. Those
ligands showing the poorest activity and selectivity to alcohol were L27 and L28 with A/K
ratios close to unity which for L27 was even apparent when using 10 equivalents of H2O2.
5.2.3.4 Conclusions on the activity of the catalysts; [Fe(L)(CH3CN)x]2+ (L = L11,15,16,21,22
and L24) On basis of the A/K ratios it is concluded that none of the iron(II) complexes of
L11,15,16,21,22 and L24 are particularly effective in catalysing cyclohexane oxygenation by H2O2
certainly when compared to the established literature systems; [Fe(TPA)(CH3CN)2]2+ and
Fe(BPMEN)(CH3CN)2]2+. Even so within the reactivity patterns seen the 6-n-hexylurea-
substituted TPA complexes; [Fe(L21)(CH3CN)2]2+ and [Fe(L22)(CH3CN)2]2+ are slightly more
active (A/K = 2.1 – 3.3; 100 equivalents of H2O2) compared to the alkyl-ether linked 6-py
TPA derivative complexes; [Fe(L15)(CH3CN)2]2+ (CH3OCH2-substituent) and
[Fe(L16)(CH3CN)2]2+ (C8H15OCH2-substituent (A/K = 0.8 – 1.6) although
[Fe(L15)(CH3CN)2]2+ showed the highest efficiency (6.4% based on H2O2 at 10 equivalents).
The bis-6-n-hexylurea-substituted TPA complex [Fe(L22)(CH3CN)2]2+ exhibited the highest
A/K of all the complexes studied (3.3). However the most active catalyst based on a balance
between efficiency, turnover and A/K ratio was that using the 6-Br3-TPA ligand;
[Fe(L24)(CH3CN)2]2+ . 6-Br3-TPA was only synthesised as a possible precursor to making 6-
(NH2)3-TPA (chapter 4) but it was decided to screen it nonetheless. Given the relative poor
reactivity of all of the complexes and their high spin nature (with the exception of the
peroxoiron(III) derivatives with L21 which are low spin) it would be premature to make
judgments on the virtue of L24. It could be proposed that the electron donating Br groups are
active in pushing e-density onto the O-O group of the bound peroxide so facilitating O-O
cleavage rather than Fe-O cleavage in the same way as seen on the introduction of e-donating
co-ligands on the iron like py+O-, acetate and RS-.53-55 However the principal reason for the
poor reactivity of [Fe(L)(CH3CN)x]2+ (L = L11,15,16,21,22 and L24) lies in the predominantly high
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spin nature of the iron(II) and resulting peroxoiron(III) complexes. This is believed to be as a
result of a weakening in the ligand field due to the steric effect of the 6-substituent. Que has
observed that the introduction of two or more 6-substituents on the py groups of TPA induces
a spin change of the iron complex from low spin for [Fe(TPA)(CH3CN)2]2+ and [Fe(6-
MeTPA)(CH3CN)2]2+ to high spin for [Fe(6-Me2TPA)(CH3CN)2]2+ and [Fe(6-Me3-
TPA)(CH3CN)2]2+.22 This is found to strongly influence the catalytic activity shown by the
complexes with the high spin complexes showing evidence of radical based processes (low
A/K ratios) whereas the low spin complexes exhibit evidence of a high valent iron-oxo based
oxidants (high A/K, KIE and 3o/2o ratios). However, provided the 6-substituent position on
the py ring is avoided so maintaining the low spin configuration, some positive (enhancing)
substituent effects have interestingly been observed, Table 5.2, in the catalysis of alkane
oxygenation by H2O2. Firstly, low spin [Fe(5-Me3TPA)(CH3CN)2]2+ and [Fe(3-
Me3TPA)(CH3CN)2]2+ show enhanced activity (A/K ratios of 9 and 14 respectively) compared
to that found for [Fe(TPA)(CH3CN)2]2+ itself (5) (the KIEs are fairly constant for all at
between 3.5 – 3.8 with 3o/2o values in the range 15-21. 10, 29 Furthermore [Fe(5-
Me3TPA)(CH3CN)2]2+ and [Fe(3-Me3TPA)(CH3CN)2]2+ are, if anything, slightly more
efficient (Eff 40% based on 10 equivalents H2O2) compared to [Fe(TPA)(CH3CN)2]2+ (37%).
Secondly, the single 6-Me-substituted low spin complex [Fe(6-MeTPA)(CH3CN)2]2+ exhibits
a higher 3o/2o ratio (30) for adamantane oxygenation compared to that found using
[Fe(TPA)(CH3CN)2]2+ (17).56
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5.3. Suggestions for further work
The focus of this project was to synthesize a number of 6-substituted peralkylated TPA ligand
derivatives aimed ultimately at enhancing the activity of their subsequent iron complexes
towards the 1-(terminal) oxygenation by H2O2 on linear n-alkanes as providing new catalytic
routes to valuable C-1 oxygenates. The focus was also on the incorporation of a urea spacer
group (ligands L21 and L22) in the hope that it might hydrogen-bond to bound OOH in the
hydroperoxoiron(III) precursor so facilitating heterolytic O-O cleavage (via facilitated OH-
dissociation) to generate the putative powerful oxo-iron oxidant LFeV=O encapsulated within
the hydrophobic channel. However the findings of the catalytic studies have shown that any
beneficial (enhancing) effect that might have arisen from the presence of the hydrogen –
bonding and the hydrophobic channel created via the 6-peralkylurea substituents was largely
outweighed by the shift to high spin peroxoiron(III) intermediates that cleave homolytically at
the Fe-O bond leading to OH radical based products. However as discussed above, studies
with iron complexes of certain methylated-TPA ligands have shown that, provided the 6-
substituent position on the py ring is avoided so maintaining the low spin configuration at the
iron, some positive (enhancing) substituent effects on the catalytic properties are observed,
table 5.2. Thus future work could shift to the utilisation of the 5-py position for attaching
enhancing peralkyl or supramolecular substituents to enhance selective substrate binding.
Molecular modelling shows that the 5-position could also be used to create a range of
potentially supramolecular iron-TPA derivatives such as those shown in figure 5.23 for
methane binding and activation towards oxygenation to methanol.
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Figure 5.23: Geometry optimised model of a hydroperoxoiron(III) complex of a putative 5-
py-substituted hydrophobic TPA-cryptophane based on an ether-attached cyclotriveratrylene
to promote methane binding and selective oxygenation (to methanol).
The promoting effect of acetate in enhancing the tendency towards heterolytic O-O
cleavage of the hydro(alkyl)peroxoiron(III) precursors also needs further study in order to
understand fully the effects. [Fe(TPA)(OAc)(H2O)]+ remains one of the most efficient and
active non-heme catalysts known, albeit towards mCPBA oxygenation of cycloalkanes, so
further work in regard to catalysis of H2O2 and or O2 oxygenations by this and related
complexes is required.
Finally, studies to synthesise ligands that incorporate a carboxylate donor group into
the polypyridine ligand backbone are of interest. An attempt to synthesise one such ligand; a
derivative of BPMEN with a pendant carboxylate moiety, shown in figure 5.24, is described
in chapter 6 using a copper(II)-templating method.
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Figure 5.24: A putative carboxylate-pendent BPMPN ligand (see chapter 6)
5.4. Experimental section
GC analysis was carried out on Agilent 6890A chromatograph with HP-5 column (30 m x
0.25 mm, film thickness 0.25 µm) Toluene was used as a standard for quantitative analysis.
UV-vis spectra were recorded at 25 ºC in acetonitrile solution on a Perkin-Elmer Lambda 2
spectrometer. EPR experiments were recorded on Bruker EMX 10/12 spectrometer operating
at 9.5 GHz with 100 kHz modulation. The sample was transferred to a quartz EPR tube,
(12cm length x 0.4cm i.d.) which was then immersed in a Dewar of liquid nitrogen, and
transferred to a cooled sample holder within the EPR spectrometer whose cavity was
maintained at 110 K
5.4.1 Materials
Reagents and solvents used were of commercially available reagent quality unless otherwise
stated. Deoxygenation of solvents was effected by bubbling N2 directly through the solutions.
Preparation and handling of air-sensitive materials were performed under an inert atmosphere
of Argon in a glove box. The synthesis of [Fe(SO3CF3)2(CH3CN)2] was described in chapter
3.
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5.4.2 Characterisation of peroxoiron(III) complexes by X-band EPR
The reaction intermediates were obtained by adding tBuOOH or H2O2 to samples of the
iron(II)(L) (L = L2-L5) complexes prepared in situ from the ligand and
[Fe(SO3CF3)2(CH3CN)2]. The CH3CN solutions of the iron(II) complexes were prepared as
follows:
5.4.2.1 [Fe(L15)(CH3CN)x](O3SCF3)2:
A solution of L15 (0.025 g, 0.0349 mmol) in CD3CN (3.5 cm3) was added to a pale yellow
solution of [Fe(SO3CF3)2(CH3CN)2] (0.01522 g, 0.0349 mmol) in CD3CN (3.5 cm3) under N2
atmosphere to yield a reddish-orange solution. The final stock solution concentration was 5 x
10-3 mol dm-3. For each EPR experiment a 0.3 cm3 aliquot was transferred to the quartz EPR
sample tube.
5.4.2.2 [Fe(L16)(CH3CN)x](O3SCF3)2:
A solution of L16 (0.0147 g, 0.0349 mmol) in CD3CN (3.5 cm3) was added to a pale yellow
solution of [Fe(SO3CF3)2(CH3CN)2] (0.01522 g, 0.0349 mmol) in CD3CN (3.5 cm3) under
N2 atmosphere to yield a reddish-orange solution. The final stock solution concentration was 5
x 10-3 mol dm-3. For each EPR experiment a 0.3 cm3 aliquot was transferred to the quartz EPR
sample tube.
5.4.2.3 [Fe(L21)(CH3CN)x](O3SCF3)2: A solution of L21 (0.0043g, 0.01 mmol) in CD3CN (2
cm3) was added to a pale yellow solution of [Fe(SO3CF3)2(CH3CN)2] (0.0044 g, 0.01 mmol)
in CD3CN (2 cm3) under N2 atmosphere to yield a reddish-orange solution. The final stock
solution concentration was 2.5 x 10-3 mol dm-3. For each EPR experiment a 0.3 cm3 aliquot
was transferred to the quartz EPR sample tube.
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5.4.2.4 [Fe(L22)(CH3CN)x](O3SCF3)2:
A solution of L22 (0.0057g, 0.01 mmol) in CD3CN (2 cm3) was added to a pale yellow
solution of [Fe(SO3CF3)2(CH3CN)2] (0.0044 g, 0.01 mmol) in CD3CN (2 cm3) under N2
atmosphere to yield a reddish-orange solution. The final stock solution concentration was 2.5
x 10-3 mol dm-3. For each EPR experiment a 0.3 cm3 aliquot was transferred to the quartz EPR
sample tube.
5.4.3 Time-resolved UV-VIS spectrophotometric studies of the reactions of
[Fe(L)(CH3CN)x]2+ species with H2O2 and tBuOOH in CH3CN solvent at 25oC
5. 4.3.1 Reaction of [Fe(L21)(CH3CN)x]2+ with H2O2.
A solution of L21 (0.0043g, 0.01 mmol) in CD3CN (2 cm3) was added to a pale yellow
solution of [Fe(SO3CF3)2(CH3CN)2] (0.0044 g, 0.01 mmol) in CD3CN (2 cm3) under N2
atmosphere to yield a reddish-orange solution. The final stock solution concentration was 2.5
x 10-3 mol dm-3. For each UV/Vis experiment a 1 cm3 aliquot was transferred to the quartz
UV/Vis cubette and 100 fold excess of H2O2 at 25oC
5. 4.3.2. Reaction of [Fe(L21)(CH3CN)x]2+ with tBuOOH.
A solution of L21 (0.0043g, 0.01 mmol) in CD3CN (2 cm3) was added to a pale yellow
solution of [Fe(SO3CF3)2(CH3CN)2] (0.0044 g, 0.01 mmol) in CD3CN (2 cm3) under N2
atmosphere to yield a reddish-orange solution. The final stock solution concentration was 2.5
x 10-3 mol dm-3. For each UV/Vis experiment a 1 cm3 aliquot was transferred to the quartz
UV/Vis cubette and 100 fold excess of tBuOOH at 25oC
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5. 4.3.3 Reaction of [Fe(L22)(CH3CN)x]2+ with 18 fold excess tBuOOH.
A solution of L22 (0.0043g, 0.0078 mmol) in CD3CN (5 cm3) was added to a pale yellow
solution of [Fe(SO3CF3)2(CH3CN)2] (0.0034 g, 0.0078 mmol) in CD3CN (5 cm3) under N2
atmosphere to yield a reddish-orange solution. The final stock solution concentration was 7 x
10-4 mol dm-3. For each UV/Vis experiment a 1 cm3 aliquot was transferred to the quartz
UV/Vis cubette and 18 fold excess of tBuOOH at 25oC
5. 4.3.4 Reaction of [Fe(L22)(CH3CN)x]2+ with 350 fold excess tBuOOH.
A solution of L22 (0.0043g, 0.0078 mmol) in CD3CN (5 cm3) was added to a pale yellow
solution of [Fe(SO3CF3)2(CH3CN)2] (0.0034 g, 0.0078 mmol) in CD3CN (5 cm3) under N2
atmosphere to yield a reddish-orange solution. The final stock solution concentration was 7 x
10-4 mol dm-3. For each UV/Vis experiment a 1 cm3 aliquot was transferred to the quartz
UV/Vis cubette and 350 fold excess of tBuOOH at 25oC.
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Chapter Six
Synthesis of some new ligands for low temperature bleaching applications
6.1. Attempted synthesis of N,N’-bis(pyridylmethyl)-1,3-diamino propane-
2-carboxylic acid, (L25) and crystallographic characterization of 1, 3-
diaminopropane-2-carboxylic acid. 2HCl.
6.1.1. Introduction
The search for better and more effective low temperature metal based oxidation (bleaching)
catalysts continues to be very important for the viewpoint of reducing energy costs in the use
of domestic and industrial detergents.1 As outlined in chapter 1, a range of biomimetic iron
complexes of ligand containing pyridines and tetracoordinated amines have been investigated
for their ability to catalyse the efficient catalytic air oxidation of various organic substrates.
Popular target substrates for benchmark studies of catalytic activity have been cyclic
hydrocarbons such cyclohexane or adamantane which are oxidised to the corresponding
alcohol or ketone under ambient conditions.2-4 Iron complexes showing some of the highest
activity so far seen include those of the ligands containing; TPA (tris(pyridylmethyl)amine)
and BPMEN (N,N'-dimethyl-N,N'-bis(2-pyridylmethyl)ethane-1,2-diamine). Moreover the
high relative yields of alcohol versus ketone (cycloalkanes)5 and the stereoselective
epoxidation6 and cis-dihydroxylation7, 8 of alkenes by H2O2 observed using
[FeII(BPMEN)(CH3CN)2]2+ and [FeII(TPA)(CH3CN)2]2+ provided strong evidence for the
participation of a high-valent iron-oxo species.9 Since complexes of BPMEN show the highest
activity there is continuing interest in the studying the behaviour of metal complexes with
related ligands of similar structure in the hope of discovering even higher activity. Here the
attempted synthesis of a BPMEN analogue; N,N’-bis(pyridylmethyl)-1,3-diaminopropane-2-
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carboxylic acid, L25 is reported. L25 shares common structural features with BPMEN; e.g. two
pyridyl and two amino nitrogens but has an additional pendent carboxylate group, see figure
6.1. The availability of a additional carboxylate donor group in BPMEN-type ligands is of
interest since Que and co-workers have shown that acetate/acetic acid enhances alkene
epoxidation activity by both [FeII(BPMEN)(CH3CN)2]2+ and [FeII(TPA)(CH3CN)2]2+
attributed to significant accessing of the formally perferryl FeV=O state. This highly oxidising
metal-based oxo species is also believed to be responsible for preferential alcohol product
formation (versus ketone formation) in catalytic oxidation reactions on cycloalkanes.10
Figure 6.1: Schematic representation of L25 and BPMEN.
The synthesis of L25 derives from the reported template synthesis of N,N’-bis(2-
pyridylmethylene)-1,3-diamino-2,2-dicarboxyethyl propane, L26, in the form of its copper
complex [Cu(L26)(H2O)](ClO4)2, see figure 6.6.11 Decarboxylation of [Cu(L26)](ClO4)2 with
base followed by demetallation via reduction with zinc powder/HClaq to give L25 was
however unreported despite being similar to the method used to make a number of
carboxylated polyamine and macrocyclic amine ligands.12-18 These reactions offer the
convenient synthetic routes to a range of macrocyclic and open chain polychelate metal
complexes, many of which can not be synthesised easily by others methods, the template
effect may arise from the stereochemistry imposed by metal ion coordination of some of the
reactants, promoting a series of controlled steps.19-21 A wide variety of template reactions
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involving metal-promoted condensation of primary amine functionalities with formaldehyde
and either nitrogen or carbon acid in the presence of a base has been reported.12, 18, 22, 23Among
the variety of metal centred templates that have been used in these reactions, the most
common ones are Ni(II) and Cu(II), although other more recent examples use a “bisaminal
route”,15 where no metal is required. These reactions can be designed to incorporate additional
pendant donors, such as those from primary amino24, 25 and carboxylate12, 24, 26 functionalities,
into the resulting ligand systems.
In 1985 Comba et al reported the structural characterisation of N,N’-bis(2-pyridyl
methyl)-1,3-diamino-2-methyl-2-nitropropanecopper(II) perchlorate; [Cu(L27)]2+ below,
figure 6.2, via the reaction of copper(II) nitrate trihydrate in methanol with 2-aminomethyl
pyridine, formaldehyde and nitroethane in the presence of ethanolamine as a non-coordinating
base.13
[Cu(L26)]2+ [Cu(L27)]2+
Figure 6.2: Schematic representation of [Cu(L26)]2+ and [Cu(L27)]2+
Later Lawrance et al 24, 27, 28 reported preliminary details of the synthesis of [Cu(L26)]2+ via the
corresponding reaction using diethylmalonate as the carboxylic acid in the presence of
ethanolamine. The crystal structure of [Cu(L26)(H2O)](ClO4)2.H2O; L26 = N,N’-bis (2-
pyridylmethylene)-1,3-diamino-2,2-dicarboxylethylpropane, was reported in 2002 by our
group revealing a penta-coordinated copper(II) centre, in a distorted square-pyramidal
geometry with a weakly bonded axial water molecule.11 The behaviour of the complex in acid
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media has been studied by kinetics as a function of [H+].11 The study showed that
[Cu(L26)(H2O)]2+ rapidly decomposes via protonation of L10 to give back a mixture of
[Cu(pyCH2NH2)2]2+, diethylmalonate and formaldehyde. Base hydrolysis to give L25 however
looked more promising. Base-promoted decarboxylation of related copper(II) macrocyclic
complexes such as [Cu(dimest)]2+ (L28, dimest = trans-6,13-bis(methoxycarbonyl)-1,4,8,11-
tetraazacyclotetradecane), figure 6.3, deriving from condensations of [Cu(en)2]2+ (en =
ethane-1,2-diamine) with diethylmalonate yield the macrocyclic amino acid trans-1,4,8,11-
tetraazacyclotetradecane-6,13-dicarboxylic acid (diacH2),26 followed by Zn/HCl demetallation
has successfully afforded a number of chelating amine ligands with single pendant
carboxylates.24, 27, 29
Figure 6.3: Base-promoted decarboxylation of the copper(II) macrocyclic complex
[Cu(dimest)]2+ to yield ligand diacH2
Therefore it was conceivable that the same base-catalysed decarboxylation/demetallation
could be carried out on [Cu(L26)(H2O)] (ClO4)2.H2O as a route to putative L25. However,
when the demetallation of [Cu(L25)](ClO4) was attempted using zinc powder and aqueous
hydrochloric acid to release free L25 the only product isolated was a hydrolysis product of L25,
the new amino acid; 1,3-diaminopropane-2-carboxylic acid isolated as its hydrochloride salt.
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6.1.2. Results and Discussion
6.1.2.1 Synthesis of N,N’-bis(2-pyridylmethyl)-1,3-diaminopropane-2-carboxylato
copper(II) perchlorate; [Cu(L25)](ClO4).
Using the method described by Lawrance et al27, figure 6.4, the pH of a solution of
[Cu(L26)](H2O)](ClO4)2 in water was raised to 10 with the addition of aqueous NaOH and
stirred at ca. 70°C for 12 h. The solution was then evaporated to dryness to give a green
powder, the IR spectrum of which showed the expected band for a coordinated carboxylate
group at 1644 cm-1, figure 6.6.27 Comparison with the corresponding spectrum for
[Cu(L26)(H2O)](ClO4)2.H2O, figure 6.5, shows that the decarboxylation step had been
achieved successfully. It was decided at this stage however not to isolate and further
characterise [Cu(L25)]2+ but to proceed on with the demetallation step below.
N NH2
Cu(NO3)2
N NH
N NH
Cu2
Figure 6.4: Schematic representation of the synthetic route to [Cu(L25)]2+
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Figure 6.5: IR spectrum of the green solid obtained following treatment of
[Cu(L25)](H2O)](ClO4)2 with aqueous NaOH.
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Figure 6.6: IR spectrum of [Cu(L26)](H2O)](ClO4)2.
The crystallographic characterisation of 1,3-diaminopropane-2-carboxylic acid is reported
below. The mechanism for the hydrolysis of L8 during the zinc/HCl demetallation step is
discussed below along with suggestions of possible future alternative routes to the synthesis
of L25 and its analogues.
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6.1.2.2 The attempted synthesis of N,N’-bis(2-pyridylmethyl)-1,3-diaminopropane-2-
carboxylic acid, L25.
Using the method reported by Lawrance et al 27 a solution of the green solid above and a
solution of hydrochloric acid were added dropwise from different dropping funnels into a
flask containing zinc powder over a 1 h period. The solution was stirred for a further 0.5 h at
60°C and then filtered to remove metallic copper and any remaining zinc powder. The
solution was then diluted with water and loaded onto a 5 cm x 40 cm column of Dowex 50W
X2 cation-exchange resin (H+ form). The column was washed with 1.0 mol dm-3 HCl to
remove Zn2+ ions until no further evidence was found (i.e. failure to give a white precipitate
(zinc hydroxide) on the addition of base). The desired amino acid ligand product was then
eluted with 3.0 mol dm-3 HCl, testing fractions obtained for the presence of free L25 via the
development of a green colour on the addition of a base to neutrality and then aqueous Cu2+,
see figure 6.7.
Figure 6.7: Synthetic route to obtain to obtain free L25 from its Cu2+ complex
Each fraction believed to contain L25.4HCl was then evaporated to dryness. The residue was
then taken up in water and reloaded onto the cation-exchange column charged again in its H+
form. This time elution was carried out with different concentrations of hydrochloric acid;
0.5, 1.0 and 1.5 mol dm-3. In each case the fractions were evaporated to dryness and the 1H
and 13C NMR spectra recorded in D2O. These are shown in figures 6.8 (for elution with 0.5
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mol dm-3 [H+]), figure 6.9 (1.0 mol dm-3) and figures 6.10 (1.5 mol dm-3). The 1H NMR of the
1.5 mol cm-3 eluate, figure 6.10, displays the expected resonances in the aliphatic
Figure 6.8: 1H NMR spectrum in D2O corresponding to the evaporated fraction eluted with
0.5 mol dm-3 HCl.
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Figure 6.9: 1H NMR spectrum in D2O corresponding to the evaporated fraction eluted with
1.0 mol dm-3 HCl.
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Figure 6.10: 1H NMR spectrum in D2O corresponding to the evaporated fraction eluted with
1.5 mol dm-3 HCl.
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Figure 6.11: DEPT 13C NMR spectrum in D2O corresponding to the evaporated fraction
eluted with 1.5 mol dm-3 HCl.
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and aromatic regions for the protons of L25. However closer analysis showed that the
integration did not fit. This became further apparent when the spectra from the earlier
fractions were analysed showing highly variable peak integrations even though resonances
appeared in the regions expected for L25. The 13C NMR spectra, figure 6.11, of the 1.5 mol
cm-3 eluant showed the presence of the carboxylate group (172 ppm) but no resonance for the
expected methylene. It was quickly concluded that ligand fragmentation must have occurred
during the Zn/HCl treatment to give aliphatic amine and pyridine moieties eluting as separate
species from the various acid treatments. Ultimately colourless crystals suitable for X ray
analysis were obtained from the 1.5 mol cm-3 fractions following slow evaporation in the air.
The X-ray structure corresponded not to L8 as suspected but to the aliphatic amino acid; 1,3-
diaminopropane-2-carboxylic acid.2HCl. The structure of this new amino acid, shown below
in figure 6.12, has not been described before, although interestingly traces of it have been
found in several meteorites,30 and its methyl ester has been described as an ntermediate in the
synthesis of tripeptides which are used as protein tyrosine phosphatase inhibitors.31
Figure 6.12: Molecular structure of 1,3-diaminopropane-2-carboxylic acid.2HCl.
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Table 6.1: Selected bond lengths (Å) and angles (°) for 1,3-diaminopropane-2-carboxylic
acid.2HCl.
___________________________________________________________________________
O(1)-C(1) 1.2088(16) C(3)-N(3) 1.5004(17)
C(1)-O(2) 1.3280(16) N(3)-H(3NA) 0.9798(11)
C(1)-C(2) 1.5255(18) C(4)-N(4) 1.4932(17)
O(2)-H(2O) 0.9798(11) N(4)-H(4NA) 0.9798(11)
O(1)-C(1)-O(2) 124.04(12) H(3NA)-N(3)-H(3NB) 106.3(15)
O(1)-C(1)-C(2) 123.11(11) C(3)-N(3)-H(3NC) 112.7(11)
O(2)-C(1)-C(2) 112.83(11) H(3NA)-N(3)-H(3NC) 107.4(15)
C(1)-O(2)-H(2O) 111.9(12) H(3NB)-N(3)-H(3NC) 105.9(15)
C(1)-C(2)-C(4) 111.56(10) N(4)-C(4)-C(2) 111.86(10)
C(1)-C(2)-C(3) 108.78(10) C(4)-N(4)-H(4NA) 108.4(12)
C(4)-C(2)-C(3) 114.99(11) C(4)-N(4)-H(4NC) 116.4(12)
N(3)-C(3)-C(2) 113.13(10)
Table 6.2: Hydrogen bond distances (A) and angles (°) for 1,3-diaminopropane-2-carboxylic
acid.2HCl. The hydrogen bond donor atoms are denoted as D and the acceptors as A
___________________________________________________________________________
D-H H...A D...A DHA
___________________________________________________________________________
O(2)-H(2O)...Cl(1)#1 0.9798(11) 1.981(3) 2.9543(11) 172.0(19)
N(3)-H(3NA)...Cl(1)#2 0.9798(11) 2.542(10) 3.3904(12) 144.8(14)
N(3)-H(3NA)...Cl(2)#3 0.9798(11) 2.592(15) 3.2028(13) 120.5(12)
N(3)-H(3NB)...Cl(1) 0.9798(11) 2.299(9) 3.1846(12) 149.9(14)
N(3)-H(3NB)...O(1)#4 0.9798(11) 2.525(16) 3.0055(15) 110.1(12)
N(3)-H(3NC)...Cl(2)#5 0.9798(11) 2.269(5) 3.2167(13) 162.4(14)
N(4)-H(4NA)...Cl(1)#6 0.9798(11) 2.293(9) 3.1888(13) 151.6(15)
N(4)-H(4NB)...Cl(2)#2 0.9799(11) 2.354(9) 3.2125(12) 145.9(13)
N(4)-H(4NB)...Cl(1)#3 0.9799(11) 2.885(14) 3.5030(13) 121.9(12)
N(4)-H(4NC)...Cl(2) 0.9798(11) 2.461(14) 3.2380(12) 135.9(15)
N(4)-H(4NC)...Cl(2)#3 0.9798(11) 2.701(17) 3.3554(13) 124.5(14)
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iSelected interatomic distances and bond angles are given in table 6.1, and hydrogen bonding
parameters appear in table 6.2. In the (3) the carboxyl group has hydrogen bonds with the
amine protons. The C=O and C-O(H) distances respectively are 1.209 and 1.328 Å. No
solvent inclusion occurred in structure.
6.1.3. Experimental
6.1.3.1. Materials:
All reagents/ solvents were of reagent grade quality unless specified. Sodium chloride,
sodium perchlorate and hydrochloric acid (all Aldrich AR grade) were used as supplied.
6.1.3.2. X-ray crystallography
Data were collected on a Rigaku AFC7S diffractometer using graphite monochromated Mo-
KA radiation (L= 0.71013 A). the data were corrected for Lorenz and polarisation effect.
Hydrogen atoms were inserted in calculated positions but not refined. No decay or absorption
corrections were applied.
6.1.3.3. Synthesis of N,N’-bis(2-pyridylmethyl)-1,3-diamino-2,2-dicarboxyethylpropane
copper(II) perchlorate, [Cu(L9)(H2O)](ClO4)2.
The synthesis of [Cu(L27)](ClO4)2 was carried out as reported by Richens et al.11 The
Copper(II) nitrate trihydrate (2.5g, 0.01 mols) was dissolved in methanol (380 cm³) and to this
solution was added 2-aminomethylpyridine (2.1 cm³, 0.02 mols). To the resultant bluish-
purple suspension of bis(2-aminomethylpyridine)-copper(II) nitrate was added
diethylmalonate (1.5 cm³, 0.012 mols), formaldehyde (2.5 cm³ 0.09 mols) and ethanolamine
(0.61 g, 0.6027 cm³, 4 mmol) in order and the mixture stirred at ~50 °C for 4 hours. After this
time water (170 cm³) was added, resulting in dissolution of the suspension, followed by
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further quantities of diethylmalonate (10 cm³, 0.06 mols) and formaldehyde (12.5 cm³, 0.45
mols) and the mixture stirred at 50 °C for a further 3 hours. The volume of solution was
reduced to 400 cm³ and cooled in ice bath during the addition of a saturated (3.5 mol/ cm³)
solution of sodium perchlorate (100 cm³). The resulting lilac coloured precipitate was
removed by filtration and the air dried, yield 3.34 g. Analysis showed that the title complex
was contaminated with 0.8 equivalent of sodium perchlorate. Recrystallisation from methanol
however yielded purple crystals of the title complex, yield 2.84 g (41.3 %). Analysis:
calculated for C21H28N4O12Cl2Cu, C 39.9, H 4.2, N 8.4%; found C 38.3, H 4.16, N 8.51%;
IR (cm-1) (KBr pellet) 3251s (υ NH), 1718 s(υ C=O, ester), 1105s, 624 (ClO4-); λ max (H2O)
594 nm (ε =125 M-1 cm-1).
6.1.3.4. Synthesis of N,N’-bis-(2-pyridylmethyl)-1,3-diaminopropane-2-carboxylato)
copper(II) perchorate, [Cu(L25)](ClO4).
Using a method based upon that used by Lawrence et al.27 The pH of a solution containing (2
g. 4.3 mmols of [Cu(L26)(H2O)](ClO4)2 was raised to ca. 10 with 2.5 mol dm-3 aqueous NaOH
and it was stirred at ca. 70°C for 12h. The green solution was evaporated to dryness in
vacuum to leave a green residue of [Cu(L25)](ClO4): IR (cm-1) (nujol) 2995s (υ NH), 1644 s (υ
C=O, carboxylate). The coordination of the carboxylate is confirmed by the low frequency
C=O shift; cf. 1720 (COOH) to ~1620 cm-1 (COO-).8
6.1.3.5. The attempted synthesis of N,N’bis(2-pyridylmethyl)-1,3-diaminopropane-2-
carboxylic acid, L25.
Following the method reported by Lawrence.27 The green solid obtained above was dissolved
in water and this solution along with hydrochloric acid (3 mol dm-3, 10 cm3) were added from
separated funnels dropwise over 1 h to a 100 cm3 flask containing zinc powder (1.5 g) while
stirring. The solution was stirred for a further 0.5 h. at 60° C, and then filtered to remove
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copper metal and any remaining zinc. The solution was diluted to 5 cm³ with water and then
absorbed onto a Dowex 50W X2 resin (H+ form, 2cm x 30cm). The column was washed with
1 mol dm-3 HCl until no further evidence of Zn2+ ions were detected (formation of zinc
hydroxide on addition of base) and then eluted successively with 1.5, 2.0 and 3.0 mol dm-3
HCl. The combined eluates were then taken to dryness on a rotary evaporator and dried in
vacuum. The residue was then dissolved in water and reloaded onto the column in the H+
form. It was eluted successively with 0.5, 1.0 and 1.5 mol dm-3 HCl solution and following
evaporation to dryness the fractions were analysed by 1H and 13C NMR in D2O. Crystals
suitable for X-ray crystallography were obtained from the 1.5 mol dm-3 HCl fraction via slow
air evaporation.
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6.1.4. Conclusions:
Structural characterisation of the new amino acid 1,3-diaminopropane-2-carboxylic acid.2HCl
has been reported. This species was obtained as a consequence of our attempted synthesis of
the free BPMEN ligand analogue; N,N’-bis(2-pyridylmethyl)-1,3-diaminopropane-2-
carboxylic acid, L25, via Zn/HCl demetallation of its Cu(II) complex. The first step,
decarboxylation of the gem diester amine complex [Cu(L26)(H2O)](ClO4)2 was carried out
successfully. However ligand fragmentation is believed to have occurred during the final
treatment of [Cu(L26)](ClO4) with Zn/HCl in the attempt to remove the Cu(II) ions via
reduction to copper metal. This step has been carried out successfully in the case of related
aliphatic polyamine ligands.27 However it is believed that the acute sensitivity of L26 to acid
stems from the electrophilic reactivity of the benzylic methylene groups adjacent to the
pyridine upon protonation of the secondary amine groups, figure 6.13 below. A mixture of 2-
hydroxymethylpyridine and 2-picoline is suspected as responsible for the pyridine resonances
seen in the fractions eluted along with and contaminating samples of the crystals of 1,3-
diaminopropane-2-carboxylic acid.2HCl.
Figure 6.13: Mechanistic scheme for the acid catalysed hydrolysis of L25 to 1,3-
diaminopropane-2-carboxylic acid.
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A number of alternative synthetic routes to L25 or close analogues of it are proposed below
based on the reaction of 3,3’-dichloropivalic acid with 1,2 diaminoethane, figure 6.14,
according to the method of Bernhardt et al.16
Figure 6.14: A possible synthetic route to the synthesis of analogues of L25 using 3,3’-
dichloropivalic acid.
A similar alternative route could use a 3,3’-dichloropivalic acid derivative 3-bromo-2-
(bromomethyl) propanoic acid reacting with 2-aminomethylpyridine. In the first example, 2,
figure 6.15, the pendant carboxylate is not found to coordinate when using copper(II) as the
metal centre. This was explained by the greater rigidity imposed by the adjacent methyl
group.16 However this may be overcome by using 3-bromo-2-(bromomethyl)propanoic acid.
Finally another possible alternative involves starting from methyl 3-bromo-2-
(bromomethyl)propanoate, transforming it to methyl 3-amino-2-(aminomethyl)propanoate31
and then reacting with pyridine-2-carbaldehyde.32
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6.2. Convenient ‘One-Pot’ Synthesis of the Benzene-1,3,5-Tricarboxamide
of L-Histidine Methyl ester L28
6.2.1. Introduction:
The imidazole group of l-histidine is a commonly found binding ligand for metal centres in a
variety of metalloproteins and enzymes. As many as four imidazole N donors have been
found coordinated to one metal centre, an example being the copper(II) site of the bovine
form of superoxide dismutase.33-35 Many more examples have three histidine imidazole
groups attached to the metal; these include zinc(II) in human carbonic anhydrase36, 37 and in
the T and R states of 2-Zn-insulin hexamer,38-40 iron(III) in soybean lipoxygenase-141,
iron(II),(III) in marine hemyrithrin,42 Cu(I),(II) in arthropoda and mollusca hemocyanin43, 44
and bacterial tyrosinase45, 46, the type 2 copper(II) site of the blue oxidases; laccase47,
ascorbate oxidase48, 49, ceruloplasmin47 and amine oxidase50, the CuB site of cytochrome
oxidase51, the copper site of nitrite reductase52 and iron and manganese superoxide
dismutase.53, 54 Despite the importance of histidine imidazole coordination there are few, if
any, examples of coordinating ligands that containing two or more histidine imidazole
moieties; most biomimetic studies preferring over the years to simulate imidazole
coordination using other N-heterocycles such as pyrazole, pyrazine, pyridine and
benzimidazole. Even more surprising are the few reported examples of single molecule
ligands containing three or more imidazole groups. A few recent examples of tripodal
imidazole-containing ligands are the Schiff-base condensation products of 1-phenyl(methyl)-
2-imidazolecarboxaldehyde55, 56 and 4-methyl-5-imidazole carboxaldehyde 57-59 with tris(2-
aminoethyl)amine (tren), and tris(3-aminopropyl)amine (trpn), L29 and L30, figure 6.15, and
the reduced Schiff-base condensation product of histamine with two equivalents of 4-methyl-
5-imidazolecarboxaldehyde, L31.60 Reaction of bis(imidazol-2-yl)nitromethane with histamine
gives the tripodal ligand L32.61
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Figure 6.15: Schematic representation of tripodal imidazole ligands L29- L32
The hexaimidazole ligand L33 has been obtained via dual metallation (potassium
diisopropylamide) at C5 of the N-protected imidazoles in 1,3-bis(2-imidazolyl)benzene,
Geometry optimised structure followed by condensation with bis(N-methylimidazolyl)ketone,
methylation of the resulting diol and deprotection,62 see figure 6.16.
HN
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N MeN
NN NMeMeN N
Figure 6.16: Schematic representation of L33
Binuclear copper(II) complexes containing L3261 and L3363 have been structurally
characterised in efforts to model the type 3 binuclear copper site of hemocyanin. Fewer, if
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any, examples of such ligands deriving from L-histidine moieties themselves have been
reported.64 The benzene-1,3,5-tricarbonyl moiety has been recently used to prepare synthetic
tripodal dentritic analogues for iron-binding siderophores65, 66 as well as an expanding range
of dentritic carboxamides with various peptides some of which have interesting globular
structures.67 68
Here the successful one pot synthesis of the benzene-1,3,5-tricarboxamide of l-
histidine methyl ester is reported in a pure state in 37% yield. A preliminary investigation of
its copper coordination chemistry is also described.
6.2.2. Results and Discussion:
6.2.2.1 Synthesis of L28.
Initial attempts at synthesizing L28 involved liberation of the free base of l-histidine methyl
ester from the dihydrochloride using sodium methoxide in methanol followed by reaction
with the acid chloride. However the difficulty of completely removing methanol from the free
base solutions led to competing methanolysis and isolation of mixed carboxamide/
carboxymethyl ester products. Karle et al recently reported reaction of 2,2-
dithiodibenzoylchloride with l-histidine methyl ester dihydrochloride producing the required
carboxamide in 56% yield using dichloromethane as solvent and triethylamine as base.67 We
have adapted this procedure herein to report the successful ‘one pot’ synthesis of the benzene-
1,3,5-tricarboxamide of l-histidine methyl ester L28 from benzene-1,3,5-tricarbonyl chloride,
l-histidine methyl ester dihydrochloride and an excess of dry triethylamine in dry
dichloromethane, figure. 6.17.
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Figure 6.17: Synthetic pathway for L28.
After stirring the above mixture for 48 hours at RT it was transferred to a separating funnel
and washed with three 20cm3 portions of aqueous NaHCO3 and water, before separating the
dichloromethane layer and drying over anhydrous MgSO4. Based on the reported amide
coupling reaction of l-histidine methyl ester free base with 2,2-dithiodibenzoylchloride26 the
dichloromethane layer was expected to contain the carboxamide product but in this case
following gentle water pump evaporation only a small amount of unreacted triethylamine was
found (1H NMR). A colourless sticky solid was, however, observed to have deposited on the
walls of the separating funnel following the aqueous washings. This solid subsequently
dissolved in methanol which, upon evaporation and drying at the vacuum pump, yielded
0.93g.
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Figure 6.18: 1H NMR spectrum of L28 in d6-DMSO
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Figure 6.19: 13C DEPT NMR spectrum of L28 in d6-DMSO
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Figure 6.20: 1H COSY NMR spectrum of L28 in d6-DMSO shows coupling of the L-histidine
CH proton at 4.75ppm to the adjacent CH2 (3.05ppm) and amide NH (9.2ppm).
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of a white solid. A 1H NMR spectrum, figure 6.18, together with a 13C DEPT NMR, figure
6.19, from the dissolved solid in d6-DMSO together with a high resolution TOF-ES+ mass
spectrum and low resolution TOF-ES- of the white solid were consistent with the presence of
the pure benzene-1,3,5-tricarboxamide L28, yield 37%.27 The 1H and 13C NMR assignments
were confirmed in standard 2D 1H COSY and 1H-13C HNQC and HMBC NMR experiments.
The 1H COSY spectrum, figure 6.20, shows coupling of the L-histidine CH proton at 4.75ppm
to the adjacent CH2 (3.05ppm) and amide NH (9.2ppm). The somewhat disappointing yield
was offset by the convenience of the ‘one pot’ method and the purity of the isolated product.
Moreover the method readily lends itself to the synthesis of benzene-1,3,5-tricarboxamides of
a range of L-amino acid esters from their hydrochloride salts.
The coordination chemistry of L28 and its tricarboxylate anion analogue with Cu(II)
was investigated. Simple molecular modelling of putative derivatives with Cu(I) and Cu(II),
Figures 6.21 and 6.22 illustrate the huge potential of L28 as a fascinating biomimetic co-
ordinating ligand.
Figure 6.21: A geometry optimised structure for putative [CuI(L28)(NCCH3)]+
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Figure 6.22: A geometry optimised structure of [(L28)CuII(O2)CuII(L28)], a putative model
for oxyhemocyanin and oxytyrosinase.
6.2.2.2. Reaction of L28 with [CuI(CH3CN)4](ClO4).
The synthesis of [CuI(L28)(CH3CN)x]+ was carried out by mixing equimolecular amounts of
[CuI(CH3CN)4](ClO4) and L28 in dry CH3CN ar room temperature overnight. Immediately a
pale-bluish solid precipitated which was found to be insoluble in all solvents. A polynuclear
structure was concluded. Attempts to grow crystals suitable for X-ray analysis were not
successful due to the insolubility. Vahrenkamp et al have reported the synthesis of the
corresponding ethyl ester derivative L34,69 figure 6.23. Reaction between L34 and zinc(II) salts
was studied yielding similar insoluble precipitates under preparative conditions whose
composition could not be ascertained. Potentiometric titration experiments under more diluted
conditions resulted in formulation of the simplest species as L34ZnOH+, figure 6.23.69 This
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metal complex models the active site of the zinc enzyme carbonic anhydrase70 as well as a
large group of matrix metalloproteases.71, 72
Figure 6.23: Schematic representation of L34 and L34ZnOH+
6.2.3 Experimental:
6.2.3.1. Materials:
Benzene-1,3,5-tricarbonyl chloride, l-histidine methyl ester dihydrochloride, sodium
bicarbonate and methanol were used as supplied. Triethylamine and dichloromethane were
freshly distilled from calcium hydride under nitrogen prior to use. Distilled water was used for
all aqueous washings.
6.2.3.2. Synthesis of Benzene-1,3,5-Tricarboxamide of L-Histidine Methyl ester L28:
The experimental operations were performed under ambient conditions unless indicated.
Benzene-1,3,5-tricarbonyl chloride (1.032g, 3.88 mmol) in 50 cm3 of dry dichloromethane
was added dropwise to an ice-cooled and stirred mixture of the free base of l-histidine methyl
ester (generated in-situ by the addition of dry triethylamine (5.75 cm3, 41.04 mmol) to an ice
cooled and stirred suspension of the dihydrochloride (3.11 g, 12.33 mmol) in 120 cm3 of dry
dichloromethane). Since the reaction is highly exothermic, care was taken not to add the acid
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chloride all at once too quickly. The resulting creamy suspension was stirred under nitrogen
for 48 hours after which it was transferred to a standard 100 cm3 separating funnel. The
organic mixture was washed thoroughly with a cold saturated aqueous solution of sodium
bicarbonate (3 x 20 cm3), followed by distilled water (2 x 20 cm3). The organic phase was
then removed to a 50 cm3 conical flask leaving a colourless sticky solid on the walls of the
funnel. This solid was found to be extractable with methanol (3 x 30 cm3). Evaporation of the
methanol extract under vacuum (10-2 torr) gave L28 as a colourless solid, yield 0.93g (37%).
Mp 80.1°C.
FT-IR (nujol mull) (cm−1): 3400 (s, br, amide N-H), 3250 (s, br, imidaz N-H), 1738 (s, ester
C=O), 1654 (s, amide C=O), 1535 (s, amide N-H), 1460, 1376, 1217 (s, ester C-O).
1H NMR: (DMSO-d6), 300 MHz, 298 K, ppm from TMS): δ 11.87 (s, br, 3H, N-H imid); 9.20
(d, 3H, N-H amide); 8.40 (s, 3H, C6H3); 7.52 (s, 3H, 2-imidCH); 6.85 (s, 3H, 4-imidCH); 4.75
(q, 3H, CH); 3.75 (s, 9H, CO2CH3); 3.05 (d, 6H, CH2).
13C NOESY NMR: (DMSO-d6), MHz, 298K, ppm from TMS): δ 172.4 (CO2CH3); 165.8
(CONH); 135.3, (2-imid CH); 134.6 (imid quat), 130.8 (2,4,6-benz CH); 129.5 (4-imid CH),
53.7 (CHCH2), 52.3 (CHCH2); 39 (CO2CH3); not observable: 1,3,5-benz quat.
MS: LCTOF ES- 662.17 (M-H); TOF ES+ 664.27 (M+H), 686.24 (M+Na)
Single Mass Analysis for M+Na: found 686.2291 (calc for C30H33N9O9Na = 686.2299).
6.2.3.3. Synthesis of [Cu(CH3CN)4](ClO4).
Cu(ClO4)2.6H2O (2.925g, 7.865 mmol) was dissolved in a mixture of dry acetonitrile and dry
methanol (20-30 cm3) and reduced with an excess of copper powder electrochemically
prepared. The suspension was stirred for 30 min and then filtered via cannula, the clear
solution was transferred to another schlenk. A colourless solid was obtained after evaporation
of the solvent. Yield. 2.1 g (95.03 %).
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6.2.3.4. Reaction of L28 with [CuI(CH3CN)4](ClO4): attempted synthesis of [CuI(L28)
(CH3CN)](ClO4).
A solution of [CuI(CH3CN)4](ClO4) (0.1g, 0.36 mmol) and L28 (0.24g, 0.36 mmol) both in dry
CH3CN were mixed at room temperature under an N2 atmosphere and stirred overnight. A
pale-bluish solid precipitated immediately which was eventually isolated by filtration. The
solid failed to dissolve in any solvent and its composition was concluded to be polymeric.
Attempts to grow crystals of the complex suitable for X-ray analysis were not successful due
to insolubility.
6.2.4. Conclusions:
A novel biomimetic benzene 1,3,5, tricarboximide of l-histidine methyl ester L28 has been
obtained pure in 37% yield via a one pot reaction of benzene-1,3,5-tricarbonyl chloride with
three equivalents of free base l-histidine methyl ester generated in situ under anhydrous
conditions via the dihydrochloride salt and an excess of triethylamine. An attempt was made
to prepare a copper(I) complex of L8 under air-free conditions using [CuI(CH3CN)4](ClO4).
However the complex (presumed to be a copper(II) species from its bluish colour) could not
be fully characterised due to its insolubility in all solvents and it was concluded to consist of
an intractable polymeric species. This seems to be general phenomenon from the reaction of
divalent metal ions with tripodal amino acid ligands of this type and it is wondered whether
spontaneous hydrolysis of the ester groups takes place upon metal ion coordination (bearing
in mind the excellent Lewis acid properties of Zn(II) and Cu(II)) giving a multidentate ligand
system that favours polynuclear complexation. Further work will be required to confirm.
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